Cre-loxP mediated genoinic targeting to develop rapid and reproducible expression of recombinant proteins in mammalian cells. by Kwabi-Addo, Bernard
Cre-loxP mediated genoinic targeting to develop 
rapid and reproducible expression of 
recombinant proteins in mammalian cells. 
Bernard Kwabi-Addo (M. Sc. ) 
A thesis presented for the degree of Doctor of Philosophy at (QMW) 
University of London, 1997. 
Abstract 
Expression levels of transgenes in mammalian cells show extreme variability 
between individual clones isolated from a single transfection. This is due to differing 
number of copies integrated into the genome and also from chromosomal "position 
effects". Therefore extensive screening is required to isolate a suitable cell line for high 
level expression of a recombinant protein. 
In this work, the Cre-loxP site-specific recombination system was investigated 
to eliminate such problems by directing the rapid targeting of any input DNA to a 
single pre-selected site in Chinese hamster ovary (CHO) cell line. Cre is a 38 kDa 
recombinase encoded by the bacteriophage P1 which mediates recombination between 
a pair of specific 34 bp target sequences called loxP sites. 
The recombination reaction was first investigated in vitro to establish which 
kinetic parameters could be relevant for efficient gene targeting: a recombinant 
baculovirus was constructed with a hexa-histidine-cre fusion gene. The activity of Cre 
protein purified (by single step, hexa-histidine/nickel-binding, affinity chromatography) 
from infected insect cells was verified by: (i) Cre-loxP interaction in gel retardation 
assays and (ii) Cre-mediated intramolecular excision between two loxP sites flanking a 
lacZ gene in a plasmid DNA. 
To investigate Cre-mediated targeting of an exogenous DNA to a 
chromosomal loxP site, three CHO cell lines were constructed, each carrying a loxP 
site between a ß-actin promoter and a secreted alkaline phosphatase (SAP) gene as a 
reporter. To demonstrate the targeting event, a promoterless lacZ/neor gene was co- 
transfected with either a cre plasmid or the purified Cre protein from the 
baculovirus/insect system. Proper targeting should activate expression of f 3- 
galactosidase from the chromosomal 0-actin promoter and give loss or reduction of 
SAP expression in G418 resistant transformants. Southern blot analysis showed 
targeted events mediated by both cre plasmid and recombinant Cre protein. 
This work should allow the development of a generic mammalian cell line by 
incorporating the Cre-loxP system for rapid and reproducible large scale production of 
recombinant proteins. 
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CHAPTER I 
INTRODUCTION 
The advent of recombinant DNA technology in the early 1970s has completely 
revolutionised cell biology. This technology comprises a mixture of techniques, which 
includes the specific cleavage of DNA by restriction endonucleases which greatly 
facilitates the isolation and manipulation of individual genes, the cloning of a specific 
DNA fragment into a self-replicating genetic element (plasmid or virus vector) which 
is maintained in bacteria so that a single DNA molecule can be reproduced to generate 
many billions of identical copies, and also genetic engineering, by which DNA 
sequences are altered to make modified versions of genes, which are then re- 
introduced back into cells or organisms. 
One of the most important contributions of DNA cloning and genetic engineering to 
cell biology is that they have made it possible to manufacture any of a cell's proteins 
in large quantities. Traditionally, proteins were purified from cell extracts, on the 
assumption that enough of the protein is made in the cell for it to be isolated in the 
first place. However, many key cellular proteins are made transiently and at very low 
levels e. g., proteins involved in cell division, lymphokines etc. In principle 
recombinant DNA technology can be used to produce any protein in large quantities. 
This is done by first cloning the gene for the protein of interest and then inserting it 
into a special plasmid called an expression vector. The vector is designed in such a 
way that when it is introduced into an appropriate type of "expression system" 
(described below), the inserted gene directs the synthesis of very large amounts of the 
appropriate protein. The impact of this goes far beyond understanding cellular 
processes, many proteins of commercial value as pharmaceuticals (e. g., human growth 
hormone, interferon [IFN-a], interleukin-2) which would otherwise be very expensive 
to purify are now easily obtained using recombinant DNA technology. 
There is a wide variety of biological expression systems which spans bacteria, yeast, 
plants, baculoviral/insect (described more fully in chapter 3) and mammalian cells for 
17 
the expression of recombinant proteins. A summary of the advantages and 
disadvantages of each host system is described in the table below. 
Organism Advantages Disadvantages 
Escherichia coli (i) easy to manipulate (i) does not usually 
(ii) promoters and gene 
regulation well understood 
Saccharomyces cerevisiae 
Baculovirus/Insect 
Mammalian cells 
(iii) many high expression 
vectors are available 
(iv) easy to culture on large 
scale (e. g. use in 
manufacture of insulin, 
interferon and 
human somatotrophin). 
(i) widely used industrial 
organism which is easy to 
culture 
(ii) glycosylates proteins 
(iii) can get export into 
growth medium of 
heterologous proteins 
(iv) high-level expression 
systems developed. 
(i) widely used industrial 
organism which is easy 
to culture 
(ii) can export proteins 
into growth medium 
(iii) good expression levels 
(i) get export of proteins 
(ii) get post-translational 
modifications and products 
which are not likely to be 
immunogenic to humans 
(iii) good expression 
systems available 
secrete proteins into 
growth medium 
(ii) ovcrexpression of 
foreign proteins often 
form aggregates of 
denatured proteins 
(iii) many foreign proteins 
rapidly degraded 
(iv) many post- 
translational 
modifications do not 
occur. 
(i) a lot still to be learned 
about control of gene 
expression 
(ii) post-translational 
modifications arc not 
necessarily the same as 
those in animal cell 
(iii) heterologous proteins 
can form inclusion bodies 
(i) only suitable for 
transient expression 
(i) largc-scalc growth of 
animal cells is costly 
(ii) great care is needed to 
avoid contamination of 
culturc. 
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The principal advantage of mammalian cells which has made it the preferred choice 
for heterologous expression of eukaryotic genes is that signals for synthesis, 
processing and secretion of higher cukaryotic proteins are properly and efficiently 
recognised. Consequently, a wide variety of cukaryotic proteins have been 
successfully expressed which are correctly processed in biologically active form 
(reviewed in Bebbington and Hentschel, 1985; MacDonald, 1991). Typically when 
eukaryotic cells are transfected, the input DNA (the transgene) integrates by 
illegitimate recombination at one or more random target site(s) in the gcnomc. The 
integration site of the input DNA can have profound effects upon levels of expression 
of the transgene. Thus, it is generally found that individual stable clones isolated from 
a single transfection express recombinant proteins at a wide range of levels from a few 
nanograms to several micrograms per 106 cells/day (Kaufman et al., 1985) due to 
these chromosomal "position effects" and/or differing copy number of transgcne 
(described below). It would be advantageous to overcome these two constraints on 
production levels, so that individual clones would express recombinant proteins at 
equivalent and preferably reproducible levels and hence decrease the number of 
individual clones which must be screened in order to identify a high-expressing clone. 
The aim of this project was to use Chinese Hamster Ovary (CHO) cells to investigate 
targeted integration of transgenes to a pre-selected locus in CHO chromosome, for the 
reproducible high level expression of recombinant proteins. This chapter reviews 
mammalian expression systems and the variety of methods used to optimise 
expression levels. As the work described in this thesis exploited the Crc-loxP site- 
specific recombination system encoded by bacteriophage PI, the biological and 
biochemical properties of these are also reviewed as are its application in other 
systems. 
1.1 Mammalian expression systems 
The wide variety of transcriptional control elements (reviewed in Levinson, 1990) and 
selectable markers (Berg et al., 1981; Mulligan and Berg, 1980; Wigler et al., 1977) 
now available allows the use of essentially any cell line for the purpose of 
heterologous gene expression. 
The key steps in the expression of heterologous genes in mammalian cells includes 
the introduction of the foreign DNA into cells, selection of cells which have integrated 
the foreign gene into their genome and their subsequent propagation to generate stable 
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cell lines. There are two general methods of introducing genetic information into 
mammalian cells; those mediated by virus infection and those mediated by direct 
DNA transfer (reviewed in Kaufman, 1990). One advantage of the former relates to its 
efficiency; it is not unusual to achieve close to targeting 100% of cells by exploiting 
the ability of the virus to infect cells efficiently. A disadvantage of this approach, and 
one that limits its utility, lies in the relative difficulty of its application; it is 
technically more difficult and more time consuming to engineer a virus to express a 
foreign gene in a manner that does not compromise its function than it does to 
administer DNA directly. As such, most attempts to express heterologous genes in 
mammalian cells rely on the construction of DNA vectors and their direct transfer by 
a number of chemical and physical methods, each with its own advantages and 
disadvantages (reviewed in Kriegler, 1990). Gage et al., (1992) showed that, at least 
for the two cell lines and three transfection methods they studied (i. e. established Rat- 
1 cell lines and rat primary skin fibroblasts; by CaPO4 co-precipitation, lipofection 
and electroporation) the transfection method does not affect the level of foreign gene 
expression achieved. 
As mentioned above, it is generally found that individual stable clones isolated from a 
single transfection express the recombinant protein at a wide range of levels due to 
chromosomal "position effects" and also differing copy number of transgene. 
Furthermore, the level of protein expression depends on other factors such as the 
efficiency of transcription, mRNA processing, transport, stability, and translational 
efficiency and protein processing, secretion and stability. A variety of approaches 
have been taken to optimise expression levels in mammalian systems which are 
described in the following section. 
1.2 Strategies to increase expression levels in mammalian systems 
Much of the work which has been done to improve the yield of recombinant protein 
from mammalian cells has concentrated on improving the amount of foreign gene 
transcription, which leads to an increase in product-specific mRNA, and hence to 
increased recombinant protein synthesis (providing other factors arc not limiting). 
This has been achieved by the use of efficient promoter/enhanccr sequences and by 
increasing the copy number of the foreign gene in the transfcctcd ccll. Because 
transfected DNA essentially integrates randomly in stably transfcctcd cells, efforts 
have been made to overcome the influence of different chromosomal regions 
("position effects") which can result in the low rate of transcription of the integrated 
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foreign gene. More recently, strategies to improve recombinant protein yield have 
focused on processes downstream of transcription, for example protein secretion. 
However, the key features for the control of heterologous gene expression consists of 
a promoter for transcription initiation in conjunction with an enhancer (a cis-acting 
DNA sequence which improves gene transcription) and a polyadenylation signal 
which directs the cleavage and polyadenylation of the transcript. In addition, a 
selectable marker is included to allow for the selection of stable cell lines. 
1.2.1 Promoter strength, transcriptional control elements 
The promoter/enhancer elements commonly used to control foreign gene expression 
may be of viral origin, for example the human cytomegalovirus (hCMV) major 
immediate early (MIE) promoter/enhancer (Foecking and Hofstetter, 1986) or the 
Rous sarcoma virus long terminal repeat ([RSV-LTR]; Gorman et al., 1982), or from 
a constitutively highly expressed non-tissue-specific mammalian cellular gene, for 
example the human ß-actin promoter. Promoters show different activity in different 
cell types, whilst enhancers may have differential activity with different promoters 
and/or in different cell types. For this reason, expression vectors are generally 
constructed to contain a promoter/enhancer combination that is highly active in a 
range of cell types. Wenger et al., (1994) evaluated the activity of ten different 
promoter/enhancer combinations after transient transfection of ten commonly used 
mammalian cell lines and found that they were not equally strong in all cell types, but 
some e. g. herpes simplex virus (HSV) thymidine kinase (TK) promoter/SV40 early 
enhancer were reasonably active in all the cell types tested. 
Transcriptional control in host systems is dependent on endogenous cellular 
transcription factors and RNA polymerase, either of which may be limiting. Other 
systems have been described in which the foreign gene is placed under the control of 
the bacteriophage T7 promoter and co-expressed in the cell with T7 RNA polymerase, 
this polymerase being highly specific for the T7 promoter. The resulting mRNA 
transcripts are not efficiently capped by the addition of a 7-methyl guanosine residue 
at the 5' end of the translational initiation codon, AUG and hence translation occurs at 
low efficiency. Inclusion of the encephalomyocarditis virus (EMCV) internal 
ribosomal entry site (IRES) downstream of the T7 promoter, so that it is at the 5' end 
of the mRNA, can circumvent this problem. Elroy-Stein et al., (1989) reported 5-10 
fold higher expression levels after inclusion of this EMCV region. 
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Hippenmeyer and Highkin (1993) describe the use of an engineered Baby Hamster 
Kidney cell line, BHK-21, stably expressing the herpes simplex (IISV)-1 
transactivator VP16, which increases transcription from immediate early (IISV)-1 
promoters. Two reporter proteins, human tissue plasminogen activator (tPA) and 
bovine growth hormone, were expressed in the BHK/VP16 cell line, under the control 
of two different immediate early promoters. Stably transfected clones were isolated 
that expressed protein at higher levels compared to control BIIK-21 transfectants (for 
example 1-15 tg tPA/106 cells/day compared to under 0.2 µg/106 cells/day). In 
addition, the BHK/VP16 system compared favourably with two other strategies 
commonly used to achieve high levels of expression in mammalian cells: the standard 
Chinese Hamster Ovary cell/dihydrofolate reductase co-amplification system 
(discussed later), with expression levels in the BHK cells as high as after time 
consuming amplification and the use of a bovine papillomavirus-based episomal 
vector (discussed later) in CHO cells. 
1.2.2 Increasing gene copy number: use of viral replicons 
As protein expression levels also depends on the copy number of the integrated DNA 
in the transfected cells, other approaches to optimise expression level has concentrated 
on increasing the vector copy number in stably transfected cells: 
1.2.2.1 viral replicons 
A viral replicon may be included in the expression vectors so that once inside the cell, 
it is capable of replicating episomally, provided the appropriate trans-acting factors 
are present either endogenously in the host cell genome or in the vector. The gene to 
be expressed is replicated to a correspondingly high copy number, leading to an 
increased amount of product-specific mRNA and hence to increased foreign protein 
synthesis. Different viral replicons work with different efficiencies, resulting in 
different expression vector copy number. Vectors containing the SV40 rcplicon 
replicate to very high copy number (> 104 copies/cell; Mellon et al., 1981) in cells 
that express viral T antigen, for example COS cells (an african green monkey cell line, 
CV-1, transformed with an origin-deficient SV40 virus). However, the high viral copy 
number leads to cell death after 3 or 4 days, so protein production is only transient. As 
an example of transient recombinant antibody expression, Whittle et al., (1987) 
expressed the chimaeric B72.3 antibody in COS cells under the transcriptional control 
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of the hCMV MIE promoter, with levels of antibody synthesis reaching 0.1-1 
microgram/ml in the culture medium after 2-3 days. Vectors based on the vaccinia 
virus (VV), another high-copy replicon, have been used for the expression of many 
proteins, including the humanised antibody Campath-lII (Carroll et al., 1992). 
1.2.2.2 Selection for the integration of multiple copy number following 
transfection 
Another approach to increase the vector copy number is to use plasmid expression 
vectors which contain all or part of the bovine papillomavirus (BPV) or Epstein-Barr 
virus (EBV) genome. The BPV or EBV fragment allows the vector to replicate to 50- 
100 copies per cell (and do not generally cause cell death; Sugden et al., 1985), 
resulting in high levels of constitutive expression of the inserted genes. These vectors 
can be used to generate stably transfected cell lines that are continuously expressing 
more modest levels of protein. However, such replicative expression vectors are not 
employed in current commercial systems for stable high-level production of proteins 
in mammalian cells because the maximum levels of expression obtained are 
considerably lower than those using integrated amplifiable (Section 1.2.2.3) vectors, 
as shown for example immunoglobulins genes (Baker et al., 1988) and possibly also 
for safety reasons. In addition, instability of expression has been reported and the 
viral-based vectors have limited host ranges, e. g. BPV will replicate in mouse but not 
in human cells. 
An alternative method (Niwa et al., 1991) used a bovine papillomavirus-based vector, 
capable of integrating into the genome, which contained a mutant neomycin resistance 
gene (which lowers the resistance to G418) under the transcriptional control of a weak 
promoter. Transfectants were selected at high concentrations of G418 (800 tg/ml) so 
that only those clones containing high copy number of the vector (>300 vector copies 
integrated) could survive the selection by high concentration of G418. Using this 
approach, the expression levels of human interleukin-2 (IL-2), under the 
transcriptional control of human ß-actin promoter, in mouse L cells and CHO cells 
were as high as previously achieved using the co-amplification strategy (see section 
1.2.2.3). 
A different approach described by Kaufman et al., (1987) involves the use of 
dicistronic mRNA expression vectors in which the gene of interest is proximal to a 
selectable marker gene. The second open reading frame (ORF) is translated with an 
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approximately 100 fold lower efficiency. Cells therefore require higher levels of the 
dicistronic mRNA to survive selection and consequently selected clones will 
synthesise high levels of the desired protein encoded by the 5' ORF. 
1.2.2.3 Use of an amplifiable, selectable marker gene 
Another approach to achieve high levels of protein expression exploits the natural 
phenomenon of gene amplification that occurs in mammalian cells (reviewed in Stark 
and Wahl, 1984). If cells are cultured in increasing amounts of specific toxic drugs, 
resistant clones can be selected. This is sometimes due to a spontaneous mutation in 
the cell's drug transport pathway particularly at high concentration of selective agent. 
In some cases, however, it may be due to an overproduction of an essential enzyme 
whose activity is non-competitively inhibited by the drug, usually caused by an 
increase in copy number of the gene encoding the enzyme. Since the region of DNA 
amplified can be as large as 1000 kb (Stark et al., 1989) a closely linked non- 
selectable gene, i. e. the gene of interest, is co-amplified, resulting in increased copy 
number and subsequently increased levels of protein expression. Amplified DNA may 
be either episomal as circular, acentromeric structures known as double minute 
chromosomes (DM), or chromosomally integrated forming a homogeneously staining 
region (HSR). 
A widely used amplification system uses the cytotoxic drug methotrexate (MTX) to 
select for the amplification of an exogenously introduced dihydrofolate reductase 
(DHFR) gene in a CHO cell line that lacks endogenous DHFR activity (reviewed in 
Bebbington and Hentschel, 1987). This strategy was first demonstrated by Kaufman 
and Sharp (1982) who achieved high levels of SV40 T antigen expression (about 10% 
total cell protein). Page and Sydenham (1991) used this system for the production of a 
humanised antibody, Campath-1H. They co-transfected CHHO-DHFR- cells with 
vectors containing the heavy and light chain cDNAs under the control of human 0- 
actin regulatory sequences, with the dl fr gene on the light chain construct. Following 
two rounds of amplification, stable clones expressing up to 50 tg/ml/day of functional 
antibody were obtained, compared to the pre-amplification transfected pool at 0.5 t 
g/ml. The system has also been used with mammalian host cells that contain an active 
endogenous dlfr gene, using a mutant DHFR selectable marker gene with increased 
resistance to methotrexate so that amplification of the transfected gene is favoured 
over that of the endogenous gene. Dorai and Moore (1987) used such a mutant dlfr 
gene when they expressed the B6.2 chimaeric antibody in a mouse myeloma cell line, 
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Sp2/0, with antibody chains under the control of Ig promoter/enhancer elements. They 
achieved a 25 fold increase in expression, from -i to 25 µg/106 cells/day, following 3 
to 6 months selection with increasing MTX concentration. The length of time required 
for amplification makes this approach not feasible for transient expression and also 
the increased in expression level is very poor compared to the Page and Sydcnham 
study. Furthermore, much higher levels of MTX were required to achieve 
amplification (500 µM compared to 1 µM in DHFR-deficient CHO cells used in the 
Page and Sydenham study). 
A limitation to the DHFR/MTX system is that both DMs and HSRs amplified DNA 
may be unstable in the absence of selective pressure. Weidle et al., (1988), studied 
three CHO cell lines containing chromosomally integrated co-amplified dhfr and WA 
genes grown for three months in the presence and absence of MTX. In all three 
amplified clones, HSRs were gradually lost in the absence of selective pressure, with 
an accompanying decrease in tPA expression level. They proposed that this was due 
to homologous recombination between the tandemly arranged amplified vector copies. 
Similarly, Page and Sydenham (1991) found that antibody yields of an amplified 
clone grown in the absence of MTX remained high for 6 weeks but then gradually 
declined. Instability after prolonged culture in the presence of MTX has also been 
reported (Pallavacini et al., 1990). 
An alternative system has been described with the glutamine synthetase (GS) gene as 
the selectable, amplifiable marker gene and methioninc sulphoximine (MSX) as its 
inhibitor. Glutamine synthetase is essential for glutamine synthesis (from glutamate 
and ammonia) and cells that lack the enzyme have a requirement for glutamine in the 
growth medium. The introduction of the GS gene into the cell provides a selectable 
marker allowing transfected cells to grow in the absence of glutamine. It is most often 
used with the GS deficient mouse myeloma cell line, NSO (Bebbington et al., 1992), 
but may be used with cells that contain an endogenous copy of the GS gene, for 
example CHO cells (Cockett et al., 1990), although higher levels of MSX are required 
for the latter. Bebbington et al., (1992) used the GS amplification system for 
expression of the chimaeric B72.3 antibody in NSO myeloma cells. After one round 
of amplification a clone was isolated that secreted 9.5 µg/106 cells/day, compared to 
the unamplified productivity of 1.5 µg/106 cells/day. 
The two amplification systems show markedly different characteristics; for example, 
amplification is generally necessary to achieve optimal levels of expression with the 
CHO/DHFR system. Gene copy number in the amplified cell lines is very high in the 
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CHO/DHFR system, with 100-1000 copies of the d! fr gene, whereas only up to 2 
gene copies are found in the MSX-amplified lines. A higher degree of stability has 
been reported for the NSO/GS amplified lines, possibly due to the lower amplified 
gene copy number. Bebbington et al., (1992) found that the production rate of one 
GS-amplified clone was constant, when cultured both in the presence and absence of 
MSX, for at least 30 generations. The two amplification systems were compared by 
Peakman et al., (1994) for the production of a humanised anti-CD4 antibody. They 
found that the heavy chain gene and marker gene copy number was much higher in 
the MTX-amplified lines but that mRNA levels of the heavy chain were not 
correspondingly higher. As a result, the levels of expression from isolated clones from 
each amplification system were comparable at -30 µg/106 cells/day. Similar yields, 
i. e. -200µg/ml in spent culture, are routinely achieved using the NSO/GS system for 
the expression of a range of humanised antibodies (C. Rossmann, Wellcome Research 
Labs [now GWR&D], pers. comm. ). 
The ability to scale-up the expression system is important for the production of 
therapeutic proteins (e. g. antibody). It has been suggested that CHO cells are less 
adaptable to fermenter conditions and final yields tend to be reduced, whereas NSO 
cells are well suited to fermenter conditions, growing at high density in suspension 
(up to 107 cells/ml). With optimised culture conditions, using serum-free medium and 
nutrient concentrations, Celltech (Slough, UK) have increased cell density and 
productivity to achieve recombinant antibody yields of hundreds of micrograms per 
ml of culture medium. With such productivity, a single 2000 L fermentor can produce 
tens of kgs per year (necessary if the antibody is to be used therapeutically). 
However, a problem associated with the use of such fermenters for long term 
production is that post-translational modifications such as glycosylation does not keep 
pace with the rate of protein synthesis and thus affects the activity of the therapeutic 
protein. 
1.2.2.4 In vitro amplification 
Another strategy has been described to increase the copy number of the gene encoding 
the protein of interest in vitro, i. e. prior to transfection into the mammalian host cell 
(Ikeda et al., 1988; Takeshita et al., 1988). The foreign gene expression cassette is 
cloned into a cosmid vector at a high cassette: vector ratio, to favour the cloning of 
multiple copies of the expression cassette. Integral to the method is the use of a 
restriction enzyme that generates single-stranded cohesive termini that arc not 
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palindromic (Sfil in the case of Ikeda et at., and BstXI in the Takeshita et al., study). 
Such a restriction site, located at either end of the fragment containing the expression 
cassette, ensures that the cloned multiple copies ligate together in a head-to-tail 
orientation only. This is important because inverted repeats, resulting from head-to- 
head or tail-to-tail ligation, would be unstable in a bacterial host cell (Sadler et al., 
1978). The cosmid clone containing the expression cassette multimer is then 
transfected into a mammalian host cell, where the increased gene copy number can 
lead to an increased expression level. 
Although, the various approaches described above can improve expression of 
recombinant proteins, the regulation of the heterologous genes at the transcriptional 
level is still influenced by chromosomal "position effects". It would be advantageous 
to overcome this position effect and still maintain high protein expression level. The 
following section describes strategies that has been applied to overcome chromosomal 
position effects. 
1.2.3 Overcoming position effects 
As previously mentioned, DNA transfected into mammalian cells integrates 
essentially at random into the host cell genome and the positions of integration can 
affect the level of expression of transfected DNA. These chromosomal "position 
effects" have been observed by several investigators (e. g. Yoshimura and Chaffin, 
1987) and in several cell types (Reff and Pfarr, 1992) and it means that many clones 
must be screened from a single transfection in order to isolate a high-expressing clone. 
However, extensive screening may be a very costly exercise (especially for the large 
scale production of recombinant proteins), it may be necessary to reduce the number 
of individual clones that have to be screened and achieve an equivalent and a more 
reproducible gene expression level. 
1.2.3.1 Transfection with a locus control region 
One approach to overcome this variability uses sequences that alleviate chromosomal 
position effect. For example, a locus control region (LCR): this is a genetic element 
that contains dominant regulatory sequences that specify position-independent 
expression. The position independent expression induced by LCR is thought to reflect 
the inherent ability of the LCR to establish an open chromatin domain and permit 
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regulatory factors, perhaps those mediating nuclear matrix attachment to gain access 
to individual genes. 
In the LCR/MEL expression system described by Needham et al., (1995), high-level 
and position-independent expression of heterologous cDNAs in murine 
erythroleukemia (MEL) cells was observed under the transcriptional control of the 
human ß-globin promoter linked to the human globin LCR. A vector was constructed 
containing the human globin LCR upstream of the foreign cDNA expression cassette, 
which uses the human ß-globin promoter. These authors expressed the human 
calcitonin receptor, a seven-transmembrane helix receptor, in this system achieving 
expression levels higher than previously achieved using an amplified CHO line and 
the baculovirus/insect cell system. Some studies have reported that the levels of 
expression obtained with the use of such LCR sequences are not higher than obtained 
following random integration and extensive screening (Grosveld et al., 1987; Phi-Van 
et al., 1990). However, the individual clones have more reproducible levels of gene 
expression following the use of one of these position-independent elements, and hence 
may decrease the number of individual clones that need to be screened to identify a 
high-expressing clone. 
1.2.3.2 Targeted integration using Site-specific recombination system 
Another approach that would eliminate the influence of chromosomal position effects 
on expression levels uses conservative site-specific recombination systems for the 
targeting of foreign DNA to a pre-selected site in mammalian genome. 
Whereas integration of LCR based vectors is still random, use of site-specific 
recombination system will target integration of heterologous genes into a previously 
determined chromosomal site. Such a strategy would be advantageous if the site to 
which the foreign gene is to be targeted is favourable for high expression leading to 
the isolation of transfected cell lines expressing relatively constant, high levels of 
recombinant protein. This approach will create the potential for the construction of 
cell lines expressing high, medium or low and/or cell cycle specific induction of 
protein expression level and promises a general application for the large scale 
production of recombinant proteins. 
One such conservative site-specific recombination system, the Crc-loxP, encoded by 
bacteriophage P1 (described in the following section) has been used extensively to 
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effect a wide range of precise modifications to DNA molecules both in vitro and in 
vivo and is exploited in this thesis as a tool that would allow the reproducible 
expression levels of recombinant proteins in mammalian cells. 
1.3 The Bacteriophage Pl Cre-loxP site-specific recombination system 
Bacteriophage P1 was recognised as one of three temperate phages harboured by 
lysogenic Escherichia coli (E. coli) by Bertani (1951). The three phages, namely P1, 
P2 and P3, were characterised by their plaque sizes on a strain of Shigella dysenteriae, 
respectively; small, large and variable. Of the three phages, P3 has received the least 
attention because preparations of it appeared markedly unstable. It is closely related to 
P2, with which it forms viable recombinants (Bertani and Six, 1988). Bertani and 
colleague concentrated their attention on P2 for the reason that its plaque 
characteristics on E. coli made it relatively easy to study away from Shigella, unlike 
the original isolate of P1. Phage P1 might have remained as obscure as is P3, were it 
not for the discovery by Lennox (1955) of P1-mediated generalised transduction 
between strains of E. coli and Shigella and the discovery by Lederberg (1957) of P1- 
mediated modification and restriction. Characterisation of P1 was instrumental in 
bringing about the age of genetic engineering, even if the P1 restriction nuclease has 
not been useful to genetic engineers. P1 as a transducing phage continues to be a key 
element for gross genetic manipulations in bacteria. 
Ikeda and Tomizawa (1968) demonstrated that P1 prophage exists 
extrachromosomally as a plasmid and that unlike, for example, bacteriophage lambda 
(k), P1 lysogeny does not require integration into the bacterial chromosome. As P1 
prophage are not maintained by passive replication with the host chromosome (c. f. 7. ) 
but are stable and replicate at a low copy number, this suggested that P1 should be 
actively partitioned between daughter cells rather than passively (and randomly) 
distributed by diffusion. 
After a considerable latent period, the findings of Ikeda and Tomizawa provided a 
new impetus and a new direction to P1 biology. Genetic studies of P1 was initiated by 
Scott (1968) and extended by Walker and Walker (1975,1976b), and I3achi and 
Amber (1977). DNA isolated from phage particles is double-stranded, linear with 
about 12% terminal redundancy, and cyclically permuted. Its molecular weight is 
about 6X 104 kDa (Ikeda and Tomizawa, 1968). In contrast to other phages with this 
29 
type of DNA organisation (P22, T4), whose genetic maps are circular, the genetic map 
of P1 is surprisingly linear despite the phage DNA being cyclically permuted. These 
findings suggested that either a large segment of DNA at the ends of the P1 genetic 
map is devoid of available genetic markers, or this region of the PI genome contains a 
hot spot for genetic recombination. The first possibility was eliminated by mapping 
studies that located markers present at both ends of the P1 genetic map on a unique 
6.5 kb EcoRI restriction fragment (EcoRI-7; Sternberg, 1978; 1979). The second 
possibility was investigated using this EcoRI-7 fragment (which most likely contained 
at least some elements of this recombination system) in genetic crosses to promote 
recombination between flanking X markers under conditions in which both X site- 
specific recombination system and host recombination systems were inactivated by 
mutation (Sternberg and Hamilton, 1981a). Sternberg and Hamilton (1981a) studies 
showed that the EcoRI-7 fragment contained all the essential components of a 
recombination system. Two components were identified, a site (loxP) that must be 
present in both partners of a genetic cross for efficient recombination, and a 
recombinase gene (cre), whose protein product, Cre can act in trans to promote 
recombination. 
1.3.1 The role of Cre-loxP recombination system in the life cycle of bacteriophage 
P1 
Various essential and diverse roles has been attributed to the Cre-loxP recombination 
system in the life cycle of P I. 
1.3.1.1 Role of Cre-loxP recombination in the cyclisation of P1 DNA 
The Cre-loxP recombination system is essential for the cyclisation of newly injected 
terminally redundant virion DNA. Segev et al., (1980), showed that circular P1 
molecules could be detected as early as five minutes after injection of linearised P1 
DNA into E. coli, well before the DNA is replicated. The importance of the 
cyclisation event is accentuated by the almost complete failure of P1 to form lytically 
or establish lysogeny in the absence of the Cre-loxP recombination system (Sternberg 
et al., 1986). Presumably, if the injected Pl DNA is not cyclised, it is rapidly 
degraded from its ends by cellular nucleases such as the products of the host recBCD 
genes. The properties of P1 cre mutants lend support to the proposed role of the Crc- 
loxP system in the cyclisation reaction. These mutants lysogenise recA bacteria 10-25 
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times less efficiently than does a cre+ phage, but they arc indistinguishable from crc+ 
phage in their ability to lysogenize recA+ bacteria (Schultz et al., 1983). Because cre 
lysogens are no less immune than cre+ lysogens (Sternberg, unpublished) the reduced 
lysogenisation frequency in the recA cells probably reflects the failure of the cre DNA 
to cyclise. Its ability to cyclise in recA+ bacteria indicates that other systems 
dependent on RecA function can replace Cre-loxP for cyclisation (Austin et a!., 
1981). The most obvious alternative to the Cre-loxP system for cyclising P1 DNA is 
the general recombination system of the host. Theoretically, it could generate P1 
" circles by recombination at any position within the terminally redundant region of an 
injected P1 DNA molecule. An indication that this alternative might not function 
comes from an experiment in which chioramphenicol-treated cells were shown not to 
be able to cyclise injected Pl DNA despite the fact that they should still be 
recombination proficient (Segev and Cohen, 1981). It is possible that P1 encodes a 
protein that enhances bacterial generalised recombination and permits injected PI 
DNA to cyclise. However, a P1 cyclisation enhancement gene has not yet been found. 
1.3.1.2 Role of Cre-loxP in P1 vegetative growth and lysogeny in host cell 
P1 DNA that has been injected into a sensitive bacterium, that has circularised by 
recombination, can induce one of two states, namely lysis or lysogeny. If conditions 
such as temperature are favourable, prophage establishment occurs. However, the 
prophage state is only as stable as the conditions that favours it. Sternberg et al., 
(1986) showed that Cre is not required for viral vegetative growth and lysogeny in a 
recA+ host but is required for both processes in a recA- host. The requirement for 
vegetative growth suggests that Cre also has a role to play in the viral lytic cycle after 
the viral DNA has been cyclised. 
1.3.1.3 Role of Cre-loxP in maintenance of unit-copy P1 plasmid prophage 
The Cre-loxP recombination system facilitates the proper partition of P1 plasmids in 
host cells. The content of P1-specific DNA in lysogenic E. coli is estimated to be 1.0 
per bacterial chromosome (Ikeda and Tomizawa, 1968); for this reason P1 prophagc is 
referred to as a unit copy plasmid or a plasmid under stringent control. Both host and 
plasmid functions contribute to copy number control as evident from the existence of 
E. coli mutants (Cress and Kline, 1976) and P1 mutants (Sternberg 1978). The role of 
Cre-loxP recombination system is to segregate PI dimers (which are formed by 
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homologous recombination between two daughter molecules after replication) into 
monomers (Figure 1.1; Austin et al., 1981). Because the daughter molecules arc 
physically linked in the dimer, they cannot be segregated to separate cells at cell 
division. Recombination between the two loxP sites present in the dimer efficiently 
regenerates the daughter monomer circles so that they can be faithfully segregated 
(Sternberg et al., 1980; Austin et al., 1981). The Cre-loxP system plays varied, and 
normally minor roles in the life cycle of P1, but owing to its intrinsic interest has been 
the object of intensive study. 
1.3.2 Cre is a member of the int family of recombinases 
A combination of methods for detecting distant relationships in protein primary 
sequences has been used to show that Cre recombinase belongs to the Int (for 
integrase) family of site-specific recombinases which includes the site-specific 
recombination proteins encoded by bacteriophage X, 4)80, P22, P2,186 and P4 (Argos 
et al., 1986). All seven of the recombinase proteins are basic and approximately the 
same size (336-440 amino acids), but there is very little amino acid sequence 
homology within this group. Despite this diversity, all of the recombinases can be 
aligned in their C-terminal halves. A 40-residue region near the C-terminus is 
particularly well conserved in all the proteins and is homologous to a region near the 
C-terminus of the yeast 2g plasmid Flp protein (McLeod et al., 1984). This family of 
recombinases does not appear to be related to any other site-specific recombinases. 
Three positions are completely conserved within this family: histidine, arginine and 
tyrosine are found at respective alignment positions 396,399 and 433 within the well 
conserved C-terminal region. It is speculated that these residues contribute to the 
active site of these proteins. It is possible that the tyrosine (Y-433) forms a transient 
covalent linkage to DNA during strand cleavage and rejoining. 
Although there are important differences among these recombination systems such as 
their requirement for accessory proteins in recombination, the genetic and biochemical 
data suggest that the basic features of recombination, particularly the strand exchange 
event are similar. The Int family of recombinases are characterised by a strand 
exchange mechanism that requires no DNA synthesis or high energy co-factor(s). As 
in the case of several DNA topoisomerases, the phosphodiester bond energy is 
conserved in a phospho-protein linkage during strand cleavage and rcligation (Craig 
and Nash, 1983; Andrews et al., 1985). The site-specific recombination systems of 
bacteriophages 080 and P22 appear closely related to that of ? in their requirement 
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for integration host factor protein (IHF) and for an excisionasc protein (Xis) during 
excisive recombination (Leong et al., 1985). P2 requires a protein (Cox) in addition to 
Int for prophage excision (Lindahl et al., 1972) suggesting that the directional controls 
are relevant in P2 as well. It is interesting that Cre and Flp, which are not under 
directional control, are also the two most distant from the other members of the Int 
family. Cre and Flp are particularly closely related to each other (functionally), as 
demonstrated by the fact that Cre binds to the Fip recombination site (albeit with a 20- 
fold lower affinity; Abremski, K. and Jayaram, M. unpublished observation). In spite 
of their apparent close relationship, Flp and Cre align only over the 40-residue 
segment near the C-terminus. 
1.3.3 The Cre recombinase 
Cre, a 38.5 kDa protein is encoded by 343 amino acids and separated from the loxP 
site on the P1 genome by a 434 base-pair (bp) region that contains a 73 amino acid 
open reading frame, ORF1 (Sternberg et al., 1981). The cre gene and ORF1 are 
oriented with their amino-terminal ends proximal to loxP. Three promoters have been 
identified as located upstream of the cre structural gene. Their activities range from 7 
to 10% of the activity of a galactose operon promoter and are active in P1 lysogens. 
The only evidence to date for the regulation of cre expression is that the promoter 
furthest from cre, pRl, contains two dam methylation sites (5' -G-A-T-C- 3') in its -35 
region (with respect to its translational initiation site) which is sensitive to 
methylation (Hattman et al., 1978). Its transcription is three to fourfold higher in a 
dam- host than it is in a dam+ host. The promoter closest to cre, pR3, directs the 
production of an RNA transcript that functions inefficiently for Cre protein synthesis 
because it lacks a ribosome recognition site (Sternberg and Hamilton, 1981a; 
Abremski et al., 1983). The transcriptional activity of the three Cre promoters is not 
affected by other proteins expressed by the P1 prophage, including the cl repressor 
protein. 
In solution, the Cre protein exists as a monomer. A limited chymotryptic digest of Crc 
results in two fragments of sizes 25 and 13.5 kDa. The sequence of the amino 
terminus of the purified 25 kDa peptide demonstrates that this pcptidc represents the 
carboxyl-terminal portion of the Cre protein. The 25 kDa peptide is capable of 
specific binding to the loxP site but binds with a lower affinity than does the wild type 
Cre protein. 
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1.3.4 The IoxP site 
A functional loxP site is quite small, comprising a 34 bp sequence (Abrcmski et al., 
1983). DNA footprinting analysis with purified Cre (Hoess and Abrcmski, 1984) as 
well as deletion analysis (Hoess et al., 1982) has revealed that the IoxP site consists of 
two 13 bp inverted repeats separated by an 8 bp spacer region (Figure 1.2). Abrcmski 
and Hoess (1984) showed that each inverted repeat and contiguous 4 bp of the spacer 
region comprises a binding domain for Cre. The absolute stoichiometry of the Cre- 
IoxP complex has been determined to be one molecule of Cre bound per inverted 
repeat, or two molecules per loxP site (Mack et al., 1992). 
From the DNA footprinting and deletion analysis, it can be determined that the 8 bp 
spacer region is the only asymmetric feature of the loxP site. This has important 
consequences for the outcome of recombination between loxP sites. When two loxP 
sites on the same DNA molecule are directly repeated, recombination results in the 
excision of the DNA between the sites. If, however, the sites are in an inverted 
orientation with respect to each other then, when recombination occurs, the DNA 
between the sites undergoes inversion rather than excision. Of particular interest to a 
number of groups is how the asymmetry of the 8 bp spacer region confer 
directionality on the site? Is the directionality achieved by DNA-DNA homology 
between the two recombining sites? 
To address these questions a number of mutant loxP sites containing alterations in the 
spacer region were made (Hoess et al., 1984). The activity of these mutants during 
recombination led to a number of important observations regarding the mechanism of 
recombination. First, sequence homology in the 6 bp overlap region is a requirement 
for recombination between loxP sites (a mutant site will not recombine with a wild- 
type site, but a mutant site will recombine with itself). These observations are 
analogous to those found for the overlap regions of the ?, att site (Weisberg et al., 
1983), the yeast 2µ Flp site (Senecoff et al., 1988), and the Salmonella lain system 
(Johnson and Simon, 1985). Thus, it seems that the requirement for sequence 
homology appears common to many site-specific recombination systems. 
A second observation is that homology is not sufficient for recombination if the 
mutation is at position +1 (position number of bases with respect to axis of dyad 
symmetry in the spacer region). The +1 position then appears critical for 
recombination suggesting that perhaps it is a base where there is an essential specific 
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contact between nucleic acid and protein. Footprinting data suggest that at least some 
of the spacer region must be in contact with Cre (Iloess et al., 1984). However, this 
was done using DNasel and not hydroxyl radicals (which is more precise for 
footprinting). A second possibility is that certain sequences themselves play a crucial 
physical role during the recombination process. Drew et al., (1985) proposed that the 
TpA sequence in the spacer region is predisposed to melting. This offers the 
possibility that the TpA sequence is critical for unwinding of the loxP site either 
during the pairing or the strand exchange step of recombination. Additional evidence 
shows that the sequence of the spacer region dictates the directionality of loxP 
recombination. By creating a loxP site with a completely symmetric spacer region, 
recombining sites now are capable of both excision and inversion in the same 
construct both occurring with approximately equal efficiency (Hoess et al., 1984). 
At a very low frequency, P1 can integrate its DNA at a specific site called loxB, in the 
E. coli chromosome (Sternberg et al., 1981), creating two hybrid sites, termed loxL 
and loxR which flank the integrated prophage. These four sites, loxP, loxB, loxL and 
loxR, have been isolated on ?, transducing phages and their DNA sequences has been 
determined (Hoess et al., 1982). The crossover point in loxP X loxB recombination 
occurs in the 8 bp spacer region, and deletion mutations that remove either of the 
repeats plus a portion of the spacer inactivates the site. The bacterial loxB site could 
be important for the transient integration of P1 DNA in the production of generalised 
transducing phage. 
1.3.5 Cryptic IoxP site(s) 
Because the loxP site of phage P1 is 34 bp in size, the natural occurrence of this exact 
sequence is unlikely in any eukaryotic genome. However, related sequences may exist 
in eukaryotic genomes that could recombine at low efficiency with an authentic loxP 
site. Such cryptic loxP sites have been identified in the yeast gcnome (Sauer, 1992). 
Because of the greater complexity of the human and mouse gcnomcs compared with 
yeast, an analogues situation is likely to exist in these organisms. This implies the 
possibility of Cre-mediated illegitimate recombination in mammalian cells. 
1.3.6 The mechanism of Cre-loxP recombination reaction 
Hoess et al., (1985) showed that the full inverted repeats and the spacer region are 
required for recombination to occur. One binding domain is insufficient. When DNA 
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containing the loxP site was incubated with Cre, specific cleavages occurred within 
the spacer region, creating a six base-pair staggered cut. The cuts were centred on the 
axis of dyad symmetry of the loxP site, resulting in a 5' protruding terminus. 
5'AATGTATGC3' 
3'T ACATAC^G5' 
At the point of cleavage, Cre becomes covalently attached to a 3' phosphate group, 
and produces a free 5' hydroxyl group (Craig and Nash, 1983). A series of 
experiments done by Hoess et al., (1985) in which a radioactively labelled loxP site 
was recombined with an unlabelled loxP site located the point at which strand 
exchange takes place during recombination. The point of strand exchange coincided 
with the sites at which Cre cleavage of the DNA backbone had been detected. Cuts in 
the recombining site of each strand were made opposite one another and strand 
exchange followed cleavage. The cleaved DNA must then pair with the 
complementary single-stranded sequences of the other loxP partner in the 
recombination reaction. The exchange of these strands results in a Holliday structure 
(Holliday, 1964), which, by virtue of the heterology surrounding it, would be 
immobile. The recombinase resolves such structures by cleaving the Holliday junction 
into the resulting heteroduplex products. 
The breakage and rejoining of partners during this recombination process must be 
rapid because it has not been possible to detect intermediates of the reaction at least 
when using wild-type system. Several mutant Crc proteins have been isolated that 
produce significant amounts of a possible intermediate product of the recombination 
reaction. A large body of evidence (both genetic and physical) has implicated the 
Holliday structure as an intermediate in recombination (Hocss et al., 1987). Perhaps 
most convincing is the direct observation of such intermediates by electron 
microscopy. 
The fundamental chemistry of recombination is phosphoryl transfer involving the 
translocation of a phosphodiester within a nucleic acid chain or between two nucleic 
acid chains (Jayaram, 1994). A nucleophile derived from the Cre recombinase enzyme 
breaks the phosphodiester bond, forming a covalent link between the DNA and the 
enzyme. The cleavage reveals a sugar hydroxyl that provides the active nuclcophile 
for the second transesterification step (strand exchange). The strand cleavage is 
catalysed by the active site tyrosine (Y-433); the linkage between protein and DNA is 
through the 3'-phosphate and the strand exchange is initiated by the 5'-hydroxyl of the 
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nicked partner DNA. The whole recombination reaction is initiated by one round of 
reciprocal single-strand exchanges, branch migration of the resulting Holliday 
junction and a second round of single-strand exchanges complete the recombination 
reaction (this general mechanism is followed by recombinases belonging to the Int 
and Resolvase/Invertase families) Craig et al., (1988). 
1.3.7 Factors required for the Cre-loxP reaction 
Known host recombination factors are not necessary for Cre-loxP recombination. 
Recombination measured in bacterial strains containing mutations that affect either 
homologous recombination (recAB) or X site-specific recombination (himA, himB; 
Miller et al., 1978) do not significantly affect the efficiency of the Pl site-specific 
recombination (Sternberg and Hamilton, 1981b). 
The in-vitro P1 recombination system requires the addition of only a Crc-containing 
extract and divalent or polyvalent cations (e. g. Mg2+ or spermidine) without any 
external energy cofactor(s) (e. g. ATP), suggesting that no external energy source is 
needed (Sternberg and Hamilton, 1981b; Abremski et al., 1983). Spermidine may act 
to condense the DNA, while the effect of Mg2+ on the reaction might affect the 
protein's ionic interaction with DNA. 
1.3.8 Topology of DNA substrate required for the recombination reaction 
A number of ? and plasmid substrates containing two IoxP sites have been 
constructed as model systems. Using these substrates it has been shown, both in vivo 
and in vitro that a fully functional loxP site is composed of no more than 60 bp 
(Abremski et al., 1983; Hoess and Abremski 1985; Sternberg and Hamilton 1981b), 
suggesting that all the informational content needed for recombination must reside 
within these sequences. 
The conformation of the DNA substrate containing the loxP site does not appear to be 
important at least for the in vitro reaction. Thus, when an extract containing Crc is 
used, intramolecular recombination between loxP sites on supercoiled, nicked-circle 
or linear DNA occurs efficiently. In addition, the intramolecular loxP X loxP reaction 
occurs efficiently regardless of the orientation of the two sites relative to one another. 
Intermolecular recombination can occur between two supercoiled DNA molecules or 
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between a supercoiled/circular/linear and one supercoiled molecule or between two 
linear DNA molecules. When both substrates are supercoiled the resulting product is a 
supercoiled dimer. When one substrate is supercoiled and the other is linear, the 
product is a linear dimer. Intermolecular reaction appears to be less efficient than 
intramolecular. The intermolecular reaction occurs very rapidly; the majority of the 
products are formed within 2-4 minutes at 370C. However, the extent of this reaction 
is never greater than 10%-15%, even after 60 minutes of incubation. In contrast, the 
intramolecular reaction reaches levels of 60% to 70% within a similar time course 
(Abremski et al., 1983). 
The most surprising result from the in vitro studies is that 50% of the products of 
recombination (intramolecular) between loxP sites on a supercoiled DNA substrate 
are present as free supercoiled circles. The ability to produce free products starting 
with a supercoiled substrate suggests a unique property of Cre-mediated loxP 
recombination (Abremski et al., 1983). Either Cre or a protein in a crude extract 
containing Cre acts as a topoisomerase (Krasnow and Cazzarelli, 1982), so that while 
the initial recombinant products are all catenated the topoisomerase activity acts to 
decatenate these products or the decatenation could be an intrinsic part of the 
recombination mechanism. For instance, Cre might recognise and bind to one or both 
loxP sites on the DNA molecule and track along the DNA by some non-specific 
"electrostatic" interaction proposed by (Berg et al., 1981), until another loxP site is 
found and recombination can take place. The net effect would be that during the 
tracking process the DNA strands between the loxP sites would be separated from one 
another effectively reducing the probability that the product molecules will be 
interwound. Cre could bring the loxP sites together by some mechanism that ensures 
the frequent separation of the two halves of the molecules. From both in vitro and ill 
vivo experiments, loxP sites separated by a few bases work just as efficiently as those 
that are surrounded by nearly a kilobase of P1 DNA (Adams et al., 1992). 
In contrast with the in vitro studies, where Cre does not show strong preference for 
substrate topology, site connectivity or pathway for synapsis, in vivo Crc is a much 
more specific enzyme (Adams et al., 1992). In vivo, Cre generates simple products 
and is stimulated by negative supercoiling. The causes of these differences in Crc 
behaviour in vivo is unknown. DNA structure and ionic conditions in vivo or the 
influence of a host protein factor are possible candidates. 
The Cre-loxP recombination event has been studied in great detail by using an in vitro 
system that efficiently shows recombination between two loxP sites (Abrcmski et al., 
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1983; Hoess and Abremski, 1985; Sternberg and Hamilton, 1981b). At equilibrium, 
Cre efficiently converts 70% of DNA substrate to products and appears to act 
stoichiometrically. The purified Cre protein binds to loxP containing DNA and makes 
complexes that are resistant to heparin (heparin competes for any non-specific 
interaction between protein and DNA; Abremski and Hocss, [1984]). This result is a 
further prove that Cre makes specific complexes with the loxP site. 
This characteristics of the Cre-loxP site-specific recombination system suggests a new 
strategy for introducing DNA into the genome of eukaryotic cells in addition to the 
already well characterised phage ? site-specific recombination system. In this system 
recombinant ? vectors carrying foreign DNA can integrate into the genome of E. colt 
at a specific location directed by the I int protein. The advantages of this phage ?. site- 
specific recombination have long been appreciated by bacterial geneticists (e. g., phage 
% replacement vectors that can contain up to 23 Kb of contiguous DNA have been 
used for the isolation and analysis of genomic DNA sequences, Sambrook et al., 
1989; Meese et al., 1990). Site-specific recombination in higher eukaryotic cells 
would be of immense importance for the precise DNA manipulations in the genome. 
Functional heterologous expression of site-specific DNA recombinases in eukaryotic 
cells has been shown not only for the Cre protein of bacteriophage (Sauer and 
Henderson, 1988), but also the Flp protein of Saccharomyces cerevisiae (Golic and 
Lindquist, 1988; O'Gorman et al., 1991) and the pSRI recombinase of 
Zygosaccharomyces rouxii (Matsuzaki et al., 1990). 
1.4 Applications of the Cre-loxP site-specific recombination system 
That the Cre-loxP site-specific recombination system of bacteriophage P1 can 
function in an efficient manner in eukaryotes was initially shown in the yeast 
Saccharomyces cerevisiae (Sauer, 1987). The yeast selectable marker, leu2 gene 
flanked by two LoxP sites was integrated into the yeast chromosome by homologous 
recombination. The cre gene was expressed in S. cerevisiae by fusing the crc 
structural gene to an inducible GAL! promoter. Induction by galactose led to the 
production of active Cre protein which was able to catalyse efficient and precise 
recombination between the two loxP sites flanking the leu2 gene. Results of 
recombination led to the excision of the leu2 gene (as measured by LEU- phenotype 
and the resulting leucine auxotrophs). This result demonstrates that Cre protein can 
enter the nucleus of the yeast S. cerevisiae to efficiently recognise and catalyse 
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recombination at loxP sites introduced to native chromosomes. The precise and yet 
simple mechanism with which Cre mediates recombination at the loxP sites suggested 
a potential method for genetic manipulation of the eukaryotic genome. 
1.4.1 Cre-loxP recombination in plants 
Recent advances in the genetic engineering of plants have led to the production of a 
large variety of crop plants with agriculturally valuable traits (Goodman et al., 1987; 
Gasser and Fraley, 1989). Notable examples are engineered plants that show enhanced 
tolerance to plant pathogens (Vaeck et al., 1987; Johal and Briggs, 1992). However 
despite the scientific advances made in crop improvement, the commercialisation of 
genetically engineered plants has been slowed by public concerns on the issue of the 
environmental safety of genetically engineered organisms. One such concern is with 
the genes that code for antibiotic resistance. Co-transformed into the host genome as 
selectable markers, they serve a necessary role in the detection of genetic 
transformants. Hence, agriculturally desirable characteristics are invariably co- 
introduced with resistance to antibiotics or herbicides. The products of these selection 
systems are not necessarily harmful, but their presence in transgenic plants does 
increase the environmental uncertainty of their distribution. This uncertainty factor 
can have a highly negative effect on the progress of plant improvement. Gene transfer 
without the incorporation of antibiotic-resistance markers in the host genome should 
ease public concerns over the field release of transgenic organisms expressing such 
traits. 
Dale and Ow (1991), described a strategy for engineering plants free of selectable 
markers. A luciferase gene was introduced into the tobacco genome using the 
hygromycin phosphotransferase gene (hpt) as a linked selectable marker which is 
flanked by two loxP sites. Cre recombinase was shown to excise the lipt in the plant 
genome by site-specific recombination at the loxP sites, resulting in plants which had 
incorporated only the required transgene. An advantage in removing the marker gene 
used to select transformants is that those cells can be re-transformed with additional 
traits in a stepwise process using the same resistance gene. This can reduce the 
restriction imposed on experimental designs by the limited availability of selectable 
markers. The concern about the environmental impact and public perception of 
widespread release of organisms expressing genes that confer resistance to antibiotics 
or herbicides can be alleviated by employing the strategy described above to remove 
selectable markers from the host genome. However, the Cre-loxP system leaves a 
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loxP site in the plant genome which may not have any effect on gene expression as 
long as it is not in a region crucial for transcription. 
The use of Cre-loxP recombination system in conjunction with transposable elements 
would create the possibility to induce chromosomal deletions (von Haaren and Ow, 
1993). This system, based on the mobility of one of the recombination sites 
introduced into the plant genome, provides the possibility to induce several forms of 
genome rearrangements; for instance an Agrobacterium tumefacien-transferred (T)- 
region containing a loxP site and a Ds (the maize dissociation transposable; Bancroft 
et al., 1993) element carrying a second loxP site has been integrated into a plant 
genome. Transactivation of the Ds element with the Ac (the maize activation 
transposable element, Chuck et al., 1993) transposase function results in relocation of 
the Ds element and the consequent separation of the two sites over different unknown 
distance on the same chromosome or on different chromosomes. Subsequent Cre- 
mediated recombination between these separated recombination sites will lead to 
deletion, inversion or translocation of DNA segments, dependent on the relative 
orientation and chromosomal location of the loxP sites. 
Thus "transposition-deletion" system could allow the screening of large segments of 
the genome for interesting genes and may also permit the cloning of the DNA 
corresponding to the deleted material by the same site-specific recombination reaction 
in vitro. This methodology may provide a unique means to construct libraries of large 
DNA clones derived from defined parts of the genome, the phenotypic contribution of 
which may be displayed by the mutant carrying the deletion. 
1.4.2 Cre-loxP mediated gene targeting in mammalian cells 
Stable transformants of mammalian cells from standard gene transfer often show 
variability in expression of the introduced transgene. This occurs both from the highly 
variable number of copies integrated into the genome and from position effects on 
gene expression due to random integration (Lacy et al., 1983). Hence experiments 
such as mutational analysis of transcriptional regulatory sequences using stable cell 
transformants is very difficult. Targeted integration of DNA into the genome would 
provide a simple solution to one of the major problems with gene transfer into 
mammalian cells. 
43 
Fukushige and Sauer (1992) used the Cre-loxP system to eliminate both the 
constraints of position effect and copy number variation on gene expression. A 
positive selection vector system was designed to directly select Cre-mediated DNA 
integration at a loxP target site previously placed into the genome of cultured 
mammalian cells. Initially an inactive lox-neon fusion gene was used as a loxP 
chromosomal target. Cre-mediated integration of a promoter-transcriptional initiating 
codon (ATG)-lox targeting construct into the chromosomal target reconstructs a 
functional ATG-lox-neor fusion gene and activates expression of a defective 
neomycin phosphotransferase gene which confers resistance to the neomycin analogue 
G418 in transfected cells which had undergo Cre-mediated targeted integration. With 
CHO cell lines containing this target, almost all of the selected transformants were 
simple single copy integrants of the target DNA. A lacZ reporter construct used to 
monitor gene expression showed that independent G418-resistant colonies from site- 
specific integration of the reporter gene all showed nearly identical levels of ß- 
galactosidase activity when the reporter construct integrated at a particular 
chromosomal position. The same construct integrated at a second chromosomal 
position exhibited a slightly different level of activity, characteristic of the second 
position. The result showed that Cre-mediated site-specific integration can facilitate 
the construction of isogenic cell lines and thereby permit reproducible gene 
expression in stably transformed cell lines. This system could be useful for the large 
scale production of recombinant proteins especially if the loxP site to which the 
foreign gene to be targeted is favourable for high level expression. Therefore the work 
described in this thesis, uses a secreted alkaline phosphatase (SAP) reporter gene 
fused to a loxP site as the chromosomal loxP target. Thus, the expression level of SAP 
from independent cell lines each containing a single copy of the loxP insert should 
give an indication of which cell lines contain a loxP site integrated into a 
chromosomal region favourable for gene expression. Subsequent Cre-mediated 
targeted integration of exogenous DNA to a loxP site in these cell lines should give 
the reproducible high level expression of recombinant protein. 
1.4.3 Manipulation of transgenes by Cre-loxP recombination system 
Transgenic mice are now routinely generated either by direct pronuclear injection of 
exogenous DNA into fertilised zygotes (Palmiter and Brinster, 1986) or by injection 
of genetically engineered embryonic stem (ES) cells into the mouse blastocyst 
(Schwartzberg et al., 1989). 
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Direct pronuclear injection results in random integration of the injected DNA into the 
genome and relies on the dominant nature of the transgenc to give a useful phenotype 
(e. g. the expression of a foreign protein or of a mutated version of an endogenous 
gene). Manipulation of endogenous genes (gene targeting or knockout) has primarily 
been performed with ES cells because they can be manipulated and grown in vitro as a 
permanent cell line and then re-introduced into the mouse blastocyst to contribute to 
the mouse germ line. A desired goal of transgene technology is efficient and accurate 
manipulation of DNA sequences after their integration in the germ line. DNA 
recombinases that mediate integration or excision of sequences at specific recognition 
sites in both prokaryotic (Stark et al., 1989; Sandmeier et al., 1990) and eukaryotic 
(Broach and Hicks, 1980; Oeltinger et al., 1990) systems are well suited for this 
purpose. 
Lakso et al., (1992) were the first to use the Cre-loxP system to investigate targeted 
activation of large tumour antigen (T. Ag. ) transgenic mice. A transgenic mouse was 
created which contained an inactivated T. Ag. created by insertion of a specially 
designed stop sequence that prevents gene expression flanked by loxP sequences. By 
crossing the dormant T. Ag. transgenic mouse lines with Cre expressing transgenic 
lines, Cre-mediated recombination at the loxP sites led to the excision of the stop 
sequence and ensuing activation of T. Ag. The event of the site-specific recombination 
led to double transgenic offsprings with developed lens tumours. Since then other 
groups have used the Cre-loxP systems for the various manipulations of mammalian 
genome (described below). 
As mentioned above, studies of gene function in mice often involve the analysis of 
embryonic stem (ES) cell-derived gene targeted mice. Such mice carry a pre-designed 
mutation in their germ line and are devoid of a particular gene product throughout 
ontogeny (Koller and Smithies, 1992; Melton, 1994). A strategy for conditional, cell- 
type specific gene targeting was developed by Gu et al., (1994) using a combination 
of the conventional transgenic technique and the Cre-loxP system. Two transgenic 
mice were constructed, one strain in which a Cre transgene is expressed in a cell type- 
specific or developmentally stage-specific manner. The second strain carries the target 
(polo) gene flanked by two loxP sites, which has been shown to be one of several 
enzymes involved in DNA repair machinery in T cells (Fry, 1983). By crossing these 
two strains, these authors were able to show that in T cells, -40% of offsprings 
derived from an intercross were homozygous for the pol(3 mutation. This was the first 
report of a normal mouse gene being selectively knocked out in just one cell type. 
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Thus in principle, Cre-loxP-mediated gene targeting should allow the inactivation of 
any gene in any tissue at any stage of development. 
The approach described by Gu et al., (1994) however has a major drawback in that the 
function of the gene product must be deduced from the phenotype of animals that arc, 
either in all cells or in certain cell types from an early time point on, constantly 
deficient throughout ontogeny for the product of the disrupted gene. A mutant 
organism may compensate for the loss of a gene product so that no obvious deviation 
from the wild-type is seen, or the organism may react to the mutation to give a 
complex, secondary phenotype. Moreover, if the complete loss of a gene product 
results in embryonic lethality (Copp, 1995), gene function at later stages of 
development cannot be analysed. 
To overcome these limitations, Kühn et al., (1995) and Zhang et al., (1996) have 
developed methods of gene targeting that allows the inducible inactivation of a target 
gene in mice. The method uses an inducible promoter to control the expression of the 
Cre recombinase which, when activated, can catalyse site-specific recombination at 
loxP sites flanking a target gene in transgenic mice. This system should prove useful 
in mutating or deleting genes at specific times during development or in adult animals 
(e. g. at a given time during T-cell ontogeny or neural development). 
In most gene targeting experiments only a small percentage of cells incorporate 
foreign DNA after transfection. Selection for a drug resistance marker contained 
within the targeting vector is applied in order to obtain cells into which the construct 
has integrated. Southern blot analysis and/or PCR are subsequently used to identify 
the desired homologous recombination from this initial pool of drug-resistance clones. 
The most widely used forms of gene targeting (simple replacement or insertion 
events, Capecchi, [1989]) commonly result in the permanent introduction of positive 
selectable markers into the mammalian genome. There are instances, however, when 
the irreversible introduction of selectable markers as a result of gene targeting may be 
undesirable. First, the relatively small repertoire of positive selectable markers 
available for use in mammalian cells limits the number of mutations that can be 
generated in a single cell (Eglitis, 1991). Second, the disruption of both alleles of an 
autosomal gene usually requires the construction of two different targeting constructs 
bearing different selectable markers. Finally, the exogenous promoter and enhancer 
elements required for the expression of these selectable markers have the potential to 
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interfere with endogenous regulatory elements present in the vicinity of the targeted 
mutations. 
Therefore it may sometimes be advantageous to remove the selectable markers after 
gene targeting. Although existing methodologies such as hit and run (Hasty et al., 
1991) and double replacement (Stacey et al., 1994) allow for the generation of 
marker-free targeted alleles, the removal of selectable markers by these techniques 
relies on a second relatively inefficient round of homologous recombination. 
Abuin and Bradley (1996) used a combination of homologous and Cre-loxP-mediated 
recombination to generate mouse ES cell lines carrying up to four targeted mutations 
and devoid of exogenous selectable markers. A cassette that contains both positive 
and negative selectable markers flanked by loxP sites, was used in homologous 
recombination and positive selection to disrupt a Rep-3 locus, a gene homologous to 
members of the mutS family of DNA mismatch repair genes. Cre mediated 
recombination and negative selection were then used to recover clones in which the 
cassette had been excised. The remaining allele of Rep-3 was then subjected to a 
second round of targeting and excision with the same construct to generate 
homologous, marker free cell lines. Subsequently, both alleles of mMSh2, another 
mutS homologue, were disrupted in the same fashion to obtain cell lines homozygous 
for targeted mutations at both the Rep-3 and mMSh2 loci and devoid of selectable 
markers. 
In principle, the Cre-loxP mediated excision or recycling of selectable markers 
(initially shown in yeast; Sauer, 1994) after gene targeting should allow for the 
generation of an unlimited number of targeted mutations in a single mammalian cell 
line. This system may prove to be particularly useful for the study of mammalian 
genes whose function can be assayed at the cellular level such as DNA repair genes. 
Chromosomal rearrangements are major causes of inherited human diseases and foetal 
loss (Epstein, 1986). Translocation (Rabitts, 1994) and loss of heterozygosity (Lakso 
et al., 1991) are important genetic changes causally involved in neoplasia. The ability 
to manipulate mammalian chromosomes in vivo to produce translocations, inversions, 
and deletions with predetermined breakpoints would be a considerable technological 
advance. However the technology for making large-scale precisely defined alterations 
to the mammalian genome has not yet been established. In the mouse very few 
deletions are available, and those that are, were generated randomly using 
mutagenesis approaches such as ionising irradiation (Rinchik and Russell, 1990). 
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Smith et al., (1995), developed a strategy for chromosomal translocation in embryonic 
stem (ES) cells that relies on sequential gene targeting and Crc-loxP site-specific 
recombination. Gene targeting was first used to integrate loxP sites at a desired c-myc 
and immunoglobulin heavy chain locus on chromosomes 15 and 12 respectively. A 
transient Cre-expressing plasmid was used to mediate site-specific recombination 
between the two chromosomal loci. Such a strategy will allow the design of a variety 
of chromosomal rearrangements that can be selected and verified in ES cells or 
activated in ES cell-derived mice for genetic studies. 
That defined deficiencies, inversions and duplication extending to more than 1 cM 
(centi-Morgan) can be constructed in embryonic stem cells was shown by Ramirez- 
Solis et al., (1995) using the Cre-loxP system. This was achieved by consecutive 
targeting of loxP recombination sites to the end points of a genetic interval followed 
by Cre induced recombination. The availability of mice with defined regions of 
segmental haploidy will allow their use in genetic screens and enable accurate models 
of human chromosomal diseases to be generated. 
1.4.4 Other applications of the Cre-loxP site-specific recombination system 
Antibody fragments comprising paired heavy (VH) and light (VL) chain variable 
domains can be displayed on the surface of filamentous bacteriophage and rare phage 
(encoding antigen binding activities) selected by binding to antigen (Phage display; 
McCafferty et al., 1990). However, the heavy and light chain genes cannot be 
packaged together within the same phage particle, and so cannot not be 
simultaneously co-selected. 
Waterhouse et al., (1993) used the Cre-loxP system to combine the heavy and light 
chain genes from two different replicons within an infected bacterium. Two vectors 
were constructed; one encoding the light chain of a first antibody (and the heavy chain 
from a second, different antibody); and the other vector encoding the heavy chain of 
the first antibody. In both vectors the heavy (VH) chain variable domains were 
flanked by two loxP sites. In order to prevent the excision of the VII genes in the 
presence of Cre recombinase, one of the loxP sites corresponded to the wild-type 
sequence and the other contained a point mutation within the spacer region. The wild- 
type loxP and the mutant loxP site do not recombine with each other in the same 
vector but recombine with sites of matching sequence in different vectors. When Cre 
recombinase was provided in vivo, the two vectors co-integrated by recombination 
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between either mutant or wild-type loxP sites to create two other chimacric 
antibodies. This strategy should allow the construction of extremely large 
combinatorial repertoires of antibody fragments for the rapid screening and expression 
of highly specific antibodies. 
The isolation and analysis of genomic DNA sequences has been facilitated by the 
development of phage X replacement vectors that can contain up to 23 Kb of 
contiguous DNA and cosmid vectors that can contain inserts of up to 40 Kb of DNA. 
Genomic libraries in phage ? are easy to screen (Sambrook et al., 1989) but present 
several problems in the analysis of insert DNA and subcloning. Subcloning and 
analysis each require the preparation of the recombinant X clone DNA. Holt and May 
(1993) developed a novel phage I replacement vector that does not necessitate the 
preparation of phage X DNA for subcloning and analysis of inserts, because the inserts 
contained in this vector can be converted to plasmids using the Cre-loxP system as 
described previously for automatic subcloning from cDNA cloning vectors 
(Maruyama and Brenner, 1992; Palazzolo et al., 1990). The subcloning technique 
described in Maruyama and Brenner, (1992) uses a bacteriophage X cloning vector 
which has a unique BamHI site engineered into ? gam gene. Cloning of foreign DNA 
into this site allows selection of recombinant vector on bacteriophage P2 lysogens of 
E. coll. Furthermore, when the recombinant phage infect a Cre-producing B. coil 
strain, a site-specific recombination event between loxP sites on the cloning vector 
results in the excision of a plasmid replicon with the cloned insert. In addition single- 
stranded DNAs can be recovered by growing helper M13 phages on bacteria 
containing such plasmids. This X cloning vector can be used instead of , ZAP (Short 
et al., 1988) because there is no direct selection for recombinants using XZAP or other 
selective phage ?. vectors (e. g. pXZd39; Murphy and Schimke; 1991) which does not 
permit the excision of the plasmid in vivo. 
The results achieved by various groups thus far, illustrate that the Crc-loxP site- 
specific recombination (and other site-specific recombination systems) can be useful 
as tools for the large scale DNA manipulation in-vitro and in-vivo of eukaryotic 
chromosomes. 
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1.5 Disadvantage(s) of the Cre-loxP recombination system 
The main drawback of the Cre-loxP system for genomic engineering is that the 
recombination event is freely reversible because recombination occurs with base-pair 
precision. Hence active sites remain after the reaction has occurred. In site-specific 
DNA integration, recombination between a site on a circular molecule and a site on a 
chromosome results in the insertion of the circular DNA into the chromosome. 
However, the integrated DNA is flanked by two recombination sites of the same 
orientation and can therefore excise if the recombinase is present. Since 
intramolecular excision is kinetically favoured over bi-molecular integration, insertion 
products are inherently unstable in the presence of the recombinase. 
For a co-integration recombination reaction, it may be necessary to limit the 
recombinase activity to prevent integrated molecule from being re-excised. This has 
been achieved by transient provision of the recombinase: either from an inducible 
promoter (Sauer, 1987; Sauer and Henderson, 1988), introducing a non-selected 
plasmid that expresses the recombinase transiently and is subsequently lost ( Sauer 
and Henderson, 1990; Fukushige and Sauer, 1992) or even using purified recombinase 
enzyme which provides a transient source of activity (Baubonis and Sauer, 1993). 
Another strategy has been to introduce selective base changes into recombination sites 
such that the product sites of a recombination reaction are less likely to undergo 
further recombination (Albert et al., 1995; described in chapter 5). 
Despite this drawback, the Cre-loxP site-specific recombination system continues to 
be used as a tool for the large scale DNA manipulation both in vivo and in vitro. 
1.6 Aims of the project 
The objective of this work was two fold; the first was to develop a mammalian 
expression system incorporating the Cre-loxP site-specific recombination system as a 
tool that would allow the targeted integration of transgenes to pre-selected 
chromosomal regions in order to obtain reproducible expression levels of 
heterologous protein. The second involves the fundamental investigation of the Cre- 
loxP reaction in vitro with the aim of identifying irreversible substrates that could be 
used to improve the efficiency of targeted integration. 
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The advantages and disadvantages of mammalian cells for the expression of 
recombinant proteins over other expression systems (such as bacteria and lower 
eukaryotic systems) has previously been described. Owing to the variable expression 
levels of recombinant proteins observed in mammalian systems, various approaches to 
optimise expression has been investigated (described above), however only the Cre- 
loxP site-specific recombination system provides a strategy that overcome variability 
due to chromosomal position effects and differing copy numbers. 
The first objective describes the use of the Cre-loxP site-specific recombination 
system as a tool for gene targeting in CHO DHFR- (Chinese hamster ovary cells 
which are deficient for dihydrofolate reductase gene) cell line. Initially a loxP site was 
targeted into the CHO genome via a plasmid encoding a reporter gene, in this case 
SAP (secreted alkaline phosphatase gene), and a selectable marker gene, d1 fr. This 
plasmid will integrate randomly into the CHO chromosomes. Given that integration is 
random, this could occur either at a promoter region, an enhancer/repressor region, a 
non-coding region or a region in the chromosome under cell-cycle/tissue specific 
induction. Integration into any of these regions would have a direct effect on the 
level(s) of gene expressions; in this case the reporter gene, SAP. The level of SAP 
therefore allowed the selection of transformants in which the loxP site has been placed 
in a favourable region for gene expression. 
The Cre-mediated site-specific targeting event was investigated by transfecting either 
a promoterless lacZ/neor fusion gene or a promoterless CAT reporter gene (each 
encoding a loxP site) into the chromosomal loxP site (Figure 1.3). A source of Cre 
recombinase was supplied by either co-transfecting with the targeting plasmid, 
purified Cre protein (purified from baculovirus/insect expression system, described 
below) or a cre expression plasmid. Proper targeting activates the expression of the 
promoterless lacZ/neor fusion gene or the promoterless CAT gene from the 
chromosomally placed (3-actin promoter. CHO cells containing this target are resistant 
to the neomycin analogue G418 and show (3-galactosidase or CAT activity. This 
targeting event was investigated in independent CHO cell lines each containing single 
copy insertions of the loxP site in a different region of the chromosome (indicated by 
the level of SAP activity). The expression level of the second reporter and the 
frequency of the targeting event from different cell lines were compared to establish 
the effect of the chromosomal environment on the efficiency of recombination and 
gene expression. The Cre-mediated targeted integration into CHO cells is described in 
chapter 5. 
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To address the second objective (and part of the first objective, which was the direct 
introduction of Cre protein into cells), the Cre protein was expressed in the 
baculovirus/insect expression system. Chapter 3 describes the construction of a 
recombinant baculovirus vector encoding the cre gene for expression in insect 
systems, a system that has been successfully used for the expression of high levels of 
active eukaryotic and prokaryotic proteins (Luckow and Summers, 1988). Two in 
vitro assay systems were set up to investigate the activity of the purified Cre protein: 
(i) A gel retardation assay was used to investigate the binding interaction of the Cre 
protein with oligonucleotide sequence corresponding to loxP sites. (ii) The ability of 
the purified Cre protein to mediate site-specific recombination in vitro was 
investigated. A loxP substrate for the in vitro analysis was constructed. This construct 
was designed such that loxP sites flanked on the one side an antibiotic resistance gene 
and on the other side a reporter IacZ gene. Cre-mediated recombination at the loxP 
sites will lead to the excision of the IacZ gene such that the recombination event could 
be analysed quantitatively either directly by restriction endonuclease digestion or by 
the phenotypic colour selection of substrates and products following an in vivo assay. 
The Cre-loxP in vitro assay system allowed the investigation of various kinetic 
parameters of the reaction and the manipulation of the loxP sites to achieve 
irreversible loxP substrates which could be used to improve the efficiency of in vivo 
targeted integration. Cre-mediated intermolecular integration event was also 
investigated using DNA fragments each containing a loxP site. The in vitro kinetic 
studies of the Cre-loxP reaction is described in chapter 4. 
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CHAPTER 2 
MATERIALS AND METHODS 
2.1 Materials 
Chemicals were purchased from Sigma or BDH, unless stated otherwise, and were 
Analytical Reagent quality (Analar) or of the highest grade available. 
2.2 General DNA and sub-cloning techniques 
2.2.1 Restriction endonuclease digestion of DNA 
Restriction digests were done in the reaction conditions recommended by the enzyme 
manufacturer (Boehringer Mannheim; see Appendix 3 for buffer composition) using 
-10 units of restriction enzyme/µg DNA, in a reaction volume at least 10 times the 
volume of enzyme used. 
2.2.2 Ethanol precipitation of DNA from solution 
DNA was concentrated or recovered from solution by ethanol precipitation. This was 
done by adding 0.1 volumes of 3M sodium acetate pH 5.2 and 2.5 volumes of ice- 
chilled ethanol (99.5%) to the DNA-containing solution and mixed. The precipitated 
DNA was pelleted by centrifugation at 14000 rpm (15800 g) in a 5415 C Eppendorf 
centrifuge for 10 minutes at room temperature and washed twice with ice cold 70% 
ethanol. The DNA pellet was allowed to air dry and dissolved in an appropriate 
volume of TE (10 mM Tris-HCI, 1 mM EDTA pH 8.0) buffer. 
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2.2.3 Extraction of a DNA solution with organic solvent 
DNA in solution was separated from protein contamination by extraction with an 
equal volume of phenol and chloroform mixed in the ratio 1: 1 (chloroform contains 
4% isoamyl alcohol, hereafter just referred to as chloroform). The two phases were 
mixed thoroughly by vortexing. The organic and aqueous phases were separated by 
centrifugation at 14000 rpm for 10 minutes. The upper aqueous phase containing the 
DNA was recovered avoiding any denatured protein at the interface. DNA solutions 
were generally extracted twice with phenol/chloroform. 
2.2.4 Agarose gel electrophoresis of DNA 
DNA fragments were separated according to size by horizontal electrophoresis 
through an appropriate percentage (0.5-1.2%) agarose gel made up in either TAE (40 
mM Tris-acetate, 1 mM EDTA) or TBE (90 mM Tris-HCI, 90 mM boric acid, 2.5 
mM EDTA, pH 8.0). Ethidium bromide (EtBr) was added at 0.5 tg/ml. Samples were 
mixed with 0.2 volumes of loading buffer (25% glycerol, 50 mM EDTA, 0.5% 
bromophenol blue) and electrophoresed in the same buffer as used to cast the gel at 1- 
10V/cm. The lambda (X) Hind III marker, 100 bp ladder or the 1 Kb DNA ladder 
(GIBCO BRL; fragment sizes in Appendix 5-7) were used as the molecular weight 
size markers. 
2.2.5 Recovery of DNA from an agarose gel 
DNA fragments were recovered from agarose gel using the Prep-A-gene kit (Biorad), 
according to the manufacturer's protocol. In this method, the DNA band was sliced 
from the agarose gel and dissolved in sodium iodide solution. A silica matrix was then 
added to bind the DNA and DNA subsequently eluted from the silica matrix in high 
salt buffer. 
2.2.6 Conversion of DNA fragments with 5' overhangs to blunt-ended fragments 
using Klenow 
DNA fragments with 5' protruding ends were converted to blunt-ended fragments in a 
DNA synthesis reaction. The Klenow fragment of Escherichia coli (E. coli) DNA 
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polymerase 1 (Promega) was added at 5 units/µg DNA in a reaction buffer containing 
Mg2+ (e. g. Boehringher Mannheim buffer B; see Appendix 3 for composition). 
Deoxyribonucleotides (dNTPs) were added in excess (each at 25 AM) and the reaction 
incubated at room temperature for 30 minutes. The reaction was stopped by heat 
inactivating the enzyme at 700C for 10 minutes and blunt-ended DNA fragments 
recovered by ethanol precipitation. 
2.2.7 Conversion of DNA fragments with 3' overhangs to blunt-ended fragments 
using T4 DNA polymerase 
DNA fragments with 3' overhangs were converted to blunt-ended fragments in a DNA 
synthesis reaction. T4 DNA polymerase (New England Biolabs) was added at 3 units/ 
µg DNA to a reaction containing Boehringer Mannheim restriction buffer A (see 
Appendix 3 for composition). Deoxyribonucleotides (dNTPs) were added in excess 
(each at 25 µM) and the reaction incubated at room temperature for 30 minutes. The 
reaction was stopped by the addition of EDTA pH 8 to a final concentration of 20 mM 
and blunt-ended DNA fragments recovered by ethanol precipitation. 
2.2.8 Si nuclease digestion 
DNA fragments with sticky ends were hydrolysed with 0.1 units of Si nuclease 
(GIBCO BRL)/µg DNA in a 500 pl reaction volume containing S1 nuclease buffer. 
The reaction was done at 370C for 10 minutes. At 0.5,1,5, and 10 minute time 
points, 100 µl of the reaction mixture was removed and the reaction stopped by the 
addition of EDTA pH 8 to a final concentration of 50 mM. The hydrolysed DNA 
fragments were recovered by ethanol precipitation. 
2.2.9 Dephosphorylation of linear DNA fragments using calf intestinal alkaline 
phosphatase 
Removal of 5' phosphate residues from DNA fragments were done using calf 
intestinal alkaline phosphatase (CIP, Promega). The enzyme works on both blunt and 
sticky ends of DNA fragments. The reaction was done in Boehringer Mannheim 
restriction buffer M (see Appendix 3 for composition; although other Boehringer 
buffers work as well), by the addition of 2 units CIP/µg DNA followed by incubation 
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at 370C for 30 minutes. The reaction was stopped by heat inactivation at 700C for 10 
minutes and the dephosphorylated fragments purified by phenol/chloroform extraction 
followed by ethanol precipitation. 
2.2.10 Phosphorylation of linear DNA fragments using bacteriophage T4 
polymerase kinase 
The 5' termini of double-stranded oligonucleotide sequences were phosphorylated by 
T4 polymerase kinase (Promega) using 5 units/µg DNA in a reaction volume 
containing the kinase buffer (Promega). The reaction was incubated at 370C for I 
hour and stopped by heat inactivation at 700C for 10 minutes. The phosphorylated 
DNA fragments were then recovered by ethanol precipitation. 
2.2.11 Ligation of DNA fragments 
Vector and insert fragments were mixed in a molar ratio of 1: 3 to give -100 ng DNA 
in a final volume of 16 µl. To this, 2 µl 10 x ligase buffer (Promega) and 2 pl T4 
DNA ligase enzyme (Promega) were added and the mixture incubated at 170C 
overnight. Approximately half of this ligation reaction was used in transformation 
reactions in E. coli DH5a competent cells (described in section 2.2.13). 
2.2.12 Preparation of E. coli DH5a competent cells 
Bacteria were made competent for transformation by plasmid DNA following the 
method of Hanahan (1983). SOB medium (2% Bacto tryptone. 0.5% Bacto yeast 
extract, 10 mM NaCl, 25 mM KCI, 10 mM MgC12,10 mM MgSO4) of which 10 ml 
was inoculated with a single colony of E. coli DH5ot and grown overnight, shaking at 
37°C. SOB medium (500 ml) was then inoculated with this overnight culture and 
grown at 370C to A550 0.4-0.6 (4-7 x 107 viable cells/ml). The culture was chilled on 
ice for 30 minutes and cells pelleted by centrifugation at 3000 rpm (1465 g) in a 
Sorval GSA rotor for 15 minutes. The cells were resuspended in 200 ml of ice-cold 
TFB 1 solution (30 mM KOAc, 100 mM RbCI, 10 mM CaCl2,50 MM M902,15% 
Glycerol, adjusted to pH 5.8 with acetic acid and filter sterilised). The cells were 
pelleted as before and resuspended in 20 ml ice-cold TFB2 solution (10 mM 3-[- 
morpholino] propanesulfonic acid (MOPS), 75 mM CaC12,10 mM RbC12,15% 
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Glycerol, adjusted to pH 6.5 with KOH and filter sterilised). Aliquots (200 itl) were 
snap frozen by transferring to microcentrifuge tubes in a dry ice bath and then stored 
at -70°C. 
2.2.13 Transformation of E. coli DH5a competent cells 
All plasmids used contained the gene encoding (3-lactamase. Transformation was done 
following the method of Hanahan (1983). Approximately 50 ng of a ligation reaction 
or 10 ng of purified plasmid DNA was added to 200 gl of thawed DH5a competent 
cells and incubated on ice for 5 minutes. Cells were heat shocked for 2 minutes in a 
420C water bath, and returned to ice for 5 minutes. After the heat shock treatment, 
800 µl of SOB medium was added to the transformed cells and then incubated at 
370C for 1 hour. Transformed cells (200 µl) were then spread onto selective agar 
plates (LB [10 g Bacto-trypton, 5g Bacto yeast extract, 10 g NaCI in 1L], 1.5% agar + 
100 µg/ml ampicillin) and incubated at 370C overnight. Transformed cells where the 
plasmid genotype (resistance to ampicillin) was expressed, were observed the next 
day as white colonies. 
2.2.14 Small-scale plasmid preparation 
The method used is a modification of the alkaline lysis method of Birnboim and Doly 
(1979). A single transformed bacterial colony was picked into 3 ml LB medium and 
grown (to stationary phase) overnight with shaking at 37°C. The culture (2 ml) was 
transferred to an Eppendorf tube and centrifuged at 14000 rpm (15800 g) for 5 
minutes and the cell pellet resuspended in 200 p1 of ice-cold 50 mM glucose, 25 mM 
Tris-HCI, pH 7.5,1 mM EDTA solution. Cells were lysed by the addition of 200 Itl 
0.2 M NaOH, 1% SDS and incubated on ice for 5 minutes. Neutralisation solution 
(2.55 M sodium acetate, pH 4.8) of which 200 µl was then added to the cell extract 
and incubated for further 5 minutes on ice. Precipitated chromosomal DNA, protein 
and SDS was pelleted by centrifugation at 14000 rpm (15800 g) for 10 minutes. The 
supernatant was transferred to a fresh tube and the plasmid DNA precipitated by the 
addition of 1 ml of 95% EtOH. The DNA was pelleted by centrifugation at 14000 rpm 
(15800 g) for 10 minutes, washed with 70% ethanol, dried and the pellet redissolved 
in 50 tl TE buffer pH 8, containing DNAase free pancreatic RNAase (50 µg/ml) and 
stored at -20°C. 
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For some purposes, plasmid DNA was extracted using the Promega Magic/Wizard 
mini-prep kit following the manufacturers instruction. This is based on an alkaline 
lysis method and utilises a DNA-binding resin. 
2.2.15 Large-scale plasmid preparation 
The alkaline lysis method of Birnboim and Doly (1979), was followed for the large 
scale preparation of plasmid DNA. A single transformed bacterial colony was picked 
into 10 ml LB medium and grown (to stationary phase) overnight with shaking at 
37°C. LB medium (500 ml) was inoculated with the 10 ml overnight culture and 
grown overnight with shaking at 37°C. Bacteria cells were pelleted by centrifugation 
at 5000 rpm (4080 g), in a Sorvall GSA rotor for 10 minutes and resuspended in 25 ml 
of 25 mM Tris-HCI, pH 8,10 mM EDTA, 50 mM glucose. Cells were lysed by the 
addition of 50 ml of 0.2 M NaOH, 1% SDS, with gentle mixing. Chromosomal DNA, 
protein and SDS were precipitated by the addition of 35 ml 2.5 M potassium acetate, 
2.5 M glacial acetic acid followed by incubation on ice for 10 minutes. The solution 
was centrifuged at 8000 rpm (10400 g) in a Sorvall GSA rotor, at 50C for 15 minutes 
and the supernatant recovered and filtered through 3 layers of gauze to remove any 
precipitate. Plasmid DNA was precipitated by the addition of 70 ml isopropanol and 
pelleted by centrifugation at 8000 rpm for 10 minutes at room temperature. The DNA 
was dissolved in 9 ml TE buffer, pH 8. This crude plasmid DNA solution was 
transferred to a Corex centrifuge tube containing 10.5 g of CsCl. Tris-HCI, pH 8 (1 
ml), 120 tl of 0.5 M EDTA, pH 8 and 320 tl of EtBr (10 mg/ml). The solution was 
clarified by centrifugation (HB4 rotor) at 8000 rpm for 15 minutes at room 
temperature. The clear supernatant was transferred to a Beckman Quick-seal tube and 
centrifuged at 45000 rpm at 220C for 40 hours (Beckman ultra-centrifuge 70.1. Ti 
rotor). This generated an equilibrium gradient in which different DNA species 
migrated as distinct band to different heights corresponding to their buoyant densities. 
Two bands of DNA were visible under normal light; an upper band of nicked plasmid 
DNA and a denser lower band of covalently closed circular plasmid DNA. The lower 
band was collected using a hyperdermic-needle connected to a2 ml disposable 
syringe pushed through the side of the tube. The top of the tube was punctured before 
the needle was gently introduced into the lower band. 
Ethidium bromide bound to the DNA was removed from the plasmid solution 
(volume noted) by repeated extractions with water-saturated butan-l-ol until the upper 
phase solution was colourless. The solution containing the plasmid DNA was 
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transferred to a Corex centrifuge tube, the volume was made up to 4 times that noted 
above with sterile water, and two volumes of 95% ethanol added. Precipitated plasmid 
DNA was recovered by centrifugation at 8000 rpm in a Sorvall SS34 rotor (7710 g) 
for 30 minutes. The DNA was washed twice with 70% ethanol and then dissolved in 
500µ1 of TE, pH 8. The concentration and purity of the DNA solution were 
determined spectrophotometrically as described in section 2.2.17. 
2.2.16 Genomic DNA preparation 
The method of Laird et al., (1991), for isolating mammalian DNA was followed with 
some modification. Mammalian cells growing on a 6-well plate or pelleted by 
centrifugation, were washed with PBS and lysed by the addition of between 0.5 to 1 
ml lysis buffer (100 mM Tris-HCI, pH 8.5,5 mM EDTA, 0.2% SDS, 200 mM NaCl, 
100 pg/ml Proteinase K). Lysis was done at room temperature for a minimum of 6 
hours with agitation. One volume of isopropanol was added to the lysate and the 
samples mixed by swirling until precipitation was complete. The precipitated DNA (if 
lysis was done on a 6-well plate) solution was carefully transferred to a microfuge 
tube and centrifuged at 14000 rpm (10508 g) for 10 minutes. The liquid was discarded 
and precipitated DNA washed once with 70% ethanol. The DNA was dried at room 
temperature and resuspended in between 50 to 500 µl of 10 mM Tris-HCI, 0.1 mM 
EDTA, pH 7.5. 
2.2.17 Determination of DNA concentration 
The A260 and A280 of an aliquot of DNA solution diluted 1 in 100, were measured. 
Given that an A260 of 1 corresponds to 50µg/ml of double-stranded DNA solution, the 
concentration of the DNA solution was calculated. Pure DNA solutions have an 
A260/280 ratio of 1.8, lower A260/280 than 1.8 indicates protein contamination. 
DNA samples of very low concentration or low molecular weights were estimated by 
electrophoresing an aliquot (known volume) on an agarose gel with a dilution series 
of linearised plasmid standards of known concentrations. Comparison of the intensity 
of the sample band with the DNA concentration standards under UV illumination was 
used to estimate the concentration of DNA. 
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2.2.18 Southern blotting 
Localisation of particular sequences within plasmid or genomic DNA was determined 
by the transfer techniques described by Southern (1975), and Mcinkoth and Wahl 
(1984). DNA fragments, separated by electrophoresis on an agarose gel, were 
transferred to a nylon membrane prior to hybridisation with radiolabelled probes. 
After electrophoresis, DNA in the gel was denatured and slightly fragmented by 
soaking the gel in 0.25 M HCl for 10 minutes, followed by treating with 1.5 M NaCl, 
0.5 M NaOH for 30 minutes with one change of the solution. The gel was then 
neutralised by soaking in 3M NaCl and 0.5 M Tris-HC1 pH 8.0 for two 30 minutes 
washes. Denatured DNA fragments were then transferred to a nylon membrane. The 
transfer apparatus consisted of a tray containing 20 x SSC over which was placed a 
glass plate slightly narrower than the tray; two sheets of Whatman 3 MM paper 
soaked in 20 X SSC were placed on top of the glass plate with their ends dipping into 
the 20 x SSC solution in the tray. The gel was placed directly onto the paper making 
sure that no air bubbles were trapped underneath. A piece of nylon filter membrane 
(Hybond-N, Amersham LIFE SCIENCES) pre-cut to the size of the gel was soaked in 
water for 15 minutes, washed briefly in 20 x SSC and then placed onto the gel taking 
care to avoid air bubbles. Four sheets of Whatman 3 MM paper cut to the size of the 
gel were soaked in 20 x SSC and placed on top of the membrane and surrounded by 
saran-wrap, followed by a stack of paper towels 8-10 cm high. The various layers 
were compressed using another glass plate and a 1.5 Kg weight. Transfer was allowed 
to proceed overnight. The apparatus was dismantled, nylon membrane separated from 
gel and rinsed briefly in 2x SSC to remove any adherent agarose particles. The filter 
was then air dried and DNA fixed onto the membrane using a U. V crosslinker. 
2.2.19 Preparation of radioactively labelled DNA probes 
DNA fragments were labelled to high specific activity with 32P using the random 
primer kit (Stratagene), following the manufacturers protocol. The method relies on 
the ability of random hexanucleotides to anneal to multiple sites along the length of a 
DNA template. The primer-template complex is then a substrate for Klenow fragment 
of DNA polymerase I. The enzyme synthesises new DNA by incorporating nucleotide 
monophosphates at the free 3'-OH group provided by the primer. The newly 
synthesised DNA is made radioactive by substituting a radiolabelled nucleotide for a 
non-radioactive one in the reaction mixture. 
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2.2.20 Hybridisation of Southern blot 
Southern blots (described in section 2.2.18) were hybridised with radioactively 
labelled DNA probes. Prehybridisation and hybridisation of Southern blots were done 
in a hybridisation buffer. The hybridisation buffer consists of 21.3 ml of 100 x 
Denhardt's solution (2g Ficoll 400,2g polyvinylpyrolidine [PVPI, 2g BSA fraction V 
in 100 ml [Denhardt, 1966]), 22.4 g NaCl, 11.2 g Na2Citrate, 42.6 g Dextran sulphate 
(Pharmacia) and 0.5% SDS made up to 500 ml. 
Just before pre-hybridisation, 0.5 ml of denatured salmon sperm DNA (10 mg/ml, 
GIBCO BRL), was added to 10 ml of the hybridisation buffer at 650C. The mixture 
was then added to the Southern blot presoaked in 2x SSC in a hybridisation flask. 
Prehybridisation was done at 65°C for 4 hours in a Hybaid hybridisation oven. The 
pre-hybridisation solution was subsequently discarded and 10 ml of pre-warmed (at 
65°C) hybridisation buffer added to the flask. Heat denatured radiolabelled DNA 
probe (by incubating the radiolabelled DNA probe at 100°C for 5 minutes) and 0.5 ml 
of denatured salmon sperm DNA were added to the Southern blot and hybridised 
overnight. The probe solution was discarded by pouring it down a designated 
radioactive disposal sink. The filter was washed twice for 20 minutes with 2x SSC 
and 0.1% SDS at 65°C. The filter was repeatedly washed in a higher stringency 
solution of 0.1 x SSC and 0.1% SDS at 65°C for 30 minutes, until most of the non- 
specific probe-DNA interactions were removed, using Geiger monitor to detect 
background. The filter was then wrapped in Saran wrap, removing excess liquid but 
keeping the filter damp. Hybridisation signals were detected by autoradiography. 
2.2.21 DNA Sequencing 
Sequencing of plasmid DNA was done by the dideoxy chain termination method 
(Sanger et al., 1977) using sequenase kit Version 2.0 (United States Biochemicals), 
following the protocol supplied with some modifications. Plasmid DNA preparation 
(1-5 µg DNA) in a volume of 18 µl was mixed with 2 µl of NaOHH/EDTA (2 M/2 
mM), and incubated at 650C for 15 minutes. The denatured DNA was precipitated by 
adding 2 µl of 3M sodium acetate pH 5.2 and 50 µl of ethanol (95%), mixed and 
incubated on dry ice for 10 minutes. The precipitated DNA was pclleted by 
centrifugation at 14000 rpm for 10 minutes and washed with cold 70% ethanol. The 
DNA was resuspended in 7 µl of distilled water and mixed with 2 µl of 5X 
sequencing buffer (0.5 M Tris-HCI, pH 8,10 mM MgCI2,150 mM NaCI), and 1 µl of 
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primer (0.2 tg/µl). The mix was incubated at 650C for 15 minutes and then cooled to 
room temperature. The annealed plasmid DNA and primers were used in labelling and 
termination reactions as described in the kit protocol, using [a35S]-dATP at > 1000 
Ci/mmol (Amersham). 
An 8% polyacrylamide/urea gel was made by adding 400 . tl 10% ammonium 
persulphate (AMPS; BDH) to 75 ml acrylamide + urea solution (Acryl-a-mix 8, 
Promega; i. e. acrylamide to bis-acrylamide at 19: 1,8M urea, 1x TBE, 0.05% 
N, N, N', N', tetramethylethylenediamine [TEMED]), to initiate polymerisation. 
Immediately before loading, the reactions were denatured by heating to 95% for 5 
minutes. The sequencing reaction was analysed by electrophoresis through the 8% 
polyacrylamide/urea gel in TBE buffer for 2 hours at 70W. Gels were then fixed in 
5% methanol, 10% acetic acid for 10 minutes and then transferred to a Whatman 3 
MM paper and dried under vacuum at 800C. Signals were visualised by 
autoradiography. 
2.2.22 General polymerase chain reaction (PCR) 
The PCR technique used is a modification of Saiki et al., (1988). A pair of DNA 
oligonucleotide primers (0.2µg of each) were used to amplify DNA sequences from a 
plasmid (0.1µg) or genomic (0.1µg) template DNA in a PCR reaction. The reactions 
were done in a final 50µl volume containing 5 µl 10 x Taq polymerase buffer 
(Boehringer Mannheim), 1 tl each of dATP, dTTP, dCTP and dGTP ( of a 10 mM 
stock each) and 0.5µ1 Taq polymerase (Boehringer Mannheim). The reaction was 
overlaid with mineral oil and placed in a thermocycler. The PCR reactions were run 
for 35 cycles (30 seconds at 95°C, 2 minutes at 600C, 3 minutes at 72°C ) unless 
otherwise stated. Aliquots (10µl) of the PCR products were separated on a 0.7% 
agarose gel and DNA visualised by ethidium bromide staining. 
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2.3 Mammalian cell culture techniques 
2.3.1 Cell line 
The cell line used is the Chinese Hamster Ovary (CHO-DUKX B 11, American Type 
Culture Collection, Reference: CCL 61), obtained from the Wellcome Research Labs., 
Kent (now Glaxo Wellcome Medicines Centre, Stevenage). 
2.3.2 Cell Culture Media 
2.3.2.1 Complete Medium 
The complete medium used for the maintenance of CHO-DUKX B 11 cell line was 
Iscove's modified Dulbecco's medium (Iscove's DMEM, containing L-Glutamine, 
GIBCO BRL). The medium was supplemented with 10% foetal calf serum (FCS, 
Advanced Protein Products Ltd), non-essential amino acids (NEAA; alanine, 
aspartate, glycine, serine, proline, glutamate and asparagine each at 100 µM; 
Flow/ICN), penicillin (100 units/ml), streptomycin (100 µg/ml), and HT medium (0.1 
mM hypoxanthine/0.01 mM thymidine, GIBCO BRL). 
2.3.2.2 Select Medium 
The medium used for the selection of dihydrofolate reductase positive (DHFR+) 
phenotype was Iscove's DMEM as above supplemented with non-essential amino 
acids, penicillin (100 units/ml), streptomycin (100 µg/ml), as above, 10% dialysed 
FCS (Advanced Protein Products Ltd), and omitting the hypoxanthine/thymidine 
solution. 
2.3.3 Maintenance of CHO-DUKX 1311 cell line 
CHO-DUKX B 11 cells were grown in Iscove's-DMEM complete medium as adherent 
cultures, in flasks at 370C in a 5% CO2 atmosphere. Adherent cells were passaged 
when they reached confluency (-80% viability), approximately 3-4 days. Culture 
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medium was discarded and the cells washed with phosphate buffered saline (PBS, 
GIBCO BRL). Cells were detached from the flask wall by incubation with vcrscne 
(0.2 g EDTAIL in an isotonically buffered saline; GIBCO BRL) + 0.25% trypsin 
(GIBCO BRL). Approximately 5 ml of the versene/trypsin solution was added to a 
T75 flask and left for 3 minutes at room temperature. Following this, the dislodged 
cells were diluted with 5 ml of fresh medium. Cell suspension was transferred to a 15 
ml Falcon centrifuge tube (Becton Dickinson), and pelleted by centrifugation in a 
Sorvall RT6000B centrifuge (as were all further mammalian suspensions), at 1000 
rpm (-. 135 g) for 5 minutes. The cell pellet was resuspended in 5 ml of fresh medium, 
an aliquot was diluted ten fold with trypan blue solution (0.4% in saline, ICN Flow), 
and viable cells (non-stained) counted using a haemocytometer. Tissue culture flasks 
were seeded at ~2x 105 cells/ml. 
2.3.4 Freezing cell lines for long term storage in liquid nitrogen 
CHO-DUKX B 11 cells in exponentially growing phase (-80% viability) were pelleted 
by centrifugation as above. The cells were resuspended in ice-cold freezing medium 
(i. e. complete culture medium containing 20% FCS and 10% dimethyl sulphoxide 
[DMSO]), at -4x 106 cells/ml. Aliquots (1 ml) were transferred to cryovials and 
placed in Bicell freezing vessels, in a -700C freezer overnight, and then transferred to 
liquid N2 the following day. 
2.3.5 Reviving frozen cells 
Vials of cells were removed from liquid N2 and the contents thawed immediately. 
Cells were slowly added to 9 ml of pre-warmed medium in a 15 ml Falcon tube, to 
allow the DMSO to diffuse out of the cell membrane. The cells were pelleted by 
centrifugation as above, and the supernatant, containing DMSO, discarded. Cells were 
resuspended in 12 ml of medium and transferred to a T75 flask. 
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2.4 Mammalian cell transfection techniques 
2.4.1 Transient transfection of CHO"DUKX B11 cells using Transfectam 
Transfectam, a synthetic cationic lipopolyamine molecule (Promega), was used 
following the manufacturer's instructions with optimisation for CHO-DUKX B 11 
cells. Transient transfections were done in a 6-well tissue culture plate. Wells were 
seeded with 2.5 x 105 cells, a day before transfection. For each well of cells to be 
transfected, 20µg Transfectam, DNA (different amount) and 0.5 ml serum-free 
medium (SFM) were mixed together in a polystyrene Bijoux. This mix was incubated 
for 10 minutes at room temperature, to allow transfectam and DNA complex to form. 
Meanwhile, adherent cells (approximately 75% confluent), were washed twice with 
SFM (serum interferes with the action of transfectam). The DNA/transfectam/SFM 
mix and a further 0.5 ml SFM were added to each well after the second wash and the 
plates incubated at 37°C for 4 hours. The transfection mix was removed and each well 
fed with 1 ml serum-containing Iscove's DMEM medium. The plate was returned to 
the 370C incubator for 1 to 2 days. Transfected cells were harvested by centrifugation 
and plasmid DNA isolated using Promega mini-prep kit. 
2.4.2 Stable transfection of CHO-B11 cells using Transfectam 
The method described for transient transfection in section 2.4.1 was followed, but 
scaled up fourfold. A T25 flask was seeded with 1x 106 cells the day before 
transfection. Plasmid DNA (16 µg) was mixed with 80µg Transfectam and the 
mixture added to the CHO-DUKX B 11 cells and incubated at 370C for 4 hours. Cells 
were fed with 15 ml of complete serum medium and incubated without selection for 2 
days. Transfected cells were dilution cloned into select medium as described in 
section 2.4.3. 
2.4.3 Dilution cloning of stably transfected CHO-DUKX B11 cells 
Transfected cells growing in complete medium were harvested 2 days after 
transfection and counted. Cells were suspended in select medium and viable density 
adjusted to 1.5 x 103 cells/ml and diluted in select medium to 500 cell/ml, 150 
cell/ml, 50 cell/ml, 15 cell/ml, 5 cell/ml and 1.5 cell/ml. The diluted cells were plated 
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out in 96 well plates at 200 µl/well to give 100,30,10,3,1, and 0.3 cells/well. The 
plates were incubated at 370C for approximately three weeks until individual clones 
appeared. The supernatant from wells containing single clones was assayed for 
secreted alkaline phosphatase (SAP; see section 2.8.3) expression and positive clones 
expanded. Clones were named according to the plate and well co-ordinates from 
which they were picked. 
2.4.4 Targeted transfection of CHO-DUKX 1311 transformants using 
LipofectACE 
LipofectACE reagent, a 1: 2.5 (w/w) liposome formulation of dimethyl 
dioctadecylammonium bromide and dioleoyl phosphatidylethanolamine (Life 
Technologies, Inc. ) was used essentially as suggested by the manufacturer with the 
following modifications. Cells were seeded in a six well tissue culture dishes and 
grown to -80% confluency (1 x 105 cells). Plasmid DNA and recombinant Crc 
protein (purified from baculovirus-insect system), or DNA and pBS (Bluescript, 
Stratagene), were mixed with opti-MEM (Life Technologies Inc. ) to give a final 
volume of 100 µl, and incubated at 0°C for 5 minutes. In a separate aliquot, 12 pl of 
the lipofectACE was added to 88 µl opti-MEM. The two aliquots were combined and 
incubated for 10 minutes at room temperature. The volume was brought to 1 ml by the 
addition of opti-MEM and the mixture added to a single well of cells that had been 
previously washed twice with opti-MEM. Cells were incubated for 5 hours at 370C, 1 
ml of DHFR+ select medium was added and incubation continued overnight. The next 
day, the medium was replaced with fresh DHFR+ select medium. Selection for 
targeted transformants was done 48 hours after the lipofection procedure in DIIFR+ 
select medium supplemented with G418 (400 tg/ml final concentration, Sigma). 
G418 resistant clones observed (2-3 weeks later), were picked and propagated for 
further analysis. 
2.4.5 Stable transfection of CHO-DUKX Bll by electroporation 
Exponentially growing cultures of CHO-DUKX B 11 cells were harvested by versene 
+ trypsin treatment and the viable cell density determined. For each electroporation, 1 
x 107 cells in a 0.8 ml of complete medium were transferred to a sterile polystryrene 
Bijoux containing plasmid DNA. The cells/DNA mix was transferred to a sterile 
electroporation cuvette (Biorad, 0.4 cm electrode gap) at room temperature. Cells 
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were pulsed once at 250V, 960µF, using a Biorad gene pulser. The cuvcttc was 
returned to room temperature for 5 minutes, after which the contents were added to 12 
ml of complete medium in a T75 flask, and returned to the 370C incubator. Two days 
after transfection cells were harvested and counted. The cells were dilution cloned (as 
described in section 2.4.3) in DHFR+ select medium and returned to 370C for 2-3 
weeks, until resistant clones appeared in the wells. Wells containing single clones 
were assayed for SAP expression and positive clones expanded. 
Alternatively, cells for electrporation were washed with 10 ml of cold PBS after 
viable cell density had been determined. Cells were resuspended in 0.8 ml of cold 
PBS (to 1x 107 cells), and added to a sterile polystyrene Bijoux containing DNA 
with or without Cre protein. The mix was transferred to a sterile clectroporation 
cuvette and placed on ice for 5 minutes. Cells were pulsed once at 250V, 960µF using 
a BioRad gene pulser. The cuvette was returned to ice for 5 more minutes after which 
the cells were transferred to T75 flask and grown as described above. 
2.4.6 Expanding CHO-DUKX B11 transformed clones 
To expand single clones expressing SAP in 96-well plates, a few drops of versene + 
trypsin solution was added to each well. Dislodged cells were transferred to one well 
of a 24-well plate, containing 0.5 ml of fresh DHFR+ select medium. Plates were 
placed in a 370C incubator. When the cells reached confluency, they were assayed for 
SAP production, and, if still positive, they were expanded further from the 24-well 
plate to a 6-well plate, T25 and T75 flasks, using appropriate amount of versene + 
trypsin to detach the adhered cells at each stage. G418 resistant clones were expanded 
in DHFR+ select medium containing G418 (400 µg/ml). 
2.5 Insect cell and Baculovirus Techniques 
2.5.1 Maintenance of SF9 cell line 
The Spodopterafrugiperda cell line Sf9 (originated from IPLB-SF-9 cells, Vaughn et 
al., 1977; obtained from WRL [now GWR&D]), was maintained in TC 100 medium 
(GIBCO BRL Life Technologies) which was supplemented with 10% foetal calf 
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serum (Advanced Protein Products), L-Glutamine (GIBCO BRL), and antibiotic- 
antimycotic solution (GIBCO BRL). All Sf9 cells were grown in this (complete) 
medium unless stated otherwise. For serum-free TC 100 medium, the FCS and 
antibiotic-antimycotic solutions were omitted. Cells were maintained as suspension 
cultures, grown in spinner flasks at 170C. Flasks were seeded at approximately 0.3 X 
106 cells/ml and passaged after 3 to 4 days, when the density had reached 
approximately 1.5 x 106 cell/ml. 
2.5.2 Production of recombinant baculovirus 
BacPAK6, an engineered Autographa Californica DNA digested with 11su36I 
(Clontech; Fig 3.2), was used as the viral genomic DNA into which the foreign gene 
was targeted. Production of recombinant baculovirus was done essentially by 
following the manufacturers protocol. A 6-well plate was seeded with 2x 106 Sf9 
cells/well (one well for each recombinant virus to be made), and the cells allowed to 
adhere for 1 hour at 28°C. For each transfection, 100 ng of BacPAK6 DNA digested 
with Bsu361,500 ng of transfer vector containing the cre gene and 5 µg of lipofectin 
(GIBCO BRL) were mixed together in a polystyrene container and incubated at room 
temperature for 15 minutes to allow lipofectin-DNA complex to form. The adhered 
insect cells were washed twice with serum free TC 100 medium (lipofectin-mediated 
transfection is inhibited by a component of serum), and 1.5 ml of serum free medium 
added to each well. The Lipofectin-DNA mixture was added dropwise to a single well 
of cells and the plate incubated at 280C for 5 hours to allow co-transfection of the 
cells with transfer vector and BacPAK6 DNA to take place. Subsequently, 1.5 ml of 
complete TC 100 medium was added to each well to stop the action of the lipofectin 
and incubation continued for 2-3 days at 28°C. Recombinant viruses formed as a 
result of homologous recombination between BacPAK6 and the transfer vector were 
released by cell lysis into the medium. The medium was harvested and used to infect 
Sf9 cells for plaque purification in order to isolate a single recombinant virus clone. 
2.5.3 Plaque purification of recombinant baculovirus 
A 6-well plate was seeded with 2x 106 Sf9 cells/well and the cells allowed to adhere 
for 1 hour at 28°C. The supernatant from insect cells (co-transfected with BacPAK6 
and the transfer vector) putatively containing recombinant virus was serially diluted in 
complete TC 100 medium to a million fold. The medium was removed from the cells 
69 
and replaced with 1 ml of the diluted virus solution per well. The plate was rocked for 
1-2 hours at room temperature during infection. The inoculum was removed from 
each well and the infected cells overlaid with 2 ml agarose/TC 100 (I g of Scaplaquc 
agarose autoclaved in 16 ml distilled water, cooled to 370C and 32 ml warmed 
complete TC 100 medium added). The agarose was allowed to set for 15 minutes and 
then 2 ml of complete TC 100 was added to each well and plate returned to 280C 
incubator for 2-3 days. 
Plaques were visualised by staining the cells with 100µl Neutral Red/well for 2 hours 
and destained by inverting the plate at 40C overnight. To isolate a clonal recombinant 
virus, a plug of agarose over an isolated plaque was removed, using a wide-bored 
plastic pastette and dropped into 1 ml of complete TC 100. Recombinant virus 
dispersed out of the plug into the medium after several hours of incubation at 40C. 
A second round of plaque purification was done to ensure that a recombinant virus 
was clonal by following the same procedure as above; by infecting cells with 10-1,10- 
2 and 10-3 dilutions of the medium containing recombinant virus dispersed from the 
agarose plug. A well separated plaque was picked and assumed to contain a clonal 
recombinant virus. 
2.5.4 Preparation of a high titre virus stock 
One well of a 6-well plate was seeded with 2x 106 Sf9 cells and the cells allowed to 
adhere for 1 hour at 28°C. Complete TC 100 medium (1 ml) containing recombinant 
viruses (isolated by agarose plug purification) was used to infect the cells for 1-2 
hours, rocking at room temperature. Complete TC 100 medium (1 ml) was then added 
to the well and the plate incubated at 280C for 3-4 days, after which time the majority 
of the cells would have been infected and the replicated virus released into the 
medium. This high titre supernatant was harvested and passed through a 0.2µm filter 
unit (Coster) to remove cell debris. Larger-scale infections, following a similar 
protocol, gave rise to larger volumes of high titre, filtered virus stock. 
2.5.5 Titration of recombinant virus 
Using a method essentially the same as that for the plaque purification of recombinant 
virus (Section 2.5.3), high titre viral stocks were serially diluted in complete TC 100, 
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and 500 µl of the 10-4 to 10-9 dilutions used to infect 2x 106 Sf9 cells/well in a 6-well 
plate. Infected cells were overlaid with agarose/TC 100 and 2 ml complete TC 100, 
and incubated at 280C for 3-4 days. Following staining with neutral red and 
destaining, wells containing between 10 and 100 plaques were scored to give the 
number of plaque forming units (pfu) in 500 µl of a certain dilution of the virus. The 
titre, in pfu/ml, of the virus stock was calculated and confirmed by repeating the 
titration. 
2.5.6 Infection of Sf9 cells 
Small-scale infections of Sf9 cells were generally done in a 12-well plate. Cells were 
plated at 1x 106/well and allowed to adhere for 1 hour. The medium was removed 
and replaced with approximately 0.5 ml complete TC 100 containing an aliquot of the 
viral stock, to give the required multiplicity of infection (designated time 0 hours 
post-infection). The plate was rocked at room temperature for 1-2 hours, during which 
time the cells were infected. A further 0.5 ml of medium was added to the wells and 
the plate incubated at 280C until the supernatant and/or cells were harvested. 
2.5.7 Recombinant baculovirus DNA preparation 
Sf9 (2 x 106) cells were infected with the recombinant virus at 10 pfu/cell. After 2-3 
days incubation at 280C, the culture medium containing virus at high titre was 
harvested and filtered to remove cell debris. 1 ml of this clarified supernatant was 
transferred to a microcentrifuge tube and the virus preparation pelleted by 
centrifugation at 14000 rpm (15800 g) for 30 minutes at 4°C. The virus preparation 
was lysed by gentle resuspension in 100 µl of 10 mM Tris-HCI, pH 7.6,10 mM 
EDTA, 0.25% SDS. The protein in the lysate was degraded by the addition of 
Proteinase K to a final concentration of 0.5 mg/ml and incubated at 370C for 1 hour. 
The viral DNA in solution was isolated by extraction with an equal volume of phenol- 
chloroform. Extraction was done twice by gentle mixing of the two solutions (with no 
vortexing because the high molecular weight viral genomic DNA is susceptible to 
shearing forces). The upper aqueous phase containing the DNA was recovered 
avoiding any denatured protein at the interface. The DNA was precipitated by adding 
0.1 volumes of 3M sodium acetate pH 5.2 and 2.5 volumes of ice-chilled ethanol 
(95%) and mixed. The precipitated DNA was pelleted by centrifugation at 14000 rpm 
(15800 g) for 10 minutes at room temperature and washed twice with ice-cold 70% 
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ethanol. The DNA pellet was allowed to air dry and dissolved in 50 tl TE buffer p1I 
8.0 containing DNAase free pancreatic RNAasc (50 pg/ml) and stored at -200C. 
2.5.8 Screening recombinant virus by the polymerase chain reaction (PCR) 
A combination of oligonucleotide sequences designed as forward primer (BK59) to 
anneal within the polyhedrin locus and a reverse primer (CB 1741; see appendix 2 for 
sequence) to anneal at the 5' end of the cre gene were used to amplify DNA sequences 
from the viral DNA. For the PCR reaction, 0.1 tg of viral DNA and 1 Al of each 
primer (0.2 µg/µl) were used. The PCR reaction was done in a final 100 tl volume 
containing 10 t1 10 x Taq polymerase buffer (Boehringer Mannheim), 2 tl each of 
dATP, dTTP, dCTP and dGTP (of a 10 mM stock each) and 0.5 tl Taq polymerase 
(Boehringer Mannheim). The reaction was overlaid with mineral oil and placed in a 
thermocycler. The PCR reaction was run for 35 cycles (30 seconds at 950C, 2 minutes 
at 60°C, 3 minutes at 72°C). An aliquot (10 µl) of the PCR product was separated on 
a 0.7% agarose gel and DNA visualised by ethidium bromide staining. 
2.6 Protein techniques 
2.6.1 Polyacrylamide gel electrophoresis (PAGE) of protein samples 
Polyacrylamide gels were used for the separation and analysis of proteins. All gels 
had an acrylamide to bis-acrylamide ratio of 29.5: 1 (Bochringer Mannheim). Gels 
consisted of a 5% acrylamide stacking gel portion made up in 125 mM Tris, pH 6.8, 
0.1% SDS, 0.05% AMPS and 0.001% TEMED. The resolving part of the gel, 12.5% 
acrylamide, was made up in 374 mM Tris, pH 8.8,0.1% SDS, 0.1% AMPS and 
0.001% TEMED. Samples were diluted 1 in 2 with protein sample buffer (62.5 mM 
Tris, pH 6.8,2.5% glycerol, 25 mM dithiothreitol [DTT], 0.025% bromophenol blue), 
and heated at 950C for 2 minutes before loading onto the gel. Gels were run in 25 mM 
Tris, 259 mM glycine, 0.1% SDS at 20 mA until the bromophenol blue dye front 
reached the bottom. Sea Blue molecular weight size markers (Norex), were also run 
on the gel (See Appendix 8 for molecular weight sizes). 
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Proteins which had been separated by SDS-PAGE were stained in the gels with 
Coomasie Brilliant Blue R250. The gels were submerged in staining solution (45% 
methanol, 10% glacial acetic acid, 0.25% Coomasie Brilliant Blue R250) and left to 
rotate gently on a platform shaker for 4 hours at room temperature. The gels were 
removed and placed in destaining solution (45% methanol, 10% glacial acetic acid) 
with gentle shaking for 4-18 hours. The gels were photographed and/or stored in 10% 
acetic acid. 
2.6.2 Metabolic labelling of proteins produced by the recombinant baculoviral 
vector 
Sf9 (0.5 x 106) cells were seeded onto 7 wells of a 24-well cell culture dish 
(COSTAR). Cells were infected with 10 pfu/cell of the recombinant virus for 1 hour. 
The inoculum was replaced with 1 ml of complete medium and returned to 270C for 3 
days. The complete medium was subsequently removed from infected cells and 
replaced with 0.5 ml of methionine- and cysteine-free TC 100 medium (GIBCO 
BRL), and returned to 270C for 1 hour. The medium was aspirated and replaced with 
150 µl of methionine- and cysteine-free TC 100 medium containing 10 pCi of Trans 
35S-methionine and -cysteine labelling mix (Amersham; 1000 pCi/mmol; 1 
Ci=37GBq), at room temperature for 2 hours. After labelling, the radioactive medium 
was removed and cells solubilised in 100 µl lysis buffer (62.5 mM Tris-IICI, pH 6.8; 
2.5% SDS; 12.5% glycerol; 0.1 M DTT and 0.005% bromophenol blue). Cell lysates 
were heated at 950C for 2 minutes and then electrophoresed on a 12.5% SDS-PAGE 
(see section 2.6.1). Gels were transferred onto 3 MM paper and dried under vacuum at 
700C for an hour. Proteins were visualised by autoradiography and molecular weights 
were estimated by comparing electrophoretic mobility with that of Sea Blue molecular 
weight size markers (See Appendix 8 for molecular weight sizes). 
2.6.3 Purification of Cre recombinase from immobilised Ni++. spin column 
A metal chelate adsorbent, Ni+'-NTA (nitrilo-tri-acetic acid, charged with nickel 
ions) with a strong binding affinity (Kd=10-13, pH 8.0; far greater than the affinity 
between most antibodies and antigens, or enzymes and substrates) for proteins or 
peptides containing six or more consecutive histidine residues at either their N- or C- 
terminus (Hochuli et al., 1988), was used for the purification of proteins containing 
histidine tag in a single-step by affinity chromatography. 
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Sf9 (5 x 109) cells were infected with the recombinant baculovirus at 10 pfu/ccll. Sf9 
infected cells were harvested 3 days after the infection by centrifugation at 1000 rpm 
(- 135 g) for 5 minutes and washed twice with PBS. The cell pellet was resuspended 
by vortexing in 5 ml of cold binding buffer (4 mM NaH2PO4; 46 mM Na2IIPO4; 300 
mM NaCl; 2.5 mM Imidazole, pH 8; to which 10 mM 13-mercapthoethanol and 1X 
protease inhibitor cocktail [ Pancreas extract 15 µg/ml; Pronase 1.5 µg/ml; 
Chymotrypsin 1.5 gg/mi; Thermolysin 0.8 tg/ml; Trypsin 0.002 tg/ml and Papain I 
mg/ml] were added just before use). The cell suspension was freeze-thawed three 
times and centrifuged at 14000 rpm (10508 g) for 10 minutes. The supernatant was 
removed and loaded onto Ni+'-NTA spin column (prepared by adding 2 ml of Ni++- 
NTA agarose [Qiagen] to a 10 ml column and then centrifuged at 1000 rpm [-135 g] 
to pack the column), which had been equilibrated with 5 ml of the binding buffer. The 
column was erected to allow protein(s) to bind under gravity for 10 minutes and then 
centrifuged at 1000 rpm (-135 g) for 15 minutes to remove unbound proteins. 
The column was subsequently washed twice (to remove proteins that bound non- 
specifically to the NTA resin) with 4 ml of wash solution (4 mM NaI2PO4; 46 mM 
Na2HPO4; 30 mM NaCl; 5 mM Imidazole; pH 8,10 mM ß-mercapthoethanol and 1x 
protease inhibitor cocktail) by centrifugation at 1000 rpm (-135 g) for 15 minutes 
between washes. After the second wash, 1.5 ml of elution buffer (0.4 mM NaH2PO4; 
4.6 mM Na2HPO4; 30 mM NaCl; 50 mM Imidazole; pH 8,10 mM ß- 
mercapthoethanol and 1x protease cocktail inhibitors) was added to the column. 
Hexa-histidine-tagged (Cre recombinase) protein was eluted from the column by 
centrifugation at 1000 rpm (-135 g) for 15 minutes. The eluted sample was dialysed 
against 2 litres of Cre reaction buffer (20 mM Tris-HCI; pH 7.5,300 mM NaCl and I 
ml Na2EDTA) overnight at 4°C. The dialysed sample was filtered through 0.22 µM 
filter (non-pyrogenic, COSTAR), and stored as 1001t1 aliquots at -700C or in 50% 
glycerol at -20°C. Aliquots (20 µl) were taken at each step in the purification process 
and 30 tI of protein sample buffer (62.5 mM Tris-HCI, p11 6.8; 2.5% SDS; 12.5% 
Glycerol; 25 mM DTT and 0.025% bromophenol blue) added prior to electrophoresis. 
Proteins were separated on a 12.5% SDS-PAGE and protein bands detected by 
Coomasie blue staining (see section 2.6.1). 
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2.6.4 Determination of protein concentration 
Protein concentrations were determined by a calorimetric method based on the one 
described by Bradford (1976) using a commercially available reagent (Bio-Rad 
Protein Assay dye reagent). Protein samples (100 µl) were mixed with 5 ml of the 1x 
reagent in a test tube. This was left at room temperature for 5-15 minutes before 
reading the absorbance at 595 nm. A standard curve was constructed using bovine 
serum albumin (BSA). The concentration of a protein sample was estimated by 
interpolating from the curve. 
2.7 Protein-DNA interactions in Band Shift Assays 
2.7.1 Non-denaturing polyacrylamide gels 
All gels had an acrylamide to bis-acrylamide ratio of 29.5: 1 (Boehringer Mannhein). 
Band shift assays were loaded onto 5% (w/v) non-denaturing polyacrylamide 
continuos gel made up in 0.5 x TBE buffer (89 mM Tris/borate, 89 mM Boric acid, 2 
mM EDTA, pH 7.8), 0.1% AMPS, and 0.001% TEMED. Gels were pre- 
electrophoresed for 1 hour in 0.5 x TBE buffer and then run at room temperature for 
2-3 hours at 30 mA. After electrophoresis gels were transferred onto 3 MM paper and 
dried - under vacuum at 700C for 1 hour. Band shifts were visualised by 
autoradiography. 
2.7.2 Band shift assays 
Band shift (or gel retardation) assays were done essentially as described by Zimarino 
and Wu, (1987) using recombinant protein purified from the insect-baculovirus 
system and double stranded oligonucleotides comprising DNA sequences. 
2.7.2.1 Synthesis of oligonucleotides 
All oligonucleotides were synthesised and purified by Hugh Spence (WRL [now 
GWR&D]). Purified oligonucleotides were dissolved in TE buffer and precipitated 
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with ethanol. After ethanol precipitation, the oligonucleotides were redissolved in 
appropriate volume of TE buffer and stored at -200C. The concentration of 
oligonucleotide was determined by measuring it's optical absorbance at 260 nm given 
that an A260 of 1=20µg/ml of single stranded DNA. Alternatively the optical 
absorbance reading at 260 nm was used to calculate the molarity of the 
oligonucleotide using molar extinction coefficients of its components (extinction 
coefficients: T=9.7/base, C=9.2/base, G=11.4/base and A=15.4/base). 
2.7.2.1 Annealing of complementary oligonucleotides 
Oligonucleotide sequences were designed as sense and anti-sense strands to 
correspond to loxP, frt and IoxP/frt hybrids sites (hybrid contains either loxP spacer or 
frt spacer sequences, see Appendix 4 for sequences). The complementary sense and 
anti-sense strands (2µg of each) were annealed in a 20 µI annealing buffer (10 mM 
Tris pH 8.5 and 50 mM NaCl). The solution was heated at 850C for 5 minutes and 
left to cool slowly to room temperature. 
2.7.2.2 5' labelling of oligonucleotide with 32P 
The 5' termini of the annealed oligonucleotides (0.1 µg) were radiolabelled by T4 
polynucleotide kinase (Promega) at 2 units/µg of DNA in a 20 µl reaction volume 
containing 10 µCi [y-32P] dCTP (Amersham; 3000 Ci/mmol), and 1x polynucleotide 
kinase reaction buffer (Promega). The reactions were incubated at 370C for 30 
minutes followed by inactivation of the enzyme by incubation at 700C for 10 minutes. 
2.7.2.3 Removal of unincorporated 'y-32P dCTP 
Unincorporated nucleotides were removed by Sephadex G-25 gel filtration 
chromatography. Columns were prepared in 2 ml disposable syringes. The tip of the 
syringe was plugged with sterile siliconised glass wool. The column was packed with 
2 ml of Sephadex G-25 pre-swollen in TE buffer. The column was placed in a 15 ml 
Falcon tube and packed by centrifugation 1000 rpm (135 g) for 2 minutes in a bench- 
top centrifuge. The column was washed with 500 µl of TE buffer and centrifuged as 
above. The kinased oligonucleotide sample was applied to the column and spun at 
1000 rpm for 2 minutes. The radiolabelled oligonucleotide was collected into a sterile 
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microfuge tube which was placed inside the 15 ml Falcon tube. An cstimatc of the 
efficiency of incorporation was achieved by measuring the counts per second in 
solution before and after purification from the column using a Geiger counter. The 
radiolabelled oligonucleotides were stored as 10 µl aliquots at -200C. 
2.7.2.4 DNA-protein interaction in band shift assay 
The 32P-labelled oligonucleotides were incubated with or without the recombinant 
Cre protein in a total reaction volume of 10 µl containing the assay buffer (50 mM 
Tris-HC1, pH 7.4; 10 mM MgC12; 30 mM NaCI; I mg/ml BSA; 1 µg/ml poly dI-dC; 
20% Ficoll). The reactions were started by the addition of the Crc protein and 
incubated at room temperature for 20 minutes. In the control reactions the interaction 
of the recombinant Cre protein and radiolabelled oligonucleotides were competed 
with 100-fold molar excess of the corresponding unlabelled oligonucleotides. 
After incubation, reactions were loaded onto a 5% (w/v) non-denaturing 
polyacrylamide gel (see section 2.7.1). The gels were run at room temperature for 2-3 
hours at 240V (30 mA). After electrophoresis, gels were dried and signals detected by 
autoradiography. 
2.7.3 "On rate-off rate" band shift competition assays 
The "on-rate" of Cre-loxP binding interaction was assayed by incubating the 32P- 
labelled loxP oligonucleotide with Cre protein in a total reaction volume of 80 Al in 
the binding buffer (described above) at 37°C. At various time points, 10 tl of the 
reaction mixture was removed and run on a 5% non-denaturing polyacrylamide gel (as 
above). 
The "off-rate" of Cre-loxP binding interaction was assayed by adding 10-fold molar 
excess of non-radiolabelled loxP oligonucleotide to the mixture after 10 minutes of 
pre-incubation of the Cre protein with radiolabelled loxP oligonucleotides ("on-rate"). 
At various time points into the competition reaction, 10 µl of the mixture was 
removed and immediately loaded onto the same gel as for the "on-rate". 
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2.8 In vitro assay systems 
2.8.1 In vitro Cre"mediated recombination assay 
Cre-loxP site-specific recombination in vitro was done by incubating the substrate 
plasmid (containing loxP sites) with or without the Cre protein in a 30 ltl total 
reaction volume containing assay buffer (50 mM Tris-IICI, pH 7.4; 10 mM MgCl2; 30 
mM NaCl; 1 mg/ml BSA at 370C for 20 minutes (unless otherwise stated). The 
reaction was stopped by heating at 700C for 10 minutes. After heat inactivation, the 
recombination event was analysed in three ways: 
2.8.1.1 Restriction digestion and Southern hybridisation analysis 
DNA in the recombination reaction was separated from the Cre protein by 
phenol/chloroform extraction (see section 2.2.3). The DNA was recovered by ethanol 
precipitation (see section 2.2.2) and resuspended in 20 tl of distilled water. DNA was 
then digested with the restriction endonucleases BamHI and ScaI and separated on a 
0.7% agarose gel. The DNA fragments were then transferred onto a nylon membrane 
(Hybond- N, Amersham) and hybridised (as described in section 2.2.20) with a 
radiolabelled DNA fragment corresponding to the ß-lactamase ampicillin resistance 
(ampr) gene. Hybridisation signals were quantified using a phosphoimager (Molecular 
Dynamics). 
2.8.1.2 Restriction digestion and quantification by Fluorescence 
DNA in the recombination reaction was extracted with phenol/chloroform, recovered 
by ethanol precipitation and resuspended in 20 µl of distilled water as described 
above. The DNA was then digested with the restriction endonuclease Scal and 
separated on an agarose gel. The gel was soaked in a SYBR Green solution (The stock 
solution was diluted 1: 10,000 in TE buffer; Molecular Probes, Inc). The staining was 
done in the dark (by covering the staining container with aluminium foil) with gentle 
agitation at room temperature for between 10-40 minutes. The amount of DNA in 
each band was then quantified using fluorimager (Molecular Dynamics). 
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2.8.1.3 Analysis of recombination event by phenotypic blue/white colour selection 
An aliquot of the recombination reaction (containing -50 ng of DNA) was used to 
transform E. coli DH5a competent cells (see section 2.2.13) and dilutions plated onto 
L-agar (containing 100 tg/m1 ampicillin 100 µg/ml IPTG and 150 µg/ml X-gal [5- 
bromo-4-chloro-3-indoyl-p-D-galactopyranoside]) and incubated at 370C overnight. 
2.8.1.3b Analysing recombinants by sequencing 
Single white colonies isolated on L-agar plates (see section 2.8.1.3) were picked into 
10 ml of LB medium and grown overnight with shaking at 37°C. Plasmid DNA was 
prepared from these cultures using Promega Magic/Wizard mini-prep kit following 
the manufacturer's protocol. Plasmid DNA preparations were sequenced as described 
in section 2.2.21. 
2.8.2 CAT ELISA assay of transformed CHO-DUKX B11 cells 
Enzyme-linked immunosorbant assay (ELISA) was used for the quantitative 
determination of chloramphenicol acetyl transferase (CAT) in transfected CIlO- 
DUKX B 11 cells. The CAT ELISA was done following the manufacturer's protocol 
(Boehringer Mannheim). 
The CAT ELISA is based on the sandwich-immunoassay principle. Antibodies to 
CAT (anti-CAT) were prebound to the surface of microtitre plate modules (MTP 
modules). Following lysis of the transfected cells, the cell extracts, which contained 
CAT were added to the MTP wells. All CAT contained in the cell extracts binds 
specifically to the anti-CAT antibodies bound to the plate surface. Next a digoxigenin- 
labelled antibody to CAT (anti-CAT-DIG), was added which binds to CAT. In the 
next step, an antibody to digoxigenin-conjugated to peroxidase (anti-DIG-POD) was 
added which binds to the digoxigenin. In the final step, the peroxidase substrate was 
added. The peroxidase catalyses the cleavage of the substrate yielding a coloured 
reaction product. The absorbance of samples were determined using a microtitre plate 
(ELISA) reader at 405 nm with a reference wavelength at approximately 490 nm. 
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2.8.3 Secreted Alkaline Phosphatase (SAP) assay 
SAP assay was used for the quantitative determination of transfected C11O-DUKX 
B11 cells expressing the reporter gene encoding SAP. A 200µl aliquot of the culture 
medium was transferred to a microcentrifuge and centrifuged at 14000 rpm (15800 g) 
for 2 minutes, to pellet cell debris. The clarified supernatant was transferred to another 
microcentrifuge tube and heated at 65°C for 30 minutes to inactivate non"placental 
alkaline phosphatases present in the serum (SAP is stable at 650C). The supernatant 
was diluted 1 in 100 (or less if low levels of SAP expected), in diethanolamine (DEA) 
buffer (1 M diethanolamine [Sigma], 0.5 mM MgC12, pH 9.6). Substrate solution 
made by dissolving one 20 mg tablet of p-nitrophenyl phosphate (Sigma) in 10 ml of 
DEA buffer (to give 2 mg/ml was p-nitrophenyl phosphate in DEA buffer) was 
dispensed into a 96 well microtitre plate at 180 µl per well. The assay (done in 
duplicates) was started by adding 20 µl of diluted culture supernatant (Time 0). The 
initial absorbance at 405 nm (Time 0) was determined by a microtitre plate reader. 
Assay plates were incubated at 37°C for at least 30 minutes and the A405 measured 
again. The absorbance of more than 1 unit was disregarded ( because absorbance 
reading of more than 1 did not fit a linear curve) and the change in absorbance used 
as a measure of SAP activity. 
2.8.4 Determination of Specific Production Rates (SPR) 
The levels of SAP expression in transfected CHO-DUKX B 11 cell lines were 
compared by determining the specific production rates of SAP, expressed in arbitrary 
units/106 cells/day (where arbitrary unit is defined as the change in absorbance in 30 
minutes). 
A T75 flask was seeded with 1x 106 cells in 5 ml of culture medium and incubated 
overnight at 370C. The medium was aspirated and replaced with 5 ml of fresh 
medium. After 24 hours of adding the fresh medium (± 30 minutes), 0.5 ml of 
medium was removed for SAP determination. The adherent cells in the flask were 
detached by versene + trypsin treatment, and viable cell density determined. 
Following this, the dislodged cells were diluted with 5 ml of fresh medium. Cell 
suspension was transferred to a 15 ml Falcon centrifuge tube (Becton Dickinson), and 
pelleted by centrifugation in a Sorvall RT6000B centrifuge at 1000 rpm (- 135 g) for 
5 minutes. The cell pellet was resuspended in 5 ml of fresh medium, an aliquot was 
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diluted with 9/10 volume of trypan blue solution (0.4% in saline, ICN Flow), and 
viable cells (non-stained) counted using a haemocytometer. 
Specific production rate (SPR) was calculated as; 
SPR (arbitrary units/106 cells/24 hours) = Arbitra unit of SAP activity 
cell density (106/ml) 
2.8.5 ß-gal staining of transformed CHO-DUKX 1311 clones 
ß-gal staining was used as an in situ method to detect transfected CHO-DUKX B 11 
clones expressing activated lacZ ((3-galactosidase) reporter gene. 
CHO-DUKX B II transformed colonies (growing on 10-cm petri dishes) were washed 
once with 10 ml of PBS (GIBCO BRL) after the culture medium has been aspirated. 
Transfected colonies were fixed onto the petri dish by the addition of 10 ml of 2% 
paraformaldehyde/0.3% glutaraldehyde in PBS solution. Fixation was done at room 
temperature for 15 minutes after which colonies were washed twice with PBS 
solution. Staining was done by adding 5 ml of a chromophore solution (consisting of 
0.1% X-Gal [5-bromo-4-chloro-3-indoyl-ß-D-galactopyranoside; Promega], 5 mM 
K4Fe(CN)6.3H20,5 mM K3Fe(CN)6, and 2 mM MgC12 in PBS; Promega) diluted 
1: 50 with X-Gal mixer solution (Promega) and incubated at 370C for between 30 
minutes and 18 hours. ß-galactosidase expressing clones were observed as blue 
colonies under a light microscope. 
2.8.6 ß"galactosidase enzyme assay of transformed CHO"DUKX 1311 
ß-galactosidase enzyme assay was used for the quantitative determination of ß- 
galactosidase expression in transfected CHO-DUKX B 11 cells. The assay was done 
using the ß-galactosidase enzyme assay kit according to the manufacturer's protocol 
(Promega). 
CHO-DUKX B II transfected cells (1 x 106 cells) were harvested by versene-trypsin 
treatment. Cell suspensions were transferred to microcentrifuge tubes and centrifuged 
at 14000 rpm for 1 minute to pellet the cells. Cells were washed twice by resuspension 
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into PBS solution and centrifuged at 14000 rpm for 2 minutes in between washes. 
Cells were then freeze-thawed (freeze in dry ice and thaw at 37°C) three times in Ix 
lysis buffer (Promega), to lyse the cells, vortexing after each thaw cycle. The cell 
extract was centrifuged in a microfuge for 5 minutes at 14000 rpm (10508 g) and the 
supernatant transferred to another microfuge tube. 
An equal volume of 2x assay buffer (120 mM Na2HPO4,80 mM Na12PO4,2 mM 
MgC12,100 mM ß-mercapthoethanol, 1.33 mg/ml o-nitrophenol-ß-D- 
galactopyranoside [ONPG], Promega) was added to 100 µl of the supernatant and the 
mixture incubated at 370C for between 30 minutes and 6 hours during which time the 
ß-galactosidase hydrolysis the substrate ONPG to o-nitrophenol (which is yellow). 
The reaction was terminated by the addition of 400 µl of IM Na2CO3, mixed and 200 
tl transferred to a 96 well microtitre plate. The absorbance of the samples were 
determined using a microtitre plate reader at 420 nm. 
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CHAPTER 3 
Expression and purification of bacteriophage P1 Cre recombinase in insect cells 
using a recombinant baculovirus vector 
3.1 Introduction 
As was mentioned in the introduction to this project, one of the main objectives was to 
investigate the kinetics of the Cre-loxP site-specific recombination reaction in vitro 
with the aim of identifying irreversible substrates that could be used to improve the 
efficiency of gene targeting in mammalian cells. Another objective was to directly 
introduce Cre protein into cells to mediate targeted integration. Both objectives 
require a source of Cre protein. Therefore, to achieve these aims, the gene encoding 
Cre recombinase was expressed under the transcriptional control of the very strong 
baculovirus viral promoter, Ppolh (which normally drives the expression of the 
polyhedrin gene, described below) in insect cells infected with a recombinant 
baculovirus in the hope of obtaining high levels of biologically active Cre protein. 
Escherichia coli (E. coli) has been used extensively as the host for the expression of a 
variety of prokaryotic and eukaryotic genes to produce large quantities of recombinant 
proteins (Pillot et al., 1996; Amrein et al., 1995; Itakura et al., 1977); however, 
because of the highly reducing intracellular environment, over-expressed foreign 
proteins often fail to assume the proper tertiary structure or to be properly modified 
after translation. Consequently, the yields of biologically active proteins produced 
tends to be low. The baculovirus/insect expression system on the other hand, has the 
potential for the high expression of biologically active recombinant proteins because it 
provides a "eukaryotic environment" which is more suitable for gene expression 
including the necessary cellular post-translational modifications such as glycosylation, 
cleavage of signal peptide, disulfide-bridge formation, and proper folding. 
As the work described in this chapter exploits baculovirus as an expression vector for 
Cre expression in insect cells, the biology of baculoviruses and the use of 
baculoviruses as expression vectors for heterologous gene expression in insect cells 
are described. 
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3.2 The biology of baculoviruses 
Baculoviruses are a diverse group of viruses found mostly in insects. They arc not 
known to have any non-arthropod hosts (reviewed in Miller, 1988a; Griffiths, 1994). 
The baculo portion of the name refers to the rod-shaped capsids of the virus particles. 
The following section describes the genetic organisation of baculoviruses. 
3.2.1 The genetic organisation of baculoviruses 
The DNA genome of a baculovirus is double-stranded, covalently closed and circular 
(Summers and Anderson, 1972). The DNA of the two baculoviruses commonly used 
for expression vector work, Autograppa californica nuclear polyhedrosis virus 
(AcNPV) and Bombyx mori nuclear polyhedrosis virus (BmNPV) are both 
approximately 130 kbp. The baculovirus genome is compact in nature, this is 
exemplified by the observation that the translational termination signal (UAA) of an 
open reading frame (ORF) often overlaps the AAUAAA polyadenylation signal of the 
transcript. Similarly, promoter elements of ORFs may be found in the coding 
sequence of an upstream ORF (e. g., up39 and cg30 or p26 and pl0). Furthermore, the 
sequences between many ORFs are extremely A+T rich, which may be related to 
promoter and transcriptional termination functions. The available information 
concerning the biological activity of some characterised essential genes for viral 
replication are summarised in the table below. 
Class Designation Function 
VL poll: Polyhedrin, required for virus coat formation 
L p74 essential for occluded virus (OV) infectivity 
L or VL fp25 involved in nuclear envelopment process of OV 
L or VL clx involved in the stability of polyhedrin inclusion 
bodies (PIBs) 
L vp39 major capsid protein 
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E and L gp64 major envelope glycoprotcin of budded virus 
(BV) involved in virus infection 
E dnapol DNA polymerase homologue, involved in viral 
DNA replication 
E pcna stimulates DNA replication and late gene 
expression 
E hel helicase homologue, required for DNA 
replication 
E p35 blocks apoptosis 
L ubi ubiquitin homologue, may be involved in the 
stability of heterologous gene products. 
E, L, and VL indicates that a gene is transcribed in the early, late, or very late phases 
of infection respectively. 
Some of the other genes encoded by baculoviruses appear to be non-essential for 
replication as determined by the ability of viruses with null mutations in the given 
gene to replicate in both cell culture and insects. Genes that have been characterised to 
be non-essential include; egt (O'Reilly and Miller, 1989), the da26 ORF (O'Reilly el 
al., 1990) and plO (encoding the p10 protein that constitutes the fibrillar structures 
[Kuzio et al., 1984]). However, these non-essential genes may have other functions, 
for instance a role for p10 in the melting or disintegration of the larval host has been 
proposed and also deletion of plO is reported to prevent insect cell lysis at very late 
times post infection (p. i), (Williams et al., 1989). Several genes that appear to be 
involved in gene regulation have also been identified. These genes include those 
encoding IE-0, IE-1, IE-N, PE-38 and CG 30. IE-0 and IE-1 are able to transactivate 
some early promoters in transient assays (Guarino and Summers, 1986; 1987). The 
other three proteins IE-N, PE-38 and CG 30 all share common unique structural 
motifs; an unusual, double zinc-finger like motif and a c-terminal leucine zipper 
(Thiem and Miller, 1989b). Thus baculoviruses appear to have a family of related 
genes that are probably involved in gene regulation described in the next section. 
85 
3.2.2 Mechanism of gene regulation 
Baculoviruses are transcribed in a regulated cascade. During wild-type NPV infection, 
at least three phases of viral gene expression can be distinguished; early (0-6 hours 
post infection [h. p. i. ]), late (6-20 h. p. i. ) and very late (20-72 h. p. i. ). Most viral 
genes are transcribed primarily during one phase although some genes are transcribed 
in two or possibly three phases. Early genes may be defined as those genes that are 
transcribed in the absence of any other viral gene expression. Late and very late genes 
are dependent on early viral gene expression and on DNA replication. The late and 
very late promoters are distinctive and unusual with regard to their location. The 
primary determinant of both late and very late promoter activity is the tetranucleotide 
TAAG, which is located at the transcriptional start site of all known late and very late 
transcripts (Thiem and Miller, 1989a). 
The different promoters are distinguished by their different activities during the three 
phases of infection. For instance, the polk promoter is an example of a very late 
promoter; it shows low activity during the late phase (i. e., 6 h. p. i. - 18 h. p. i) but 
becomes highly active beginning about 18 h. p. i. By 27 h. p. i. to 48 h. p. i., 
approximately 20% of the total polyadenylation RNA in the cell is polh mRNA 
(Adang and Miller, 1982). In contrast, the late vp39 promoter is most active between 
12 h. p. i. and 24 h. p. i. (Thiem and Miller, 1990). 
The biology of this infection process is what underlies the utility of baculoviruses as 
expression vectors (Miller, 1981) for heterologous gene expression in insect cells, as 
such a brief overview of this infection process in insect cells is given in the following 
section. 
3.3 Process of infection in insects 
The natural cycle of infection by baculoviruses in insect larvae is summarised in 
Figure 3.1. Two distinct forms of viruses are involved in the infection; occluded virus 
(OV) enveloped in a polyhedrin protein coat to a form known as polyhedrin inclusion 
bodies (PIBs) and the budded viral (BV) forms. PIBs provides protection of the 
embedded virus particles during the horizontal transfer among larvae and a means of 
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-I. Ingest ov 2. Midqut 3. BV in hemolymph 
in other tissues 
5. Death and OV release 
Figure 3.1- The natural cycle of infection by baculoviruses in insect larvae. 
Two different forms of baculoviruses are involved in the infection process; the 
occluded viral (OV; also known as occlusion bodies) and budded viral (BV) forms. 
Occlusion bodies provide: (1) protection of the embedded virus particles during the 
horizontal transfer among larvae and (2) a means of delivering the virus particles to 
the primary site of infection, the midgut epithelial cells. The alkaline midgut 
facilitates dissolution in the midgut lumen thereby releasing the virus particles. DV 
released into the haemolymph cause the spread of infection to other tissues of the 
insect. Most larval tissues are susceptible to infection, and eventually the insect dies, 
the cuticle is disrupted, copious amounts of OV are released onto the plant surface, 
and another insect encounters the OV as a contaminant of its food. 
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4. More BV and OV produced 
delivering the virus particle to the primary site of infection, the midgut cpithelial cells. 
BV which is released from the primary site of infection causes the spread of infection 
to other tissues of the insect. 
Insect larvae ingest PIBs as contaminants of their food. The crystalline polyhedrin 
coat is solubilised in the alkaline midgut of the insects, releasing embedded virions 
(Harrap and Longworth, 1974). The virions enter midgut cells by fusion with the 
membrane of the microvilli (Granados and Williams, 1986a). Infection in the 
polarised midgut cells results in BV release from the basement membrane side of the 
cell causing the spread of infection to other tissues of the insect. This BV can gain 
access to the hemocoel and is transported via the hemolymph to other tissues in the 
insect (insects have an open circulatory system). BV released from the midgut also 
infects the epithelial cells of tracheoles, which provide oxygen to the midgut, 
spreading the infection along the tracheal network (Keddie et al., 1989). During a 
typical BV infection, the insect continues to feed during most of the infection process, 
which takes approximately five to seven days. The integument becomes swollen and 
changes in lustre. Both BV and PIBs are produced in most of the tissues infected 
during the secondary phase. Infection of a late instar larva probably involves 
approximately 10 generations of virus. Eventually, the insect becomes lethargic and 
stops feeding. The cuticle melanizes due to a polyphenol oxidase-mediated process 
that results in a discoloration (browning). The musculature disintegrates, and the larva 
becomes a cuticular sac of milky fluid containing PIBs. A substantial portion (e. g., ca. 
25%) of the dry weight of the liquefied carcass is polyhedra. The cuticle eventually 
ruptures releasing the PIBs into the environment. Polyhedra are relatively stable in the 
environment, although they exhibit significant sensitivity to UV light. They are 
naturally dispersed by a variety of routes and may eventually be consumed by another 
permissive insect host, thereby reinitiating the infection cycle (Evans, 1986). 
The polyhedrin coat, whilst being important for the horizontal transfer of virus to new 
insect hosts, is not important for the propagation of virus in insect cell culture. Hence 
the polyhedrin (and p10 proteins), which comprise up to 50% total cell protein 
synthesised at late stage of infection, are not essential for virus replication in vitro. 
Understanding the biology and the molecular basis of the baculovirus infection 
process has allowed the manipulation of the baculovirus genome for the expression of 
heterologous proteins in insect cells (Luckow and Summers, 1988; Smith et al., 
1983a) which is described in the next section. 
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3.4 Use of baculovirus infected insect cells for the expression of heterologous 
proteins 
As previously mentioned, two of the highly expressed proteins in insect cells infected 
by baculoviruses, namely polyhedrin and plO are not essential for the propagation of 
the virus in insect cell culture. Therefore, recombinant baculovirus expression vectors 
can be constructed by the replacement of one of these nonessential genes, usually 
polyhedrin gene (polk), with the coding region of the heterologous protein so that high 
levels of expression can be achieved under the transcriptional control of the strong 
polyhedrin promoter following infection. 
3.4.1 Development of recombinant baculovirus expression vectors 
The basic design of the first baculovirus gene expression vectors involved the 
replacement of polk with the heterologous gene under polh promoter control (Miller et 
al., 1983b; Smith et al., 1983b; Pennock et al., 1984; Maeda et al., 1985). One 
advantage of substituting the heterologous gene in place of polk is that such 
recombinant viruses replicate normally as BV in cell culture and can be distinguished 
visually from wild-type (wt) virus: as they lack the crystalline coat polyhedrin protein, 
they appear round and clear (white) compared to the wild-type virus which appears as 
opaque clusters of crystals on an agarose overlay assay under a light microscope. 
Such recombinant viruses are not efficient at infecting larvae by the natural oral route 
of infection and do not persist in the environment; these features have some benefits 
from environmental and recombinant DNA safety perspectives (Miller, 1981). 
The two baculoviral DNAs commonly used as expression vectors are Autographa 
californica nuclear polyhedrosis virus (AcNPV) and Bombyx mori nuclear 
polyhedrosis virus (BmNPV). AcNPV genome (-130 kbp) is too large for the efficient 
introduction of the foreign gene by conventional DNA cloning techniques. 
Consequently a two step procedure is followed in which the gene to be expressed is 
first inserted into a transfer vector containing a viral expression cassette flanked by 
viral DNA sequences which are required for the targeting of the gene to the viral 
genome. This recombinant transfer vector is co-transfected with viral gcnomic DNA 
into host insect cells. Subsequently host enzymes in the cells catalyse homologous 
recombination between the recombinant transfer vector and the viral DNA which 
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leads to the targeted integration of the foreign gene into the polyhcdrin locus. These 
recombinant viruses can be selected or screened for described in section 3.4.1.2. 
3.4.1.1 Transfer vectors 
Transfer vectors (reviewed in O'Reilly et al., 1992 and Bishop, 1992) consist of a 
fragment of AcNPV DNA, usually the EcoRI "I" fragment which contains the 
polyhedrin gene promoter, coding region and polyadenylation sequence flanked by 
other viral sequences, cloned into a pUC based plasmid vector. A multiple cloning site 
containing unique restriction endonuclease sites is usually inserted downstream of the 
promoter for the cloning of heterologous genes. 
Early transfer vectors directed the synthesis of a fusion protein, containing the amino 
terminus of the polyhedrin protein, by inserting the heterologous gene downstream 
and in frame of the polyhedrin transcriptional initiation codon (ATG). Later vectors 
have the polyhedrin transcriptional initiation codon mutated to ATT or ATC (e. g. 
pVL941; Luckow and Summers, 1989; p36c; Page, 1989), so that transcription starts 
at the ATG codon of the inserted cDNA to produce an authentic, nonfusion protein. 
Other improved derivatives of the initial transfer vector has been described elsewhere 
(Matsuura et at., 1987; Peakman et al., 1992a; Belyaev and Roy, 1993). 
3.4.1.2 Advances in the isolation of recombinant baculovirus 
Originally, recombinant baculoviruses were identified phenotypically as polyhedra 
negative because the polyhedrin protein is not expressed, with lytic plaques appearing 
clear rather than opaque on an agarose overlay assay. However, screening was made 
difficult by the fact that the recombination event is relatively inefficient with 
recombinant polyhedrin negative clones only making up 0.1-1% of progeny virus. 
Various strategies have been developed to increase the percentage of recombinants 
among the progeny viruses and to aid their identification (reviewed in Davies, 1994). 
Several modifications of this procedure have been described that facilitate the 
identification of recombinant viruses by placing a reporter cassette adjacent to the 
gene to be expressed (Vialard et al., 1990; Vlak et al., 1990) or that increase the 
proportion of the viruses that are recombinants (Peakman et al., 1989; Kitts et al., 
1990). 
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Kitts et al., (1990) engineered an AcNPV derivative, AcRP6-SC, that containcd a 
single Bsu361 restriction site downstream of the polyhedrin transcription start site. 
They showed that linearised viral DNA has a greatly reduced infectivity (one 
fifteenth) in comparison to the circular form but is still able to recombine with a co- 
transfected transfer vector to yield circular recombinant virus. Hence the use of 
linearlised virus reduces the background of non-recombinant parental viruses, 
resulting in (30%) of progeny viruses being recombinant (rather than 0.1-1%). The 
remaining non-recombinants result from incomplete Bsu361 digestion of AcRP6-SC 
or self-circularisation of linearlised AcRP6-SC. 
A further improved selection system, resulting in -95% of progeny virus being 
recombinant, was described by Kitts and Possee (1993). They engineered an AcNPV 
derivative, BacPAK6 (Figure 3.2), which contains three 13su36I restriction sites near 
the polyhedrin locus. One is in the lacZ gene under the control of the polyhedrin 
promoter, another is in a non-essential gene (ORF 603) upstream of the polyhedrin 
promoter and the third is in the essential gene (ORF 1629) downstream of the 
polyhedrin gene. When Bsu361 digested BacPAK6 is used as the parental virus, only a 
double recombination event between the large Bsu361 fragment and a transfer vector 
will restore the essential ORF 1629 gene and create a circular virus capable of 
replication. This results in the majority (-95%) of the viable progeny produced being 
recombinant. Furthermore, double recombinants lack the lacZ gene, hence viral 
progeny (observed as plaques) will appear colourless rather than blue after incubation 
with medium containing X-gal. The frequency of non-recombinants is reduced to 
approaching 0% by the more efficient linearlisation due to the presence of three 
Bsu361 sites and the fact that self-ligation of three virus fragments to a form that can 
replicate is unlikely. 
More recently, use of herpes virus thymidine kinase (tk) enzymes has allowed drug 
selection of recombinant viruses. An AcNPV-derivative has been engineered that 
contains the herpes simplex virus type 1 tk gene under the control of the baculoviral 
immediate early (IE-1) promoter, active in the immediate early phase of infection 
(Godeau et al., 1992), making the virus sensitive to the anti-herpes drug, Gancyclovir. 
A recombination event between the virus and a transfer vector results in progeny 
viruses that lack the tk gene and can be selected over parental virus by passaging in 
the presence of Gancyclovir. 
Alternative, in vitro methods for the creation of recombinant viruses have been 
described, for example, the use of the bacteriophage P1 Cre"loxP system. A loxP site 
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Figure 3.2-Simplified restriction map of BacPAK6 (Clontech, labs. Inc). 
BacPAK6, a derivative of AcMNPV, is engineered to contain three Bsu36I sites; one 
in the lacZ gene under the control of the polyhedrin promoter, another in a non- 
essential gene (ORF603) upstream of the polyhedrin gene, and the third in the 
essential gene (ORF1629) downstream of the polyhedrin gene. Digestion of BacPAK6 
with Bsu361 releases two small fragments, one of which contains part of the ORF 1629 
gene which is essential for viral replication. If the large fragment recircularises by 
itself, part of ORF1629 is missing and so the viral DNA cannot give rise to viable 
viruses. If however it recombines with a transfer vector containing the missing 
sequences, the resulting circular viral DNA can produce viable viruses. 
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inserted into the viral genome and the transfer vector allows recombination at high 
frequency in the presence of Cre recombinase (Pcakman et al., 1992a). However, 
although the probability of successive recombination events, leading to unwanted 
multiple insertions and rearrangements is high, appropriate recombinant viruses are 
easily identified by simple polymerase chain reaction (PCR) protocols. Furthermore, 
this is the only system that is independent of the size of the inserts. 
3.4.2 Recombinant protein expression 
As was mentioned previously, the baculovirus/insect cell system is an attractive 
alternative to E. coli as the host for foreign protein expression because protein 
expression levels can be very high, with some heterologous proteins comprising up to 
50% of total cell protein (Miyamoto et at., 1985). 
Furthermore insect cells expresses enzymes required for post-translational 
modifications. Post-translational modifications observed in the system include 
glycosylation (up to high mannose), fatty acid acylation, amino-terminal acetylation, 
carboxy-terminal a-amidation and phosphorylation (although differences in the extent 
of modifications in insect and mammalian cells have been observed, e. g. glycosylation 
and phosphorylation [Hoss et al., 1990]). In most cases, a recombinant intracellular 
protein is targeted to its appropriate intracellular location in the insect cell, for 
example to the nucleus (human c-myc; Miyamoto et al., 1985). Insect cells are 
capable of recognising and cleaving both insect and mammalian signal peptides that 
direct proteins to the ER (Jarvis et al., 1993), after which correct targeting to the cell 
surface (influenza virus haemagglutinin; Possee, 1986) or secretion (human beta 
interferon; Smith et al., 1983) are observed. Other specific proteolytic cleavages have 
been observed, for example activation of influenza virus haemagglutinin by 
proteolytic cleavage of the precursor into two fragments (Possee, 1986). 
For the expression of a protein consisting of more than one polypeptide chain insect 
cells may be co-infected with multiple recombinant viruses, each containing a single 
foreign gene, or a virus containing multiple foreign gene expression cassettes may be 
constructed. Early vectors expressing two foreign genes contained two copies of the 
polyhedrin promoter in opposite orientation. Vector instability due to homologous 
recombination between the two copies led to the development of vectors containing 
different promoters e. g. the polyhedrin and p10 promoters (reviewed in Griffiths, 
1994). Both hetero- and homo-oligomeric assembly have been demonstrated. For 
93 
example, Belyaev and Roy (1993) co-expressed four bluetongue virus proteins in 
insect cells using a quadruple recombinant virus, which assembled into bluetonguc 
virus-like particles. 
3.4.3 Limitations to the baculovirus/insect cell expression system 
Although the baculovirus/insect expression system is increasingly being used for the 
expression of heterologous proteins, a number of limitations of this system has been 
identified which are described in this section. 
3.4.3.1 Expression levels 
Most heterologous proteins are not expressed at levels comparable with those of the 
polyhedrin protein in a wild-type infection. In addition, expression levels of different 
proteins vary widely, with recombinant proteins having been produced as fusion or 
non-fusion proteins at levels ranging from 1 to >500 µg/ml. Expression levels also 
appear to be protein-specific, because different genes inserted into the same vector are 
expressed at different levels and the stage at which protein expression is limited seems 
to vary depending on the protein (Luckow and Summers, 1988; O'Reilly et at., 1992). 
Hasnain et al., (1994) observed a difference at the level of transcription and suggested 
that the secondary structure of the foreign gene may influence the efficiency with 
which it is expressed. They expressed two proteins; firefly luciferase (luc) and the 0- 
subunit of human chorionic gonadotrophin (ßhCG), using a double recombinant 
baculovirus, both under the control of the polyhedrin promoter and found that luc 
mRNA (and synthesised protein) levels were higher than ßhCG mRNA levels. 
Sequence analysis indicated extensive secondary structure and stem-loop complex- 
forming potential for the ßhCG gene, which could be responsible for the 
transcriptional difference observed. 
In some cases, the limiting step appears to be post-transcriptional. For example, 
Carbonell et al., (1988), found that the levels of scorpion toxin mRNA (a fusion 
containing the first 58 codons of the polyhedrin gene) were equivalent to polyhedrin 
mRNA in a wild-type infection, but foreign protein levels were much lower than the 
polyhedrin protein level. In this case it appears that recombinant protein expression is 
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limited by mRNA stability and/or translation efficiency and/or protein stability. 
However, the recombinant toxin protein produced could also be toxic to the cell. 
Paradoxically, although a codon bias exists in the highly expressed late baculovirus 
proteins, this may not be a major limitation to the translation of foreign mRNA 
because E. coli ß-galactosidase (lacZ) gene which contains many codons under- 
represented in the late proteins, is still expressed at a very high level (200 tg/m1, 
Jarvis et al., 1990). 
Low expression levels may be attributable to the pathways through which the protein 
is co-and post-translationally processed in the cell; secreted glycoproteins are 
particularly poorly expressed compared to cytoplasmic or nuclear proteins. It was 
initially thought that heterologous signal peptides might be inefficiently recognised by 
the protein translocation machinery in lepidopteran insect cells, and evidence for this 
was presented by Tessier et al., (1991), who showed that secretion of plant propapain 
was enhanced by replacing its native signal peptide with that from honeybee 
prepromellitin. However, this is not the case for all proteins, for example Jarvis et al., 
(1993) found that low human tPA secretion (<5µg/ml) was not enhanced by an insect- 
cell derived signal peptide because similar yields were obtained from the insect 
secretory protein (tPA) containing a baculovirus glycoprotein-signal peptide. They 
concluded that some other factor, downstream of protein translocation into the ER, 
was limiting tPA secretion. This limitation could be glycosylation and/or protein 
folding and/or disulphide bond formation particularly if the cell's (organelle) 
membranes are highly compromised due to late stage lysis. 
3.4.3.2 Quality of recombinant protein 
The polyhedrin promoter is generally utilised in the baculovirus/insect cell expression 
system due to its very high activity (polyhedrin protein making up to -50% of the 
total cell protein in wild-type baculovirus-infected insect cells). In addition, its 
activity late in viral infection, after the virus DNA has replicated (replication begins at 
-6 hours p. i. ), means that foreign protein synthesis should not interfere with virus 
replication and the increased foreign gene copy number within the cell contributes to 
the high protein expression level. The other very late promoter, plO, has also been 
used to drive foreign gene expression, and has similar activity as the polyhedrin 
promoter. 
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However, for some proteins, transcription initiated by one of the very late, strong 
promoters, results in only a small proportion of synthesised protein being biologically 
active and/or correctly processed. For example, Aris et al., (1993) found that the 
intracellular protein, protein kinase C-S was expressed at a relatively high level in 
insect cells, comprising 10-20% of total cell protein, but that less than 1% of the 
material was catalytically active, the majority aggregating in insoluble complexes. In a 
different study, Jarvis and Summers (1989) reported that whilst secreted human tPA 
produced in a recombinant baculovirus/insect cell system was glycosylated, the 
processing of terminal residues was incomplete, with some of the material having a 
complex carbohydrate addition and the remainder having a high-mannose pattern. 
These and numerous other reports of incomplete protein processing suggest that when 
expression is controlled by a very late promoter, leading to relatively high levels of 
the foreign protein (up to 50% total cell protein, in some cases), the insect cell's post- 
translational modification machinery becomes saturated plus cell membranes are 
compromised. Furthermore, there may be insufficient time for the complete 
processing of the protein from its synthesis, very late in infection, to insect cell lysis. 
This situation may be exacerbated by the fact that the majority of insect cell-specific 
protein synthesis is switched off in the very late stage of viral infection, possibly 
resulting in a compromised processing and secretory pathway. A variety of 
approaches have been taken to overcome these limitations at the transcriptional 
regulation level, which are described in the next section. 
3.4.3.3 Overcoming limitations by the use of earlier viral promoters 
The use of promoters active at an earlier stage of infection has been investigated in an 
attempt to overcome some of the limitations associated with the use of the very late 
polyhedrin and p10 promoters, i. e. the incomplete processing of recombinant protein 
and low expression of secretory protein. Many early and late viral genes encode for 
essential proteins required for replication of the virus and so transfer vectors 
containing a copy of such an early or late promoter in the polyhedrin locus are used. 
Late promoters are transcriptionally weaker than the very late promoters, but show 
peak activity at earlier times in infection (12-24 h. p. i. ), when the cell's protein 
synthesis machinery is efficient for post-translational modification and secretion. In 
addition, proteins expressed from a late promoter will have an additional 12 hours to 
move through the Endoplasmic reticulum (ER) and the Golgi apparatus, compared to 
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expression from a very late promoter. One late phase promoter used for foreign gene 
expression is that of the basic protein, a core-protein tightly associated with the viral 
DNA (Hill-Perkins and Possee, 1990), which is expressed a high level of ß- 
galactosidase, although lower than with the polyhedrin promoter. Rankt et at., (1994) 
found that expression levels of protein kinase C-S were four-fold lower from the basic 
protein promoter, compared to the polyhedrin promoter, but that the enzyme was 10 to 
15 fold more active with the basic protein promoter. Thus the earlier expression of the 
protein resulted in the production of more active enzyme. It is not always the case that 
a late promoter results in a lower protein expression levels, compared to the very late 
plO and polyhedrin promoters. Bonning et al., (1994) showed that the expression 
levels of two enzymes, ß-galactosidase and juvenile hormone esterase, were higher for 
the late phase basic protein promoter than the two very late promoters, plO and 
polyhedrin, both in terms of amount of protein and activity of the protein. This is 
perhaps due to the different phases of maximal activities observed with the different 
promoters. 
Whilst the use of early phase baculoviral promoters in recombinant baculoviruses to 
improve their insecticidal activity has been investigated (O'Reilly and Miller, 1989; 
O'Reilly et al., 1990), their use to achieve higher levels of active recombinant protein 
has not been extensively studied. The immediate early 1 (IE-1) promoter is active 
immediately post-infection, with the IE-1 mRNA transcript being detected in wild- 
type virus-infected cells within 1 h. p. i. (Guarino and Summers, 1986). The IE-1 
protein is implicated in the regulation of viral gene expression, including 
transactivation of other early genes. The IE-1 promoter was used by Sharp and Gewert 
(unpublished) for ß-galactosidase expression, and active levels of the enzyme were 
found to be 1000 fold lower, compared to the use of the polyhedrin promoter. A 
similar study (Griffiths, unpublished) found that the difference in the active levels of a 
secreted protein, SAP, was considerably smaller, with only 10-20 fold lower levels for 
the IE-1 promoter compared to polyhedrin promoter. Whilst a higher level of active 
material for both these proteins was achieved with the very late polyhedrin promoter, 
the difference was greatly reduced for the secreted protein suggesting that for other 
highly processed secreted proteins, the IE-1 promoter may be equally, or even more 
efficient than the polyhedrin promoter. A potential limitation to the use of an early or 
late phase promoter is the risk of interference with virus replication. 
Because proteins expressed under the transcriptional control of IE- I promoter does 
not cause insect cell lysis, the IE-1 promoter could be used in the construction of a 
stable insect cell line for recombinant protein expression. Such a stable cell expression 
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system has been described (Jarvis et al., 1990) however, the levels of protein 
expression was usually lower than the levels observed in a regular baculovirus 
expression system. With further development an insect-based cell expression system 
will probably compare well to mammalian expression system. 
3.5 Results of Cre recombinase expression and purification in the 
baculovirus/insect system 
As mentioned in the introduction to this chapter, the aim of this project was to use the 
baculovirus/insect expression system to express high levels of Cre protein for the 
investigation of the Cre-loxP reaction in vitro and also the direct introduction of Crc 
protein into mammalian cells to catalyse gene targeting. 
In order to investigate the baculovirus/insect expression system for producing 
recombinant Cre protein, the cre gene was cloned into a transfer plasmid pAcH6N 1 to 
generate pAcH6N1-Cre. Insect cells were co-transfected with pAcH6N1-Cre and 
BacPAK6 viral DNA digested with Bsu36 I. Recombinant viruses resulting from the 
co-transfection in insect cells were observed as colourless plaques after a neutral red 
staining in a standard plaque assay procedure and validated by PCR analysis using 
viral DNAs prepared from isolated plaques. Metabolic labelling was used to 
investigate recombinant virus mediated synthesis of Cre protein infected insect cells. 
Cre protein synthesised in insect cells infected with the recombinant viruses was 
purified from an affinity chromatography column. The purified protein was then 
assayed for Cre activity using a simple in vitro assay system. In addition, various 
parameters for the Cre protein reaction were studied and compared to native Cre 
recombinase of Bacteriophage P1. Finally the advantages of using baculovirus-insect 
system for producing Cre protein on a large scale for gene targeting and in vitro 
analysis are discussed. 
3.5.1 Construction of chimeric transfer vector pAcH6N1-Cre 
As previously noted, the baculovirus genome is too large and usually contains more 
than one recognition site for known restriction endonucleases. This makes it difficult 
to efficiently introduce the cre gene by conventional DNA cloning techniques. In 
order to generate a recombinant baculovirus encoding the Crc protein, the cre gene 
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Plasmid pAcH6N1 (Dirk Gewert, unpublished; Figure 3.3a) is derived from a 
AcMNPV-based transfer vector pVL1392 (Invitrogen). The pVL1392 transfer vector 
contains 6.5 Kb of the wild-type AcMNPV genomic DNA, including the polyhc drin 
gene promoter, Ppolh, protein coding sequence and polyadenylation signal sequences, 
and flanking viral DNA sequences. A polylinker for the insertion of foreign genes is 
located at the +35 with respect to the mRNA transcriptional initiation site at +1. The 
plasmid was designed in this way because several groups demonstrated that sequences 
downstream from the polyhedrin transcriptional initiation codon, ATG contributed to 
optimal promoter activity (Luckow and Summers, 1989; Page, 1989). The polyhedrin 
translational initiation codon, ATG was mutated to ATT, so that translation initiates at 
the ATG start site of the foreign gene. Recent evidence obtained with recombinant 
viruses generated with these plasmids indicated that despite the mutation at +3, some 
translation still initiates at the +1 position (Beames et at., 1991). 
Plasmid pAcH6N1 is derived from pVL1392 by replacing the polylinker sequence 
between BgIII and KpnI sites with oligonucleotide sequences encoding six histidine 
residues (the strong binding affinity of histidine residues for cations, means that 
heterologus genes fused to a hexa-histidine tag can be expressed and purified in a 
single-step by affinity chromatography; described in detail in section 3.5.4). The hexa- 
histidine sequence cloned into the Bg1II and KpnI sites was out-of-frame with the ATT 
at +1, to ensure that translation would initiate at the first ATG of the histidine domain. 
The 1.1 kbp crc gene encoded by bacteriophage P1 is engineered to have a nuclear 
localisation signal in plasmid pMC1-Cre (Gu et al., 1993). By including the nuclear 
localisation signal, it was hope that this would increase the rate of transport of Crc 
protein into nucleus to improve the efficiency of site-specific recombination In vivo. 
The cre gene was amplified from pMC1-Cre in a PCR reaction. A combination of 
oligonucleotide sequences designed as forward (CB1741- 
gacaaGAGATCTATGCCCAAGAAGAAGAGGAAGG) and a reverse (CB1742- 
gacaaGAGATCTCTAATCGCCATCTTCCAGC) primers were used in the PCR reaction 
(Figure 3.3b). CB 1741 anneals at the 5' end and CB 1742 anneals at the 3' end of the 
cre coding sequence ( see appendix 1). (The ATG initiation and the CTA [anti-sense] 
termination codons in CB 1741 and CB 1742 respectively are in bold. The introduced 
Bgl1l sites are underlined and lower case letters indicates non-specific nucleotide 
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Figure 3.3a-Map of transfer vector pAcH6NI. 
The transfer vector was derived from pVL1392 (Invitrogen). It contains 6 Kbp of the 
wild-type AcNPV genomic DNA (shown as dotted boxes), the polyhedrin promoter, 
Ppolh (shown as slashed box with arrow head) and the protein coding region 
including polyhedrin signal sequences (not shown). In addition it contains six 
histidine residues at position +35 with respect to mRNA transcriptional initiation site 
at position +1 (see Figure 3.3d). 
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extensions). The PCR product analysed by gel electrophoresis (Figure 3.3c) was 
purified and digested with BgIII and subsequently cloned as a Bglll fragment into the 
BamHI site of plasmid pAcH6N1. The resulting plasmid was designated pAcH6N1- 
Cre (Figure 3.3d). Plasmid pAcH6N1-Cre, with the cre gene inserted in the correct 
orientation and frame for translation was validated by restriction endonuclease 
digestions and by sequencing. 
The cre gene was cloned into pAcH6N1 downstream of the histidine residues, such 
that the translational initiation codon of the histidine domain would be in frame with 
that of the cre gene. The resulting transfer vector pAcH6Nl-Cre encodes an mRNA 
species, containing an extended 5' untranslated sequence plus the first 33 bp 
(corresponding to the polyhedrin N-terminal coding sequence) in addition to the 
histidine and Cre fusion gene under the transcriptional control of the polyhedrin 
promoter. 
3.5.2 Production of recombinant baculoviruses containing cre gene 
In order to produce high proportion of viral progeny corresponding to recombinant 
baculoviruses containing the cre gene under the transcriptional control of the 
polyhedrin promoter, Spodoptera frugiperda (Sf9) insect cells (2 x 106) were co- 
transfected with 500 ng of pAcH6Nl-Cre and 100 ng of Bsu36 I digested BacPAK6 
viral DNA using the lipofectin reagent. 
As shown in Figure 3.2, BacPAK6 DNA digested with Bsu36I releases two small 
fragments, one of which contains part of the ORF 1629 gene which is essential for 
viral replication. This provides two selection steps for the isolation of recombinant 
viruses: First, if the large fragment recircularises by itself, part of ORF 1629 is still 
missing and so the viral DNA cannot give rise to viable viruses. If however it 
recombines (in a double recombination event) with a transfer vector containing the 
missing sequences, the resulting circular viral DNA can produce viable viruses. Non- 
recombinant viral DNA cannot form lytic plaques because they do not have the 
essential gene for viral replication. Whereas single crossover recombinants in which 
the entire plasmid DNA has integrated into the viral genome are inherently unstable 
because they contain duplications of portions of the viral genome (i. e., the flanking 
regions present in the transfer plasmid DNA duplicate existing regions in the virus 
genome). 
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Figure 3.3b- Schematic representation of PCR designed to amplify cre gene from 
plasmid pMCI-Cre. A combination of oligonucleotide sequences designed as forward 
(CB 1741) and reverse (CB 1742) primers were used in a PCR reaction to amplify the 
1.1 kb cre gene (shown as blank box) from pMCI-Cre. The translational initiation 
codon of cre is shown as ATG and the engineered nuclear localisation signal (NLS) is 
shown as a black box. 
NLS 
ATG 
mom- 
CB 1741 
1.1 kb -000 
CB 1742 
Figure 3.3c- Agarose gel electrophoresis analysis of PCR product. A PCR product of 
1.1 kb was amplified from PCR using pMCI-Cre (lane 2). Lane 1 corresponds to 
primers only reaction (negative control). M indicates ? Hind III standard marker. 
F-1.1Kb 
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Figure 3.3d- Map of the chimeric transfer vector pAcH6N1-Cre 
The chimeric transfer vector was constructed by cloning the recombinase gene (cre) 
from pMC1-Cre as a Bg1II fragment into the BamHI site in pAcH6N1. The transfer 
vector, pAcH6N1 was derived from pVL1392 (Invitrogen). It contains 6 Kbp of the 
wild-type AcNPV genomic DNA (shown as dotted boxes), including the polyhedrin 
promoter, protein coding region and polyadenylation signal (see Figure 3.3a). In 
addition, it contains six histidines residues at position +35 with respect to mRNA 
transcriptional initiation site at position +1. The resulting vector, pAcH6N1-Cre 
contains the cre coding region fused in-frame to the upstream six histidine residues 
under the transcriptional control of the polyhedrin promoter, Ppolh (shown as slashed 
arrowhead). 
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Second, BacPAK6 contains a ß-galactosidase (lacZ) marker gene which hydrolysis 
the chromogenic indicator X-gal to give blue plaques in a plaque assay. However, a 
double recombination event loses the lacZ gene. Therefore, double crossover 
recombinants can be distinguished from non-recombinant viral DNA or single 
crossover recombinants because they are phenotypically lacZ- (detected as colourless 
plaques in the presence of X-gal in a plaque assay). 
Following transfection, 2 ml of supernatant from the infected cells putatively 
containing recombinant viruses were serially diluted in growth (TC100) medium to a 
million fold, and used to infect fresh plated Sf9 insect cells for plaque assay and 
purification. In subsequent plaque assays, colourless plaques were observed indicating 
that the double recombination reaction between the transfer vector pAcH6N1-Cre and 
the Bsu361 digested BacPAK6 viral DNA had occurred. Isolated plaques were picked 
for purification by resuspension in TC100 medium and serial dilutions used to re- 
infect insect cells for clonality. A final titre value of 4x 107 plaques forming units 
(pfu)/ml was calculated for the purified plaques. 
In order to verify further that the co-transfection of pAcH6N1-Cre and BacPAK6 viral 
DNA into insect cells generated recombinant viruses containing the cre gene, viral 
genomic DNA prepared from purified plaques were used in a PCR reaction. A 
combination of oligonucleotide sequences designed as forward primer (BK59- 
CGTGTTTTAATACGCCGGACC) to anneal within the polyhedrin locus upstream of 
KpnI site at position 4967bp-4946bp in pAcH6N1 (see Figure 3.3d), and reverse 
primer (CB 1741- GACAAGAGATCTATGCCCAAGAAGAAGAGGAAGG) to anneal at the 
5' end of the cre gene, were used to amplify sequences viral genomic DNA. For each 
recombinant baculovirus analysed (lanes 3-8), a fragment of the expected 1.1 Kbp size 
was amplified (Figure 3.4). This fragment was the same size as the PCR product from 
the positive control, pAcH6N1-Cre (lane 9). In contrast, this 1.1 Kbp product was not 
observed in the negative control (wild-type baculovirus). Instead, products of higher 
molecular weights were observed suggesting non-specific DNA amplification from 
the wild-type viral genome. 
This result provides further confirmation that the cre gene is present in the 
recombinant virus genome and that the cre gene is correctly orientated with respect to 
the viral promoter to allow for efficient expression. 
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Figure 3.4- Agarose gel separation of PUR ieaiiions OI reccoilihinau t haculm al 
genomic DNA. 
PCR reactions were clone using viral genonlic DNA isolated from wild ivpe 
haculovirus (AcMNPV; as a negative control), the recombinant baculoviruses and the 
chimeric transfer vector, pAcH6N I -Cre (as a positive control), A pair of 
oligonueleotide primers designed to prime within the polyhedrin promoter and the err 
gene was used to amplify sequence from the viral genonlic DNA. In each reaction, a 
1.1 Khp fragment was amplified for the recombinant haculoviruses (lanes 3-8). the 
same size fragment as the positive control, pAc116NI-C'rc (lane 9). Different site 
fragments were observed in the negative control, AcMNPV (Dlt 2). Lane I 
corresponds to primers only reaction (negative control). M indicates X Hind III 
standard marker. 
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3.5.3 Metabolic labelling of infected cells 
In order to evaluate whether the recombinant virus was producing Cre protein, and if 
so, to determine the levels of expression, Sf9 cells infected with the recombinant 
baculovirus were metabolically labelled with 35S labelling mix and total infected cell 
proteins analysed by SDS-PAGE gels and Coomassie blue staining. 
There are several approaches that can be used to evaluate whether a recombinant virus 
is producing the required protein. The simplest is the characterisation of whole-cell 
lysates by Coomasie blue staining or immunoblotting. Coomasie blue staining or 
immunoblotting of whole-cell lysates analysed on SDS-PAGE gels allows the 
detection of proteins during the infection process. If the cells are incubated with a 
radiolabelled amino acid for a short period prior to lysis, proteins expressed during the 
labelling period (i. e. very late infection) can be detected as long as they are relatively 
highly expressed. This is because the strength of a radioactive signal on an 
autoradiograph is proportional to the amount of radioactivity incorporated by a protein 
during the labelling period, which in turn, is partly dependent on the rate of synthesis 
of the protein. 
Plaque-purified recombinant viruses or the wild-type baculovirus were used to infect 
Sf9 (2 x 106) cells at 10 pfu/cell, and total protein products analysed 72 hours post 
infection (h. p. i) by Trans 35S-labelling (see section 2.6.2). Total cell lysates prepared 
after labelling, were analysed by SDS-PAGE and autoradiography (Figure 3.5). 
In Sf9 insect cells infected with the wild-type virus an intense signal of -33 KDa 
corresponding to the polyhedrin protein was readily detected on SDS-PAGE (lane 1). 
In cells infected with the recombinant virus, the signal corresponding to the 
polyhedrin protein was not observed. Instead a signal migrating at about 38 KDa 
(lanes 2 to 7) was observed which was absent in the wild-type virus control. This 
signal probably corresponds to the Cre protein. It was also noted that the intensity of 
these signals were much weaker than the the wild-type signal. If the 38 KDa signal 
corresponds to the Cre protein, then this shows that the expression of the Cre protein 
was much lower than the polyhedrin protein in the wild-type infection. This 
observation has been reported for the expression of other heterologous proteins 
(described in section 3.4.3). 
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Figure 3.5- The rate of Cre synthesis analysed on an SDS-PAGE. 
S. frugiperda cells (2 x 106) were infected at 10 pfu/cell with the recombinant 
baculovirus or wild-type baculovirus, AcMNPV and labelled for 2 hours with Trans 
35S-label mix at 72 h. p. i. Cells were lysed and aliquots analysed directly by SDS- 
PAGE and autoradiography. Lane 1; lysate from vAcMNPV infected cells, lanes 2 to 
7; lysates from the recombinant baculovirus infected cells. The arrow (on the right) 
indicates a band of approximately 38 kDa corresponding to the Cre protein. A band 
corresponding to the wild type (polyhedrin) protein is shown on the left. Molecular 
weight standard (kDa) are indicated to the left of the gel. 
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3.5.4 Purification of Cre protein from immobilised Ni++-NTA spin column 
Although the baculovirus/insect system allows the high level expression of recombinant 
proteins, purification from host endogenous proteins can be a time-consuming task and 
a rate-limiting step in obtaining large quantities of material. To overcome this problem 
the Cre protein was expressed as a fusion with a hexa-histidinc tag. Because histidinc 
residues interact with a strong binding affinity for metal chelate adsorbents, a rapid 
single-step purification of the Cre protein from immobilised Nip'-NTA affinity 
chromatography column was possible. 
Immobilised metal chelate affinity chromatography, first used to purify protein (Porath 
et a!., 1975) provides a simple one-step method for rapid protein purification (Hochuli 
et a!., 1987). This purification system uses a metal chelate adsorbent, Ni+'-NTA 
(nitrilo-tri-acetic acid, charged with nickel ions) resin which has a strong binding 
affinity (Kd=10-13, pH 8.0; far greater than the affinity between most antibodies and 
antigens, or enzymes and substrates) for proteins or peptides containing six 
consecutive histidine residues at either their N- or C-terminus (Hochuli et a!., 1988). 
This means that any host proteins that bind non-specifically to the NTA resin can be 
easily washed away under relatively stringent conditions, without affecting the binding 
of the histidine tagged proteins. Elution of tagged proteins from the column can be 
achieved by several methods. Reducing the pH will cause the histidine residues to 
become protonated and so dissociate from the Ni4 .. NTA. Elution can also be achieved 
by competition with imidazole, which binds to the Ni+'-NTA and displaces the tagged 
proteins (Janknecht et a!., 1991). The presence of specific proteolytic cleavage site 
allows for the histidine tag moiety to be cleaved from the desired protein. However, 
the small size means that it does not affect the physical or functional properties of 
proteins, hence there is rarely any need to remove it from the recombinant protein after 
purification. Additionally, monoclonal antibodies can be raised against the tag moiety 
which allows the detection of proteins without the need to raise specific sera against 
the protein of interest (Zentgraf et a!., 1995). 
SO (5 x 109) cells were infected with the recombinant baculovirus at 10 pfu/cell, and 
cell extract prepared 72 h. p. i applied onto an immobilised Ni++-NTA affinity 
chromatography column. The column was washed with 5 mM imidazole and bound 
proteins eluted with 50 mM imidazole. Samples taken after each purification step were 
analysed by SDS-PAGE and visualised by Coomasie blue staining (Figure 3.6), Cell 
extract prepared from pAcH6N1-E1.8 (the interferon protein E1.8 expressed as a 
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Figure 3.6- SDS-PAGE analysis of Cre purification from immobilised Ni+'-NTA spin 
column. 
S. frugiperda cells (5 x 109) were infected at 10 pfu/cell with the wild-type baculovirus 
(AcMNPV; negative control), recombinant baculovirus expressing an interferon 
protein E1.8 (BacPAK6/E1.8; positive control), and a recombinant baculovirus 
expressing the Cre recombinase protein (I3acPAK6/Cre). Cells were harvested 72 h. p. i 
by centrifugation and resuspended in binding buffer (described in materials and 
methods). The cell suspension was freeze-thawed to lyse the cells. Cellular debris was 
removed by centrifugation and proteins purified from the supernatant by affinity 
chromatography on Ni++-NTA spin column. Samples taken after each purification step 
were analysed by SDS-PAGE and proteins visualised by Coomassie blue staining. Lane 
1; total cell extract from AcMNPV infection, lane 2; total cell extract from 
BacPAK6/E1.8 infection, lane 3; total cell extract from BacPAK6/Cre infection, lane 
4; supernatant from BacPAK6/Cre infection, lane 5; eluate from Ni'-NTA column in 5 
mM Imidazole (BacPAK6/Cre infection), lane 6; eluate from Nip''-NTA column in 50 
mM Imidazole (BacPAK6/Cre infection), lane 7; eluate from Ni-NTA column in 50 
mM Imidazole (BacPAK6/E1.8 infection; ), lane 8; eluate from Ni+''-NTA column in 50 
mM Imidazole (AcMNPV infection; negative control), lane 9; standard protein 
markers. Molecular weight standards (kDa) are indicated to the right of the gel. 
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fusion gene with histidine tag) was used for positive control, whilst cell extract from 
the wild-type baculovirus infected cells was used for negative control. 
The result shows that in the presence of 5 mM imidazole, no Cre protein was eluted 
from the Ni++-NTA affinity column (lane 5), whereas in the presence of 50 mM 
imidazole, most of the Cre protein eluted from the column migrating as a single band 
of about 38 KDa on an SDS-PAGE (lane 6). As expected from the positive control, 
the E1.8 protein was eluted from the column in 50 mM imidazole (lane 7), whereas 
the wild-type polyhedrin protein which was not expressed as a fusion protein was 
eliminated in the wash through (lane 8). These results clearly show that the Crc 
protein expressed as a fusion protein with a hexa-histidine tag at its N-terminus can be 
purified in a one-step method from immobilised Ni++-NTA affinity chromatography 
column. The absence of Cre protein in the wash through shows that there is a strong 
binding interaction between the histidine residues and the Ni+ ions. 
After the purification of Cre protein from the baculovirus/insect expression system, it 
was important to establish that the protein is biologically active. In order to do this, a 
simple in vitro assay system was set up using as a substrate, plasmid pAT"lacZloxP2. 
The construction of this plasmid is described in the next section. 
3.6 Construction of pAT-IacZloxP2 
In the review of the Cre-loxP recombination reaction described in the introductory 
chapter, it was mentioned that native Cre recombinase catalyses site-specific 
recombination in plasmid substrates containing loxP sites in vitro in the presence of 
Mg2+ without any external energy cofactors (Abremski et al., 1983). Although these 
plasmids were available, a substrate plasmid which contained the loxP sequences in 
enzyme recognition sites that would be easy to manipulate by substitution with other 
sequences (described fully in chapter 4) and which can easily be assayed was required. 
For these reasons, pAT-lacZloxP2 was constructed. 
Plasmid pAT-lacZloxP2 is a 4.0 Kbp pAT153-derived vector containing P-lactamase 
(ampicillin resistance [ampr]) gene and pBR322 origin of replication (ori). The 
plasmid was constructed in the following steps: 
(i) The multiple cloning site (m. c. s) within the a peptide sequence of the lacZ (lacZ-(x 
) gene was removed by digesting pBS KS (-) with BssHII. The BssHII cohesive ends 
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were trimmed by digestion with SI nuclease followed by blunt end ligation to generate 
ApBS KS(-). 
(ii) A combination of oligonucleotide sequences designed as forward primer (13142- 
gacgtcGAATTCTTTCCATTCGCCATTCAGGCT) to anneal the 5' end of the lacZ-cc 
gene and the reverse primer (B143- gacgtcaAGCTTGCGCAACGCAATTAATGTGA) 
to anneal the 3' end of the lacZ-a gene were used to amplify the lacZ-a gene from A 
pBS KS(-) in a PCR reaction (the introduced EcoRI site in B142 and Hindill site in 
B143 are underlined and lower case letters indicate non-specific nucleotide 
extensions). The PCR product was analysed by agarose gel electrophoresis and 
subsequently purified and digested with HindIII and EcoRI restriction endonucleases. 
(iii) The lacZ-a gene was cloned into the unique HindIII and EcoRI restriction 
endonuclease sites in pAT153 vector to generate pAT-lacZ. 
(iv) Oligonucleotides corresponding to the loxP sites were synthesised as 
complementary strands with the necessary protruding ends required for cloning. The 
plasmid pAT-lacZloxP was generated by inserting a loxP site into the EcoRI site in 
pAT-lacZ. A second loxP site was inserted into the HindIII site in pAT-lacZloxP to 
generate pAT-lacZloxP2 (Figure 3.7). The orientation and sequence of the loxP sites 
and the lacZ-a gene in the plasmid were validated by restriction endonuclease 
digestions and by sequencing. 
The resulting plasmid, designated pAT-IacZloxP2, contains two loxP sites flanking 
the a peptide of lacZ gene. The loxP sites are directly repeated relative to each other, 
so that Cre-mediated recombination results in the excision of the lacZ gene flanked by 
the two catalytic sites. This is described in the next section. 
3.7 Analysing the biological activity of the recombinant Cre protein 
In order to investigate if the baculovirus/insect derived Cre protein could mediate site- 
specific recombination between loxP sites without any external energy co-factor(s) 
such as ATP (a characteristic of native Cre recombinase), a simple in vitro assay 
system (see section 2.8.1) containing pAT-lacZloxP2 in a solution of Mg2+, Na+ and 
BSA was used. As described in chapter 4, the presence of these cofactors in the 
reaction mixture optimises the efficiency of the Cre reaction, however they are not 
absolutely essential because the omission of one or two of these cofactors does not 
prevent recombination. 
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Figure 3.7- Map of plasmid pAT-lacZloxP2 
pAT-lacZloxP2 is a 4.0 Kbp pAT153-derived vector containing the (3-lactamase 
ampicillin resistance (ampT) gene and pBR322 on (origin of replication). The a peptide 
of lacZ was cloned into the unique HindIII and EcoRI sites in pAT153. 
Oligonucleotide sequences comprising loxP sites were cloned sequentially into the 
Hind III and EcoR I sites in the recombinant vector. The resulting plasmid contains 
two loxP sites in direct repeats flanking the a peptide of lacZ gene. 
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Cre-mediated recombination between the loxP sites leads to the excision of the lacZ 
gene, giving rise to two products: the vector backbone containing a loxP site (product 
A) and the lacZ gene also containing a loxP site (product B). (These fragments then 
become substrates themselves because each of them contains an active loxP site). 
Thus the Cre protein also catalyses site-specific recombination between the two 
products converting them back to the original substrate or to other recombination 
intermediates such as multiple integrations which are not detected here because they 
occur at very low frequency or are non-viable in cells. However, the integration event 
in general is less efficient than the excision event (Figure 3.8). The molecular species 
generated by the recombination event can be analysed either directly by restriction 
endonuclease digestion or by the phenotypic colour selection of substrates and 
products following an in vivo assay described in the following sections. 
3.7.1 Restriction endonuclease digestion analysis of Cre-mediated recombination 
Plasmid pAT-lacZloxP2 was incubated with various amounts of the purified 
recombinant Cre protein and the DNA was subsequently purifed and digested with 
BamHI and Scal and analysed by agarose gel electrophoresis (Figure 3.9). Restriction 
endonuclease digestion of pAT-lacZloxP2 with BamHI and Scal yields two fragments 
of 2.7 and 1.3 Kbp. After Cre mediated excision of the insert between the loxP sites, 
restriction digestion results in the formation of a 0.9 Kbp fragment in addition to the 
2.7 and 1.3 Kbp. 
The occurrence of the 0.9 Kbp band in addition to the 2.7 and the 1.3 Kbp fragments 
indicates that the Cre protein has recombinase activity. However, because the Crc 
recombinase activity is reversible it is unlikely to observe a complete excision of the 
insert fragment. As described in section 4.5, the efficiency of the excision event can 
be quantified by counting hybridisation signals from a Southern blot analysis using a 
phosphoimager. An alternative method of determining the recombination efficiency is 
described in section 3.7.2. 
3.7.2 Analysing the results of Cre-mediated recombination in-vivo 
If recombination is genuinely site-specific at the loxP sites and mediated by the Cre 
protein, then the consequence of the recombination event should be the excision of the 
lacZ-a gene resulting in recombinant products which are phenotypically LACZ'. The 
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Figure 3.8- Diagrammatic presentation of Cre-mediated excision reaction. 
Crc mediated site-specific recombination at loxP sites in the plasmid, pAT-IacZloxP2 
excises the intervening lacZ gene. The event gives rise to two products, the vector 
backbone (product A) and the lacZ gene (product B). Each product contains a IoxP 
site and is itself a substrate for Cre mediated integration reaction. 
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Figure 3.9- Restriction digestion analysis of the Cre-mediated recombination. 
The plasmid pA'I'-lacZloxP2 (2 pg) was incubated with various amounts of the 
purified Cre protein in a 30 µl reaction volume containing 50 mM iris-I t('I, pl l 7.4, 
10 mM MgCl2; 30 mM NaCl; I mg bovine serum albumin/ml for 20 minutes at 37°C. 
The reactions were purified by phenol/chloroform extraction followed by ethanol 
precipitation. Plasmid I)NA was subsequently digested with BamIII and Seal and 
separated on 0.7% agarose gel. DNA was visualised by ethidium bromide staining. 
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recombination product containing the lacZ-a gene does not contain an origin of 
replication (ori) and will therefore not replicate in cells, whereas the product that is 
resistant to ampicillin contains an on and will therefore replicate in cells. 
Aliquots of the recombination reaction (containing -50 ng of DNA) were transfected 
into E. coli DH5a competent cells and dilutions plated on L-agar (containing 
ampicillin, X-gal and IPTG). In the absence of Crc protein only blue colonies were 
observed on L-agar plates. However in the presence of the recombinant Crc protein 
both blue and white colonies were observed indicating that Cre-mediated 
recombination gave rise to products that are phenotypically LACZ-. The 
recombination event can therefore be assayed semi-quantitatively in vivo by the 
phenotypic colour selection of substrates and products on L-agar plates containing X- 
gal because the substrate pAT-lacZloxP2 contains the lacZ gene whose protein 
product, ß-galactosidase hydrolyses the chromogenic indicator X-gal to a blue 
phenotype, whilst the product containing the ampicillin resistant gene cannot 
hydrolyse X-gal. 
3.7.3 Sequence analysis of excision products 
If the Cre-mediated excision reaction gives rise to products which then becomes 
substrates for the reverse integration process, then an active loxP site must be present 
in each recombination product. In order to investigate this, DNA prepared from five 
white colonies (corresponding to a recombination product described above), were 
used in sequencing reactions. The reactions were analysed by polyacrylamide gel 
electrophoresis and visualised by autoradiography (Figure 3.10). Results showed that 
recombination event gave rise to products that contained an intact loxP site in all the 
white colonies analysed. The presence of active loxP sites in the recombination 
products demonstrates that the reversible reaction can occur. 
The quantitative analysis of the Cre-mediated excision reaction described in this 
section suggests that this assay system can be used to investigate various parameters 
of the Cre-loxP excision reaction (described in chapter 4). In order to do this, it was 
important to establish how much of the protein preparation is active Cre, for this 
reason the specific activity of the Cre protein was determined. 
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Figure 3.10- Investigating the recombination product by sequence analysis 
I'lasnnid DNA prepared from white colonies (product A; see Figure 3.8) as a result of Cre-mediated 
recombination were sequenced using an oligonucleotide sequence which primes within the anmh' gene in 
pA'1'-IacZloxP2 (see Figure 3.8). The sequencing reaction was analysed by polyacrylamide gel 
electrophoresis and visualised by autoradiography. The sequence analysis showed a loxP site 
(consisting of two 13 hp inverted repeats I shown in boxes with arrow headsJ flanking an 8 hp spacer 
region) and EcöR l and 1/indll l restriction endonuclease sites. 
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3.8 Determination of the specific activity of the Cre protein 
The effect of varying the concentration of the recombinant Crc protein on the 
efficiency of site-specific recombination was investigated in order to determine the 
activity and the purity of the recombinant Cre protein. 
The amount of Cre enzyme present or used in the recombination process is difficult to 
determine in absolute terms (e. g. grams) as its purity is often low and a proportion 
may be in an inactive, or partially active state. A more relevant parameter is the 
activity of the enzyme preparation, measured in terms of the activity unit (U), which is 
defined as the minimum amount of Cre needed to produce a maximum level of lQJE X 
12&E intramolecular recombination under the assay conditions described in Abrcmski 
et al., (1983). However the assay conditions which refer to optimal conditions, 
especially with regards to pH, ionic strength, temperature and substrate concentration 
may differ between laboratories. Therefore great care has to be taken over the 
consideration of these factors in defining the activity of Cre protein from different 
preparations. 
The specific activity of the purified Cre protein was defined by incubating 2 Itg of the 
substrate plasmid pAT-lacZloxP2 with different amounts of the Cre protein under 
standard in vitro assay conditions (described in section 2.7.4). After termination of the 
reaction, aliquots (containing -50 ng of DNA) were transfected into E. coli D115a and 
dilutions plated onto L-agar plates (as described in section 3.7.2). The results of the 
recombination, observed as white and blue colonies for recombinants and substrates 
respectively were quantified. The efficiency of excision (measured as % excision) is 
expressed as a measure of the ratio of white to blue colonies. In this experiment, a 
maximum excision was detected in the presence of 12 µg/ml of the Cre protein 
(afterwards the % excision "levelled off") per 2 µg of the plasmid (Figure 3.11). This 
corresponds to a specific activity of 27,000 U/mg (according to the calculation of 
Abremski and Hoess, 1984). 
Thus, the specific activity of the Cre protein purified from the insect/baculovirus 
system is somewhat lower, although of the same order of magnitude with the specific 
activity for the native Cre protein (40,000 U/mg; Abremski and boess, 1984). 
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Figure 3.11- Determining the specific activity of the recombinant Cre protein. 
Plasmid pAT-lacZloxP2 was incubated with 0.06,0.12,0.2,0.3, or 0.4 µg of Crc 
protein in 30 t1 reaction volume containing 50 mM Tris-HCI, pH 7.4,10 mM MgC12; 
30 mM Nacl; I mg bovine serum albumin/ml at 370C for 20 minutes. After 
termination of each reaction, aliquots (containing - 50 ng of DNA) were transfectcd 
into E. coli DH5a competent cells and dilutions analysed on L-agar plates (containing 
ampicillin, X-gal and IPTG). The ratio of white white and blue colonies 
corresponding to recombinants and substrates respectively was expressed as a 
measure of the percentage (%) excision. The efficiency of recombination (% excision) 
is displayed as a function of the concentration (. tg/ml) of the purified Cre protein in 
the reaction. 
119 
3.9 Summary 
In this chapter, the Cre recombinase of bacteriophage PI has been expressed in 
Spodoptcra frugiperda insect cells using a recombinant baculovirus vector. The 
product was synthesised as a fusion protein with six histidine residues at the amino 
terminus allowing rapid and efficient purification in a single affinity chromatography 
step. Approximately 0.9 mg of active Cre protein was purified from 5x 109 infected 
insect cells. This amount compares favourably with that achieved from E. colt source 
(0.4 mg/g of cell culture equivalent to N2x 1011 cells) Abremski and Hoess (1984). 
The baculoviralrnsect derived Cre protein has the following features in common with 
native Cre protein: (i) a molecular weight of approximately 38 KDa, (ii) migrates as a 
single polypeptide band on an SDS-polyacrylamide gel, and (iii) catalysis of site- 
specific recombination in plasmid DNA containing loxP sites in vitro. The ease with 
which the protein can be expressed, purified and stored, suggests that the 
baculovirusrnsect expression system can provide an alternative system for the large 
scale production of biologically active Cre protein that is required for further 
investigation into the mechanisms of the Cre-loxP reaction (described in chapter 4), 
and which can be directly introduced into mammalian cells to mediate targeted 
integration (described in chapter 5). 
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CHAPTER 4 
Investigating the mechanism of Cre-mediated recombination in vitro 
4.1 Introduction 
In chapter 3, the expression of Cre protein in insect cells infected with recombinant 
baculovirus was described. Having established that the Cre protein purified from the 
baculovirus/insect system was biologically active, it is then possible to investigate the 
kinetic parameters of Cre-loxP site-specific recombination reaction. In this chapter, the 
Cre-loxP reaction was investigated in vitro with the aim of gaining a greater 
understanding into the mechanism of the reaction and also to identify irreversible 
substrates that could improve the efficiency of targeted integration in mammalian cells. 
As this chapter investigates the recombinant Cre protein's interaction with loxP 
sequences in vitro, a summary of the mechanism and factors that could influence Cre- 
loxP site-specific recombination is described below. 
The first step on the pathway to site-specific recombination is the recognition of the 
loxP binding site by Cre protein. Although the mechanism by which Cre protein 
specifically recognises its loxP binding site is not known, the recognition of a specific 
DNA sequence by a protein has been studied for various proteins including the 
bacteriophage lambda Cro (Anderson el al., 1981), Salmonella Hin recombinase (Fong 
el al., 1994) and E. coli (F episome) yS Resolvase (Yang and Steitz, 1995). Structural, 
biochemical and molecular genetic studies suggests that all characterised sequence- 
specific DNA binding proteins recognises DNA helix (Watson and Crick, 1953) and 
binds without disturbing "base-pairing". This is made possible because the Watson and 
Crick model proposed for DNA structure (known as B-DNA helix) suggests that each 
DNA helix consists of ten base-pair residues and each base pair is exposed in two 
separate "grooves" called major and minor grooves which forms the contact site for 
many proteins. As previously mentioned, a loxP site is made up of two 13 bp inverted 
repeat flanking an 8 bp spacer region and each 13 bp inverted repeat of a loxP site 
forms a binding domain for Cre protein. There are a number of ways for Crc protein to 
interact with its recognition loxP sites, however if the conformation of the loxP site is 
to fit the Watson-Crick model (1953), then there is within each 13-bp inverted repeat 
of the loxP site the necessary major and minor grooves required for interaction with 
the Cre protein. 
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The interaction of loxP sequences with Cre may involve hydrogen bonding between 
amino acids at the binding sites and also van der Waals interactions between side 
chains and base pairs. Protein-protein interactions may also help Cre hold onto the 
loxP more tightly when they bind through co-operative (synergistic) binding. These 
specific interactions, together with backbone salt bridges interactions may stabilise the 
Cre-loxP complex formation. Furthermore, a DNA molecule containing loxP sequence 
in solution is not a single static structure. Instead, there is a dynamic flux of charges 
that influences its topology in addition to the topological effects by other DNA 
interacting proteins. Cations such as Na+, Mg2+ and polyamines (e. g. spermidine) 
neutralise DNA phosphate charges by forming cationic bridges with adjacent helices 
(Widom and Baldwin, 1980; Krasnow and Cozzarelli, 1982). As Cre protein binds 
loxP site(s), these neutralising charges must be displaced, as such, the equilibrium 
binding constant will depend not only on the concentration of the Crc protein and loxP, 
but also on the concentration of the charge-neutralising ion. Thus, the affinity of a Cre 
protein for IoxP site can vary markedly with salt concentration. 
There are several ways of investigating protein-DNA interactions. One approach 
describes the protection of DNA from nuclease digestion by protein. The position and 
sequence of the protected region can readily be identified by a technique called 
footprinting. In this approach, one end of DNA is first radiolabelled, protein is then 
added to the labelled DNA and the complex digested with DNase I. A control reaction 
is done where the DNA (without protein) is digested with DNase I. The resulting DNA 
fragments are separated according to size by gel electrophoresis. The gel pattern 
reveals a series of bands present in the control sample which is absent from the reaction 
containing the protein. These bands are missing because the protein shields the DNA 
from cleavage. The missing bands in the gel pattern identify the binding site on DNA 
(von Hippel el al., 1984). Using this approach, Hoess el al., (1984) showed that Cre 
recombinase binds a 34 bp sequence corresponding to the loxP site (see section 1.3.4). 
DNase I footprinting has the advantage of allowing the detection of protein binding 
DNA sequences, however it does not allow the detection of the affinity of protein for 
DNA binding sites or the determination of the stoichiometry of the protein-DNA 
interaction. 
Another approach for studying protein-DNA interaction is known as band shift. A 
band shift (Revzin) assay results in the separation of free DNA and DNA-protein 
complexes according to their different electrophoretic mobilities which are resolved as 
discrete bands by polyacrylamide gel electrophoresis. Band shift assay has two 
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requirements; (i) that the complexes formed are stable and remain intact during the gel 
run, and (ii) that the complexes migrate at a rate different to that of the uncomplcxed 
DNA fragment. This approach has the advantage of the determination of the 
stoichiometric ratio of protein specifically bound to DNA (Fried and Crothcrs, 1981; 
Garner and Revzin, 1981). Using this approach, Mack et at., (1992) determined the 
absolute stoichiometry of the Cre-loxP complex as one molecule of Crc per inverted 
repeat, or two molecules per loxP site (see section 1.3.4). 
As described in chapter 1, one round of site-specific recombination between two Cre- 
loxP complexes requires the breakage and reformation of four phosphodiester bonds 
(Jayaram, 1994). The reaction is completed by the combined action of four monomers 
of the recombinase binding at the recombination complex where strand cleavage and 
exchange occurs within the spacer region via a Holliday junction (Jayaram, 1994). The 
enzymology of the Cre-loxP reaction is very simple; Crc recombinase is the only 
protein required for strand breakage, exchange and resolution during site-specific 
recombination at loxP sites in vitro. No external energy cofactors (e. g. ATP) or 
accessory recombination proteins such as the E. coli recA are needed. Furthermore the 
in vitro recombination reaction can take place in low concentrations of a variety of 
buffers between pH 5 and 9 and ionic strength conditions between 50 and 350 mM 
(Abremski et al., 1983; Sternberg and Hamilton, 1981). 
The simplicity of the Cre-loxP site-specific recombination system has a major 
drawback for targeted integration events, in that recombination event is freely 
reversible. In site-specific DNA integration, recombination between a site on a circular 
molecule and a site on a plasmid or chromosomal DNA results in the insertion of the 
circular DNA into the plasmid or the chromosome. However the integrated DNA is 
flanked by two recombination sites of the same orientation and can therefore excise the 
inserted circular DNA if the recombinase is present. Because intramolecular excision is 
kinetically favoured over integration, insertion products are inherently unstable in the 
presence of the recombinase enzyme. In yeast and mammalian cells, a successful 
strategy used to obtain stable insertion products was to curtail post-integration 
recombinase activity through the transient provision of Crc recombinase (Baubonis and 
Sauer, 1993; Fukushige and Sauer, 1992; O'Gorman el al., 1991; Sauer and 
Henderson, 1990). A second attempted strategy was to introduce selective base 
changes into recombination sites such that the product sites of a recombination 
reaction are less likely to undergo further recombination (Henrik et al., 1995; SenecofT 
et a!., 1988). Further investigation into the mechanism of the Cre-loxP reaction may 
provide more information about aspects of the reaction that can be manipulated to 
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improve the efficiency of recombination which forms the basis of the work described in 
this chapter. 
In this chapter the Cre-loxP reaction was investigated in vitro using two different 
approaches: First, Crc protein was used in gel retardation analysis with oligonucleotide 
sequences corresponding to loxP site, Flp recombinase recognition binding (frt) site, or 
a hybrid of loxP and frt half sites to investigate the specificity of the Cre protein for its 
recognition loxP site. As previously described in chapter 1, Cre and Flp belongs to the 
int family of recombinases and are particularly closely related to each other 
functionally. It was therefore of interest to investigate if Cre binds frt in order to 
establish novel Cre binding sites that could be used to improve Cre-mediated targeted 
integration. In addition, the stability of the Cre-loxP complex was investigated in 
competition assays and the effect of different incubation temperatures on the 
interaction. 
Second, the Cre protein was used to investigate intramolecular (excision) reaction 
between two wild-type loxP sites or between a wild-type loxP and hybrid loxP/frt sites 
in the hope of identifying irreversible substrate that could be used to improve the 
efficiency of targeted integration. In addition, various factors such as temperature and 
different salt concentrations that could influence the efficiency of the Cre-mediated 
excision reaction were investigated. It was also important to establish that Cre protein 
could mediate intermolecular (integration) recombination between DNA fragments 
each containing a loxP site. This is because one of the main objectives of this thesis 
(described in chapter 5) was to introduce Cre protein directly into mammalian cells to 
mediate targeted integration. Finally the biochemical properties of the recombinant Cre 
protein reaction investigated here are compared with that of native Cre protein and 
aspects of the recombination process that can be manipulated to improve the efficiency 
of the recombination process are discussed. 
4.2 Results 
The following sections describes the results of the in vitro analysis of the Cre-loxP site- 
specific recombination reaction. 
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4.3 Recognition binding interaction using band shift assay 
As previously described in the introduction to this chapter, band shift assays provides a 
the method for studying protein-DNA interaction in vitro. In this section the 
recombinant Cre protein was used in band shift assays with radiolabelled 
oligonucleotide sequences corresponding to either a loxP, frt or a hybrid of loxP/frt 
half sites. The binding reactions were done as described in section 2.7.2. 
4.3.1 Investigating Cre-IoxP interaction 
In order to investigate if the recombinant Cre protein can recognise and bind to 
radiolabelled oligonucleotide sequence corresponding to a loxP site, a band shift assay 
was done. 
Different amounts of the recombinant Cre protein (12 ng/ml) purified from 
baculovirus/insect expression system were incubated with 1 ng of the radiolabelled 
loxP site in a band shift assay. The reactions were analysed by a non-denaturing 
polyacrylamide gel electrophoresis and visualised by autoradiography (Figure 4.1). 
The result demonstrates that when the radiolabelled loxP site was incubated with 12 pg 
of the Cre protein, two distinct signals were observed (lane 3). Because Cre protein 
can bind either a half or a full loxP site (described in chapter 1) these signals could be 
Cre binding to a half IoxP site (complex I) and a full loxP site (complex II) according 
to their different mobilities. Increasing the amount of Cre protein increased the 
intensities of the signals lanes 4 and 5 and the appearance of an "ill-defined" signal. No 
signals corresponding to either complex I or II were observed in the control reaction 
containing only loxP (lane 1) or when the reaction was competed with 100 fold molar 
excess of unlabelled loxP oligonucleotide (lane 2). 
The result suggests that Cre protein can form a complex with loxP oligonucleotide 
under the band shift assay condition described. In previous band shift assays 
investigating the optimum binding conditions (results not shown), no signals were 
observed when 1-5 pg of the Cre protein was incubated with 1 ng of the radiolabelled 
loxP site. That result in addition to the observation made here suggests that the 
optimum amount of Cre protein required for the Cre-loxP interaction is between 5 and 
12 pg. Further increase in the amount of the Cre only provides more Cre molecules to 
bind other loxP sites as evidenced by the increased intensity of the complexes formed. 
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Figure 4.1-Investigating Cre-loxP interaction in band shift assay 
Different amounts of Crc protein (12 ng/ml) were incubated with 1 ng of radiolabelled 
oligonucleotide corresponding to the loxP site in a band shift assay. Assays were done 
essentially as described in materials and methods (chapter 2). Complexes formed by the 
recombinant Crc protein and "P-labelled loxP sites were separated by non-denaturing 
polyacrylamide gel electrophoresis (5%) and visualised by autoradiography. Lane 1; no 
Crc, lane2 ; 32P-labelled loxP and Cre protein (12 pg) competed with 100 fold molar 
excess of cold loxP oligonucleotide, lanes 3-5; 32P-radiolabelled loxP incubated with 12 
pg, 24 pg or 60 pg of the recombinant Cre protein respectively. 
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The higher "ill-defined" signal observed with increasing amount of Cre protein could 
be the Cre-loxP complexes interacting with each other to form a Holliday structure as 
an intermediate for strand exchange. However, because any strand exchange would 
resolve back to the original complexes such a Holliday structure would be very 
unstable. 
The band shift result observed here only shows that the recombinant Cre protein can 
bind DNA and gives an estimate of the amount of Cre protein required to observe 
protein-DNA interaction. To investigate if the recombinant Cre protein can specifically 
recognise and interact with oligonucleotide sequence corresponding to loxP site other 
DNA oligonucleotides were used as substrates for the Cre protein described in the 
section. 
4.3.2 Investigating the specificity of the Cre protein for loxP binding site 
In order to determine whether the DNA binding activity of the Cre protein is sequence- 
specific, band shift assays were done using radiolabelled oligonucleotide corresponding 
to the frt or a hybrid of loxP/frt sites as the substrate for the Cre protein. 
As previously mentioned, Flp recombinase encoded by the yeast 2µ circle plasmid 
mediates site-specific recombination at frt sites and shows similar mechanism of site- 
specific recombination as the bacteriophage PI Cre recombinase. Furthermore, the frt 
site like loxP is a 34 bp sequence consisting of two 13 bp inverted repeats flanking an 8 
bp spacer region with each inverted repeat forming a binding site for the Flp protein 
(Andrews et al., 1985). However, comparison of the loxP sequence and the frt 
sequence (shown below) does not show much conservation (identical DNA bases 
shown as -; degenerate codes shown by the respective alphabet [see appendix 9]). The 
frt sequence is therefore an interesting substrate to investigate if the structure formed 
by a 34 bp sequence consisting of two inverted repeats flanking an 8 bp sequence is 
enough for Cre binding or that Cre interaction is sequence specific. 
LoxP ATAACTTCGTATA ATGTATGC TATACGAAGTTAT 
TATTGAAGCATAT TACATACG ATATGCTTCAATA 
Frt gaagttcctatac tttctaga gaataggaacttc 
cttcaaggatatg aaagatct cttatccttgaag 
Identity RW-RY-Y-KWWWM WWKYWWSS K-WWM-R-RY-WY 
127 
To investigate the specificity of the Cre-IoxP interaction, the recombinant Cre protein 
(20 pg) was incubated with 2 ng of radiolabelled oligonucleotide sequences 
corresponding to, the full loxP site, the Flp recognition site (frt) or a hybrid of the 
loxP 13 bp sequence and frt 13 bp sequence flanking either the lox? spacer or the frt 
spacer sequence (see appendix 4 for sequences) in a band shift assay. The reactions 
were separated on a 5% non-denaturing polyacrylamide gel and the protein-DNA 
complexes visualised by autoradiography (Figure 4.2). 
When Cre was incubated with radiolabelled oligonucleotide corresponding to the full 
loxP site, two distinct signals were observed (complexes I and II; lane 2) 
corresponding to Cre binding to a half loxP site (complex I) and a full loxP site 
(complex II) discuss below. Addition of a 100-fold molar excess of unlabelled IoxP 
sequence efficiently competed for the Cre-loxP interaction (lane 3) as shown by the 
absence of any signal. When Cre was incubated with the Frt site, no signals were 
observed (lane 4). When the Cre protein was incubated with the loxP/Frt hybrid 
containing either the loxP spacer sequence or Frt spacer sequence one band was 
observed (complex I; lanes 6 and 8). In either case the interactions were competed for 
by the addition of 100-fold molar excess of the corresponding unlabelled 
oligonucleotide sequences (lanes 7 and 9 respectively). No signals were observed in the 
control reaction containing only loxP oligonucleotide (lane 1). 
A number of observations can be drawn from this result. No complexes were formed 
between the Cre protein and the full frt site indicating that the recombinant Cre protein 
is very specific for the recognition IoxP site. When Cre protein was incubated with 
loxP/frt hybrid sequence, only one signal was observed (complex I), indicating that the 
Cre protein bound to the loxP sequence alone. Because complex I from both half (lane 
6 and 8) and full loxP site (lane 2) co-migrate, this represents Cre protein bound to half 
of the loxP site, whilst complex II represents Cre bound to the full loxP site confirming 
the initial observation that Cre forms two complexes with its recognition loxP site. 
Furthermore because the Cre protein formed complex I with a loxP/frt hybrid 
containing either the loxP spacer or the Frt spacer this indicates that the spacer 
sequence has no influence in the binding of Cre to the loxP site. The Cre protein in 
solution exists as monomers as shown by its migration as a single band of 38 kDa on 
non-denaturing polyacrylamide gel electrophoresis (section 3.5.4). Taking this data 
together, complex I could therefore represent one molecule of Cre protein bound to 
loxP inverted repeat, whilst complex II could represent each inverted repeat in a full 
loxP site bound to a single Crc molecule. This is consistent with the absolute 
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Figure 4.2-Investigating the specificity of the Crc protein for loxP binding site 
The recombinant Cre protein (20 pg) was incubated with 10 ng of radiolabelled 
oligonucleotide sequence corresponding to; the full loxP site, the full Frt site, a hybrid 
of 13 bp loxP sequence and 13 bp Frt sequence flanking either the loxP spacer region 
or the Frt spacer region in a band shift assay. Complexes formed were separated by 
non-denaturing polyacrylamide gel electrophoresis. Band shifts were visualised by 
autoradiography. Lane 1; no Cre , 
lane 2; 32P-labelled loxP incubated with Cre 
protein, lane 3; binding of Cre protein to 32P-labelled loxP competed with cold loxP 
sequence, lane 4; 32P-labelled frt incubated with Cre protein, lane 5; binding of Cre to 
32P-labelled fit competed with cold frt oligonucleotide, lane 6; 32P-labelled loxP/frt 
hybrid (containing loxP spacer sequence) incubated with Cre protein, lane 7; binding of 
Cre to radiolabelled loxP/frt hybrid (containing loxP spacer sequence) competed with 
the corresponding cold oligonucleotide, lane 8; 32P-labelled loxP/frt hybrid (containing 
frt spacer sequence) incubated with Cre protein, lane 9; binding of Cre to radiolabelled 
loxP/frt hybrid (containing frt spacer sequence) competed with the corresponding cold 
oligonucleotide sequence. 
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stoichiometry of the Cre-loxP complex to be one molecule of Crc bound per inverted 
repeat, or two molecules per loxP site (Mack el al., 1992). 
Results from band shift analysis shows that the recombinant Crc protein does not bind 
to frt (Flp recombinase recognition) site under the assay conditions used. Although 
footprinting assays were not done to investigate this further, it is possible that Cre may a 
form a weak interaction with the frt site. This has actually been reported to be the case. 
Abremski and Jayaman (unpublished observation) demonstrated that Cre binds frt 
sequence with a 20-fold lower affinity. If Cre protein binds frt sequence, this suggests 
that the frt site could be a very inefficient substrate for Cre-mediated site-specific 
recombination which could therefore be manipulated to achieve irreversible substrates 
for the Cre reaction. To investigate this, plasmid DNA substrates containing a wild- 
type loxP sequence and a hybrid of loxP/frt sequences were constructed, as described 
in the next section. 
4.3.3 Construction of "mutant" substrates for Crc-mediated site-specific 
recombination 
Two mutant plasmids, mutant A and mutant B were constructed. The mutant plasmids 
are identical to pAT-lacZloxP2 (section 3.6) in that they contain two site-specific 
recombination sequences (which are directly repeated relative to other) flanking the a 
peptide of lacZ gene. However, compared to pAT-lacZloxP2 which contained two 
wild-type loxP sequences, each mutant plasmid contained one wild-type loxP site and 
one oligonucleotide sequence consisting of a hybrid of loxP and frt half sites. In mutant 
A, the oligonucleotide sequence corresponds to one 13 bp sequence of loxP site and 
one 13 bp sequence of frt site flanking a loxP spacer whilst in mutant 13, the 
oligonucleotide sequence corresponds to one 13 bp sequence of loxP site and one 13 
bp sequence of fit site flanking an fit spacer sequence. The recombination sites are 
schematically represented in Figure 4.3. The mutant plasmids were designed in this 
way, so that if Cre protein mediates site-specific recognition between the wild-type 
loxP site and the hybrid loxP/frt site, the event would lead to the excision of the lacZ 
gene which can be analysed either directly by restriction endonuclease digestion or by 
phenotypic colour selection of substrates and products following an in vivo assay as 
described in sections 3.7.1 and 3.7.2. 
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Figure 4.3- Schematic representation of intramolecular recombination sites. The wild- 
type recombination sites consists of two loxP sites, each made up of two inverted 
repeats (shown as clear boxes with arrowheads) flanking a spacer region. Mutant A 
recombination sitesconsists of one loxP site and a hybrid loxP site made up of 13 bp 
sequence of loxP (shown as clear box with arrowhead) and 13 bp sequence of frt 
(shown as solid box with arrowhead) flanking a loxP spacer region. Mutant B 
recombination sites consists of one loxP site and a hybrid loxP site made up of 13 bp 
sequence of loxP and 13 bp sequence of frt flanking frt spacer region. 
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4.3.4 Investigating Cre-mediated site-specific recombination in mutants A and 11 
As described above, the aim of constructing mutant plasmids was to investigate if Cre 
protein would recognise frt sequence as a substrate for site-specific recombination in 
the hope of identifying irreversible substrates for the Crc reaction. 
In order to investigate this, each mutant plasmid (2'tg) was incubated with different 
amounts of the recombinant Cre protein in a 30 t1 reaction volume for 20 minutes at 
370C. After termination of the reaction, an aliquot of each (containing about 50 ng of 
DNA) was transfected into E. coli DH5a competent cells and transformants analysed 
on L-agar plates (containing ampicillin, X-gal and IPTG). When mutant A was used as 
the substrate, all the forty-seven colonies observed on L-agar plates were blue. Also 
when mutant B was used as the substrate all the sixty-nine colonies observed on L-agar 
plates were blue. In contrast, when pAT-lacZloxP2 was used as the substrate about 
47% of the colonies observed were white. 
These results suggests that the efficiency of intramolecular (excision) recombination 
using mutant A or mutant B is less than 2% and 1% respectively. This observation in 
addition to band shift assays suggests that any interaction between the recombinant Cre 
protein and the frt site, may be too weak to detect in vitro. However, this may not be 
the only factor to explain the lack of detectable intramolecular recombination events. It 
is possible that in mutant A (see Figure 4.3), the Cre protein may cause strand cleavage 
within the two loxP spacer regions generating a Holliday intermediate, but resolution 
into the heteroduplex structures becomes impossible because one of the recombining 
partners does not have the necessary homologous sequence for strand exchange and 
therefore reverts back to parental. In mutant B, the Cre protein may cause cleavage in 
the loxP spacer region but not the frt spacer region and therefore no strand exchange 
can occur. However, the data presented here cannot address this. An experiment to 
verify the effect of two different spacer sequences would be to change one of the loxP 
spacer sequence in plasmid pAT-lacZloxP2 to frt spacer sequence and investigate Cre- 
mediated intramolecular recombination using the modified substrate. However, the 
failure to observe any site-specific recombination using either mutant A or B meant 
that the recombination sites could not be investigated further to identify irreversible 
substrates for the reaction. 
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4.3.5 "On-Oft" binding assay 
For site-specific recombination to occur, the complex formed between a single loxP 
site and the Cre protein must have a stable "on-rate" until it encounters another such 
complex for synapsis and strand exchange to take place. At the same time, the Cre- 
loxP complex should be able to dissociate at a given "off rate" after the recombination 
event so that the subsequent heteroduplex structure formed does not revert back to the 
original substrates. This suggests that the stability of the initial Cre-loxP complex 
formed is very important if recombination is to occur. In order to investigate this, the 
effect of DNA competition on the "on-rate" stability of the Cre-loxP complex was 
analysed in a band shift assay. 
The recombinant Cre protein (160 pg) was incubated with 16 ng of a 32P-radiolabelled 
oligonucleotide sequence corresponding to a loxP site in 80 µl total reaction volume. 
At various time points in the reaction, 10 µl aliquots were separated on a 5% non- 
denaturing polyacrylamide gel. After a 10 minute incubation period, 80 ng (10-fold 
molar excess) of cold loxP oligonucleotide was added to the reaction. Aliquots (10 µl) 
were removed at various time points and immediately loaded onto the running gel. 
Protein-DNA complexes were visualised by autoradiography (Figure 4.4). 
This result is consistent with the Cre-loxP interaction forming two complexes. These 
complexes were observed even when the Cre was incubated with the loxP 
oligonucleotide for 30 seconds. When a 10-fold molar excess of cold loxP sequence 
was added to the reaction (time of addition indicated by a vertical arrow), complex I 
was competed off within 30 seconds, whilst complex II was not displaced even after 10 
minutes suggesting that complex II is more stable than complex I. Complex II 
represents two molecules of Cre protein bound to a full IoxP site, implying a possible 
protein-protein interaction between the Cre molecules that stabilises the complex 
formed at the loxP site. The results also show that the kinetics of the Cre-loxP 
interaction is very fast, Cre-loxP binding occurring in less than 30 seconds, however 
there is no indication of how many loxP sites are occupied by Cre protein at this time 
point. Although the rate of dissociation of the Cre molecules from the loxP site was 
not determined, as it is shown in section 4.6, the in vitro site-specific recombination 
can occur in less than a minute suggesting that the "off-rate" can be as rapid as the 
"on-rate". 
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Figure 4.4-"On-Off' binding assay 
The recombinant Cre protein (320 pg) was incubated with 16 ng of radiolabelled loxP 
site in a 80 pl total reaction volume in a band shift assay. At various time points in the 
reaction 10 µl aliquots were removed and separated by non-denaturing polyacrylamide 
gel electrophoresis. After 10 minutes incubation period, 80 ng (10 fold molar excess) 
of cold loxP oligonucleotide was added to the reaction (the vertical arrow indicates 
time of addition of excess cold loxP oligonucleotide). Aliquots (10 µl) were removed 
at various time points into the competition reaction and separated on the same gel. 
Band shifts were visualised by autoradiography. 
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The stability of the Cre-loxP binding interaction has important implications for the in 
vivo site-specific recombination approaches proposed in cukaryotic cells: these cells 
contain many DNA binding proteins which might be expected to compete with Cre for 
loxP sites so perhaps preventing encounters between either Cre and its loxP sites or 
Cre-loxP complexes. The observation that the Cre-loxP complex II is stable over at 
least 10 minutes suggests that the complex can be stabilised from non-specific 
interactions in the cell until it encounters another such complex for recombination to 
take place. An alternative experiment would have been to investigate the competition 
of total protein extract from eukaryotic cells and the recombinant Crc protein for loxP 
binding site in a band shift assay. Although this experiment was not done, results of 
Crc protein mediated targeted integration in CHO cells (described in chapter 5) 
demonstrates that despite possible competition from other cellular proteins for loxP 
binding sites, the recombinant Cre protein is able to catalyse site-specific 
recombination in vivo. 
4.4 The effect of temperature on Cre-IoxP reaction 
As previously described in the introduction section, there are many factors such as salt 
concentration and temperature that may influence protein-DNA interaction either by 
affecting the affinity of the protein for DNA or through conformational changes of the 
DNA. In order to investigate the effect of temperature on the Cre-loxP interaction, 
band shift assays were incubated at different temperatures. 
The recombinant Cre protein (200 pg) was incubated with 10 ng of radiolabelled 
oligonucleotide sequence corresponding to a loxP site in a 100 Al reaction volume. 
Incubation was done at the following temperatures; 0°C, 10CC, 15°C, 21°C, and 
37°C. At various time points in each incubation reaction, 10 µ1 aliquots were removed 
and separated on a 5% non-denaturing polyacrylamide gel and protein-DNA 
complexes visualised by autoradiography. The protein-DNA complexes observed at 
0°C were compared with those observed at 370C (Figure 4.5). 
The band shift patterns of the Cre-loxP complex were the same for all the incubation 
temperatures investigated, suggesting that the binding interaction of the Cre-loxP is 
independent of the temperature range studied. However, Drew el al., (1985) proposed 
that the TpA sequence in the spacer region of the loxP site may be predisposed to 
melting. This report, together with the observation made here, suggests that 
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temperature may be essential for other steps in the recombination process such as 
unwinding of the loxP site either during the pairing or the strand exchange steps. 
However, it is possible that the conditions chosen arc not stringent enough to allow 
detection of temperature effect on Cre-loxP interaction. Perhaps a more accurate 
investigation of the Cre-loxP binding interaction at different temperatures would be to 
cross-link the complexes at the particular temperatures before separation on a non- 
denaturing polyacrylamide gel. 
The observation from band shifts suggested that Cre-loxP binding is not affected by 
temperature, however it is possible that other steps in the recombination process may 
be affected by temperature. In order to investigate this, Cre-mediated intramolecular 
recombination assay was done at different temperatures, described in the next section. 
4.4.1 Temperature effect on the efficiency of the excision reaction 
The recombinant Cre protein (0.3 µg) was incubated with 2 µg of plasmid pAT- 
lacZloxP2 (described in section 3.6) in a complete irr vitro recombination assay 
reaction at various temperatures. After termination of each reaction, the DNA was 
subsequently purified and digested with BamHI and Sac! and analysed by agarose gel 
electrophoresis. The DNA fragments were transferred onto a nylon membrane and 
hybridised with a radiolabelled probe corresponding to the ß-lactamase ampicillin 
resistance (Ampr) gene. Southern hybridisation signals were quantified using a 
phosphorimager (described in section 4.6). The efficiency of recombination (% 
excision) which is a measure of the ratio of excised fragments to non-excised 
fragments is expressed as a function of temperature (Figure 4.6). 
These results shows that there is a broad temperature optimum for efficient Cre- 
mediated excision reaction. This observed thermostability may allow the use of the 
recombinant Cre protein in thermophilic organisms. However, the efficiency of Cre- 
mediated excision decreases substantially at higher temperatures. Given that excision is 
a more favourable process over integration, the use of Cre-loxP system for site-specific 
integration in thermophilic organisms may occur at very low frequency. 
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Figure 4.6- Investigating the effect of temperature on the efficiency of the excision 
reaction. The recombinant Cre protein (0.3 µg) was incubated with 2 ýtg of pAT- 
lacZloxP2 in a complete in vitro assay (see materials and methods) at various 
temperatures. After termination of each reaction, the DNA product was analysed by 
BamHI and ScaI restriction digestion and Southern hybridisation following agarose gel 
electrophoresis. Hybridisation signals were quantified by a phosphoimager. Results of 
recombination (% excision) was displayed as a function of temperature. 
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4.5 Investigating other requirements for the Crc-mediated intramolecular 
recombination 
As previously mentioned, the salt concentration in a solution can influence DNA- 
protein interaction and therefore recombination. In order to investigate the effect of 
ionic charges on the efficiency of the Cre-loxP reaction, Cre-mediated intramolecular 
recombination at different salt concentrations were investigated. 
The recombinant Cre protein (0.3 µg) was incubated with 2 µg of plasmid pAT- 
lacZloxP2 in a complete assay reaction or in assay reactions having one of the co- 
factors omitted. After termination of each reaction, aliquots (containing -50 ng of 
DNA) were transfected into E. coli DH5a competent cells and dilutions analysed on 
L-agar plates (containing ampicillin, X-gal and IPTG). The results of the 
recombination, observed as white and blue colonies (on L-agar plates) for 
recombinants and substrates respectively were quantified. The percentage 
recombination is expressed as a measure of the ratio of white to blue colonies (Table 
4.1). 
The results showed 48% optimum Cre-mediated excision reaction in the complete 
assay mixture. The efficiency of the reaction was not significantly affected by Na+ ions 
(25 mM-150 mM), however the complete omission of Na+ or the presence of 150 
mM Na+ significantly reduced the efficiency of recombination (the presence of Na+ in 
the Crc solution might have compensated for some of the effect that would have 
resulted from total omission in the reaction). This indicates that Na+ ions may be 
necessary for recombination by neutralising a certain portion of the phosphate groups 
in the loxP site and thereby increase the binding affinity of Cre. However, high 
concentrations of Na+ ions may bind more phosphate groups reducing the binding 
affinity of Cre for the loxP site because more Na+ ions may need to be displaced. The 
effect of omitting Mg2+ was more significant than Na+ in the reaction. Mg2+ may play 
a similar role to Na+ but in addition Mg2+ may improve the stability of the Cre-loxP 
binding interaction because Cre protein has been observed to dimerise in the presence 
of Mg2+ (Abremski and Hoess, 1984). Although the omission of BSA reduced 
recombination efficiency, the effect was not as significant as Mg2+. Whilst the 
substitution of BSA with spermidine resulted in optimum recombination efficiency, 
BSA and spermidine may act differently to produce the same result. The role of BSA 
may act to prevent denaturing of the Crc protein as a result of non-specific interaction 
(e. g. with the reaction tube) whilst spermidine may act to condense the DNA substrate 
bringing the loxP sites into close proximity for recombination to occur. These in vitro 
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Addition % Recombination 
Complete 48 
+ Na' (50 mM) 46 
+ Na (75 mM) 46 
+ Na* (100 mM) 43 
+ Na' (150 mM) 34 
-Na+ 28 
-Mg + 18 
"BSA 28 
-BSA + Spermidine 47 
-Tris-HC1 46 
-Cre protein 0 
Table 4.1- The ionic requirement for Cre-mediated intramolecular recombination 
The recombinant Cre protein (0.3 µg) was incubated with 2 Ftg of pAT-lacZloxP2 in 
an in vitro recombination assay. The complete reaction contained 50 mM Tris-HCI, pH 
7.4; 10 mM MgCl2; 30 mM NaCl; 1 mg bovine serum albumin/ml. Spermidine was 
added to 6 mM where indicated. After termination of each reaction, aliquots 
(containing - 50 ng of DNA) were transfected into E. coli DH5a competent cells and 
dilutions analysed on L-agar plates (containing ampicillin, X-gal and IPTG). The ratio 
of white and blue colonies corresponding to recombinants and substrates respectively 
was expressed as a measure of the percentage (%) recombination. 
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observations suggest that the of ciency of Cre mediated recombination is significantly 
affected by salt concentrations, this may not reflect in vivo conditions because of 
substantial metabolic buffering which means that the affinity of Cre for its recognition 
loxP sites in vivo may differ from in vitro. 
4.6 Investigating the time course for the reaction 
Next, the relationship between efficiency of recombination and the time course of the 
reaction was investigated. 
The plasmid pAT-lacZloxP2 (16 µg) was incubated in a 600 tl reaction volume with 
1.2 pg of the purified Cre protein. Aliquots (50 µl) of the reaction were taken at 
different incubation periods (0 to 60 min) and the recombination reaction terminated. 
The DNA was subsequently purified and digested with BamHI and ScaI and separated 
on an agarose gel. The DNA fragments were subsequently transferred to a nylon 
membrane and hybridised with a radiolabelled probe corresponding to the ß-lactamase 
ampicillin resistance (ampr) gene (Figure 4.7a). As previously described in section 
3.7.1., restriction endonuclease digestion of pAT-lacZloxP2 with BwnHI and Scal 
yields two fragments of 2.7 and 1.3 Kbp. After Cre mediated excision of the insert 
between the loxP sites, restriction digestion results in the formation of a 0.9 Kbp 
fragment in addition to the 2.7 and 1.3 Kbp. The hybridisation signals from the non- 
excised (1.3 kbp) fragment and the excised (0.9 kbp) fragments were quantified with a 
phosphorimager. The percentage recombination (% excision) which is a measure of the 
ratio of excised fragments to non-excised fragments is displayed as a function of time 
(Figure 4.7b). 
Excision products were observed as early as thirty seconds into the reaction. However, 
the reaction did not reach equilibrium until after five minute incubation period with 
only a small increase in the excision product at later time points. These results suggest 
that although the Cre-mediated excision reaction occurs rapidly, it takes much longer 
for the Cre protein to catalyse maximum excision. The observation of recombination 
products within 30 seconds suggests that binding and catalysis are not the rate limiting 
factors in recombination process, therefore another factor such as the recognition and 
interaction between Cre-loxP complexes could be the rate limiting step. A model 
reviewed in Gellert and Nash, (1987) proposes a common mechanism of bringing sites 
together for site-specific recombination systems that require interacting DNA 
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Figure 4.7a- Investigating the time course for the Cre-loxP reaction 
The plasmid pAT-lacZloxP2 (16 µg) was incubated in a 600 µl volume with 1.2 µg of 
the purified Cre protein in a complete in vitro recombination assay. Aliquots (50 µl) of 
the reaction were taken at different incubation periods (0 min. to 60 min). The DNA 
was subsequently purified and digested with BamHI and Scal. The digested DNA 
products were separated on a 0.7% agarose gel, blotted onto a Nylon membrane and 
hybridised with a radioactively labelled probe encompassing the amp resistance gene 
(amp`). The hybridisation signals were quantified with a phosphoimager. 
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Figure 4.7b- Investigating the time course of the Cre-loxP reaction. 
The percentage recombination (% excision) which is a measure of the ratio of the 
excised fragment to the non-excised fragment (see Figure 4.7a) is displayed as a 
function of time. 
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sequences to have specific relative orientation and site-specific recombination where 
relative orientation is not crucial. The model proposes that for all systems, 
recombination sites are juxtaposed by random collision; in the systems where 
orientation is not critical, all collisions lead to recombination, but in the other systems a 
requirement for interwrapping of the sites can place restriction on which encounters 
are productive. The complexity of the chromatin structure and the highly concentrated 
heterologous nature of the mammalian cells suggests that if the Cre-loxP site-specific 
recombination occurs by random collision, then such an event would occur very 
infrequently, however the high concentration of polycations may condense DNA 
structure bringing the loxP recombination sites into close proximity for recombination 
to take place. 
4.7 Further investigation of Cre-mediated excision reaction 
So far the percentage of maximum excision at equilibrium obtained using the 
recombinant Cre protein is 48%. This is much lower than the reported maximum 
excision (-70%) for native Crc protein (Hoess and Abremski, 1984) suggesting that 
the recombinant Cre protein may not be as active as native Cre. However, in the Hoess 
and Abremski study, the substrate plasmid (pRH43) used was different from that used 
in the present study which could explain the differences in the efficiency of excision. In 
order to investigate if the plasmid sequence could influence the efficiency of excision, 
pRH43 was used as a substrate for the recombinant Cre protein in an in vitro reaction. 
Plasmid pRH43 (described in Abremski el al., 1983) contains two loxP sites in direct 
repeats relative to each other. The sites are separated by approximately 2 Kbp of DNA 
and are flanked by two antibiotic resistance markers, ampr and kanr (kanamycin 
resistance gene; Figure 4.8a). Plasmid pRH43 (2 µg) was incubated with different 
amounts of the purified Cre protein in a 30 µl reaction volume for 20 minutes at 370C. 
After termination of the reaction, DNA from each reaction was purified and digested 
with Scal. The digested DNA products were separated on an agarose gel and stained 
with SYBRTM green solution. Restriction endonuclease digestion of pRH43 with ScaI 
yields a 4.3 Kbp fragment. After Cre mediated intramolecular recombination, 
restriction digestion is expected to result in the formation of a 2.0 and 2.3 Kbp 
fragments in addition to the 4.3 Kbp fragment. The amount of DNA in each band was 
quantified by fluorimager (quantification using fluorimager was found to be as 
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Figure 4.8a- Cre-mediated recombination in plasmid pRH43 
The construction of this plasmid is described in Abremski et al., (1983). Intramolecular 
recombination results in two smaller circular molecules, pRI-144 and pRH45. Plasmid 
pP. 1144 is 2.3 Kbp in size and contains the ß-lactamase gene, the pBR322 on and a 
single EcoRI site. Plasmid pRH45 is 2.0 Kbp in size and contains the kanamycin 
resistance gene (kanD and a single BamH I site. Each product contains a loxP site and 
hence is a substrate for Cre-mediated recombination back to the original substrate. 
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accurate as using phosphorimager [described in section 4.6], this method has the added 
advantage of directly quantifying DNA fragment in an agarose gel without Southern 
hybridisation). The percentage recombination (% excision) measured as a ratio of the 
excised (2.3 Kbp) fragment and the non-excised 4.3 Kbp fragment is displayed as a 
function of the amount of the Cre protein (Figure 4.8b). Because site-specific 
recombination excises the kanamycin resistance gene (which does not contain an origin 
of replication and therefore connot replicate in cells), the event can also be analysed by 
transfecting an aliquot of the reaction into E. coli DllSa competent cells and plating 
out transformed cells on L-agar which is supplemented with ampicillin and kanamycin. 
The recombination event can be assayed by the phenotypic selection of kanamycin 
sensitive and resistant colonies corresponding to products and substrates respectively 
on L-agar plates. However, this approach only gives a semi-quantitative analysis of the 
recombination. 
A maximum excision of 63% was observed in the presence of 0.3 µg of the 
recombinant Cre protein. This is consistent with that achieved using purified Cre 
protein from E. coli (Hoess and Abremski, 1984). The result indicates that the 
recombinant Cre protein is as good as native Cre protein. The higher excision observed 
using pRH43 could be due to the DNA sequence in pRH43 which by virtue of its 
structure (for instance hairpin or kinks conformation) enhances site-specific 
recombination. 
4.8 Intramolecular recombination between two loxP sites in inverted repeats 
Results described above shows that the recombinant Cre protein can mediate site- 
specific recombination events between two loxP sites directly oriented to excise the 
intervening sequences. In order to investigate if the recombinant Cre protein can also 
mediate inversion, plasmid pAT-lacZloxP2inv was used as a substrate for the Crc- 
mediated recombination event. 
Plasmid pAT-1acZloxP2inv is the same as pAT-lacZloxP2 except that the loxP sites 
flanking the lacZ gene are inverted relative to each other. Plasmid pAT-lacZloxP2inv 
(2 µg) was incubated with different amounts of the Crc protein in complete assay 
reaction. After termination of the reaction, the recombination products were analysed 
in two ways: 
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Figure 4.8b- Investigating the efficiency of the Cre-mediated intramolecular excision 
event. Plasmid pRH43 (2 µg) was incubated with different amounts of the recombinant 
Cre protein in a complete in vitro assay reaction. After termination of the reaction, 
DNA was purified from each reaction and digested with Scal. The digested DNA 
products were separated on a 0.7% agarose gel and stained with SYBRTM green 
solution as described in materials and methods. The amount of DNA in the excised 
(2.3 Kbp ) fragment and the non-excised (4.3 Kbp) fragment was quantified using a 
Flourimager. 
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(i) DNA purified from half of the reaction volume was digested with 13arn111 and Scat 
and separated on an agarose gel (Figure 4.9a). Restriction cndonuclcase digestion of 
pAT-lacZloxP2inv with BamHI and ScaI yields two fragments of 2.7 and 1.3 Kbp. If 
Cre-mediated recombination excises the insert between the two loxP sites, restriction 
digestion is expected to result in the formation of a 0.9 Kbp fragment in addition to the 
2.7 and 1.3 Kbp. However none of the 0.9 Kbp fragment was seen suggesting that the 
recombination event does not lead to excision of the lacZ gene. 
(ii) To confirm this observation, an aliquot of the reaction (containing about 50 ng) 
was transfected into E. coli DH5ct and plated onto L-agar (containing ampicillin, X-gal 
and IPTG). If Cre mediated recombination excises the lacZ gene between the loxP 
sites, the recombination event should give rise to the phenotypic white and blue colour 
selection for products and substrates respectively (as described in section 3.7). Only 
blue colonies were observed in all the Cre mediated reactions supporting the initial 
observation that recombination between loxP sites inverted relatively to each other 
does not excise the intervening DNA fragment. However, the control reaction (absence 
of Cre protein) also gave blue colonies, therefore to verify that the blue colonies could 
also result from Cre-mediated inversion, plasmid DNA prepared from five blue 
colonies were sequenced using an oligonucleotide sequence designed to prime within 
the ß-lactamase (ampr) gene in the vector backbone. Results of the sequencing analysis 
(data not shown) showed that one out of the five DNA preparations had the lacZ gene 
inverted between its flanking loxP sites (Figure 4.9b). A more readily assayable 
experiment to investigate the inversion event would have been to construct a plasmid 
containing the loxP sites in inverted repeat flanking on the one side the lac promoter 
and on the other side the lacZ gene. The plasmid would have been designed such that 
the lac promoter and the IacZ gene are in opposite orientation with respect to each 
other. Cre mediated recombination at the loxP sites should invert the lac promoter 
between the loxP sites so that the recombination event leads to the expression of the 
lacZ gene under the transcriptional control of the lac promoter. The recombination 
event could be quantified by the phenotypic colour selection of substrates and 
products, which in this case would give rise to white and blue respectively. 
Nonetheless, this result shows that the recombinant Cre protein mediated 
recombination between loxP sites inverted relative to each other leads to the inversion 
of intervening DNA sequences at a frequency of 20%, although no efforts were made 
to optimise this. 
148 
Figure 4.9- Investigating Cre mediated recombination between IoxP sites in inverted 
repeats. 
A-Restriction digestion of recombination event between loxP sites in inverted 
repeats. The plasmid pAT-lacZloxP2;  was incubated with various amounts of the 
purified Cre protein in a 30 µl reaction volume containing 50 mM Tris-l ICI, pI 174; 10 
mM MgCI2; 30 mM NaCl; I mg/ml bovine serum albumin for 20 minutes at 37"C. The 
reactions were then purified by phenol/chloroform extraction followed by ethanol 
precipitation. The plasmid DNA were subsequently digested with Raml II and Scat and 
separated on 0.7% agarose gel. DNA was visualised by ethidium bromide staining. M 
is 1 Kb DNA standard marker. 
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inverted relative to each other. The Cre mediated recombination leads to the inversion 
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4.9 In vitro analysis of integration event 
As previously mentioned, one of the objectives of this work was to directly introduce 
the recombinant Cre protein into cells to mediate targeted integrations (described in 
chapter 5). It was therefore important to initially establish that the recombinant Cre 
protein could mediate site-specific integration in vitro. 
Two plasmids (described in Peakman et al., 1992) each containing a single loxP site 
were used to investigate Cre mediated integration event. Plasmid pKSloxP was 
constructed by cloning an oligonucleotide pair corresponding to the sequence of loxP 
into the Kpnl site of pKS (Bluescript +, Stratagene). Plasmid p36Clox was constructed 
by cloning an oligonucleotide pair corresponding to the sequence of loxP between the 
EcoRV and KpnI sites of the baculovirus transfer vector p36C (Page, 1989). Plasmids 
pKSlox and p36Clox were digested with Sall and PvuII respectively. The linear DNAs 
(2 ig each) were mixed in the absence and presence of varying amounts of the 
recombinant Cre protein and incubated for 20 minutes at 370C. After termination of 
the reaction, the products were electrophoresed on an agarose gel and analysed by 
Southern blotting using a 445 bp PvuII probe corresponding to the lox containing 
fragment of pKSlox (Figure 4.10). 
Cre-mediated site-specific integration between the loxP sites of the linearised 
substrates, pKSIox and p361ox is expected to give rise to product species of molecular 
sizes; - 0.5 kbp, -17 kbp, -2 kbp, -3 kbp, -4 kbp and higher molecular weight 
sizes if multiple integration occurred. The results show a signal of 3.05 kbp in lane 1 
(positive control) corresponding to the 445 bp probe hybridising to the complementary 
sequence in the pKSlox fragment. No signals were observed in lane 2 (negative 
control) because the p36Clox fragment does not contain the 445 fragment sequence. 
When pKSlox and p36Clox were incubated together in the absence of Cre protein 
(lane 3), only the 3.05 kbp signal was observed suggesting that no site-specific 
recombination had occurred between the loxP sites. In the presence of Cre 
recombinase (lanes 4-6), hybridisation signals of -1.1 kbp, -1.7 kbp, -2 kbp, 3.05 kbp, 
-4 kbp were observed. These signals corresponds to site-specific integration products. 
However, the presence of 3.05 kbp suggests that not all of the substrate fragments 
were converted to integration products. The intensity of the signals was highest when 
0.3 µg of the Cre protein was used. This shows that increasing the amount of Cre 
protein in the reaction increases the recombination products because there are more 
Cre molecules to recombine more substrate DNA. However, an equilibrium is reached 
when the further addition of Cre protein favours the excision of 
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Figure 4.10- Investigating Cre-mediated integration event 
2 µg of Sall digested pKSlox and 2 pg of PvuII digested p36clox were mixed in the 
presence and absence of varying amounts of the recombinant Cre protein in a complete 
in vitro assay. After termination of the reaction, the products were electrophoresed on 
an agarose gel and analysed by Southern blotting using a 445 bp PvuII probe 
corresponding to the lox containing fragment of pKSlox. Lane 1; pKSlox, lane 2; 
p36clox, lane 3; pKSlox + p36clox, lane 4-6; pKSlox + p36clox in the presence of 0.2, 
0.3 or 0.5 pg of the recombinant Cre protein respectively. The position of molecular 
weight markers (in Kbp) are shown on the left. 
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the integrated molecules back to the original substrate as shown by the weaker signals 
and the disappearance of some signals (-1.7 kbp) in the reaction containing 0.4 pg of 
Crc protein. 
It is clear from the results that the recombination is dependent on both the presence 
and amount of Cre and also that the IoxP sequence in this context is an efficient 
substrate for the Cre protein. The observation that maximum integration was detected 
in the presence of 0.3 pg of Cre protein correlates with the maximum excision (see 
section 3.8) for the same amount of substrate DNA. However the efficiency of the 
integration event was not determined to compare with the excision event. 
4.10 Summary 
In this chapter, the baculovirus/inscct derived Crc protein was used in two in vitro 
assay systems to investigate the kinetics of the Crc-loxP site-specific recombination 
reaction: First, band shift assays showed that the recombinant Cre protein is very 
specific for its recognition loxP sites with the stoichiometry of the interaction being 
two Cre molecules per loxP site. Band shift assays and Crc-mediated intramolecular 
recombination (discussed later) suggests that the Cre-loxP binding and dissociation 
must occur very quickly because recombination products were detected in less than 
thirty seconds. However, using oligonucleotide competitors in band shift assays, results 
suggests that a loxP site bound by two molecules of Cre was stable for over ten 
minutes indicating that even though the recombination occurs very fast, a Crc-loxP 
complex is stable until another complex is recognised for recombination to take place. 
Second, the recombinant Cre protein mediated intramolecular (excision/inversion) and 
intermolecular (integration) recombination in DNA substrates containing loxP sites. In 
the context of the substrates described in this chapter, recombination was absolutely 
dependent on the presence of the Cre protein and two functional loxP sites. For the 
intramolecular event, the recombination products were dependent on the orieintation 
of the loxP sites relative to each other. Cre mediated recombination between loxP sites 
in direct repeats led to excision, whereas the recombination between loxP sites in 
inverted repeats gave rise to the inversion of the intervening DNA sequence. The in 
vitro reaction was dependent on the concentration of salts, especially Mg2+. Perhaps 
Mg2+ effects recombination by increasing the affinity of Crc for the loxP site and/or 
stabilising the Crc-loxP binding interaction. However, Crc-loxP binding was not 
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affected by temperature and furthermore, optimum recombination occurred over a 
wide range of temperatures suggesting that the Crc-lox.? reaction is thermostable. 
Because Cre-loxP site-specific recombination is reversible, and excision is kinetically 
favoured over bi-molecular integration, integrated products are inherently unstable in 
the presence of the recombinase. This would be a major drawback for site-specific 
DNA integration. An attempt to improve the stability of integrated DNA molecules 
was to introduce selective base changes into recombination sites such that the product 
sites of a recombination reaction are less likely to undergo further recombination 
(Albert et al., 1995). In this chapter, substrate plasmids containing a wild-type loxP 
and a hybrid loxP/frt site were constructed to investigate if the recombinant Cre 
protein would mediate intramolecular recombination between these sites, in order to 
manipulate these hybrid sites further to improve the integration event. Unfortunately 
no detectable recombination events were observed between the wild-type and the 
hybrid loxP/frt sites suggesting that the loxP/frt hybrid was not a substrate for the 
recombinant Cre protein. A drawback in manipulating the loxP site to improve the 
stability of integrated DNA, is that it may reduce the frequency of intermolecular 
recombination because the integration event is less efficient than excision, therefore 
any enhanced stability that will be conferred upon integrated molecules by 
manipulating the loxP sites will probably be outweighed by even fewer integration 
events. 
The results from the in vitro studies shows that the recombinant Cre protein is as 
efficient as native Cre in mediating site specific recombination at loxP sites, and 
suggests that the six histidine residues and the nuclear localisation signal of the fusion 
protein do not interfere with the recombinant Cre activity. This raises the potential that 
the histidine domain could be used as an independent molecular tag for in vivo analysis 
of Cre mediated recombination whilst the nuclear localisation signal should increase the 
rate of nuclear transport of the Cre protein in mammalian cells for targeted 
integrations, described in chapter 5. 
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CHAPTER 5 
Targeting of exogenous DNA into CIIO chromosome mediated by the Cre-Ioxl' 
system 
5.1 Introduction 
As previously described in chapter 1, the main problem involved in the use of 
mammalian expression systems as host for the high level expression of recombinant 
proteins is that the expression levels of recombinant proteins show extreme variability 
between individual clones isolated from a single transfection. This is due to a differing 
number of copies integrated into the genome and also from chromosomal position 
effects. As a result an extensive number of clones must be screened in order to isolate a 
high-expressing clone. 
A strategy that was initially described by Fukushige and Sauer (1992) used the Cre- 
loxP site-specific recombination system to eliminate both the constraints of 
chromosomal position of ects and copy number variation on gene expression. In this 
strategy a loxP site was introduced into a region in the chromosomal such that 
transgenes could be targeted to that region, a process catalysed by the Cre 
recombinase. Independent clones isolated from a single transfection all expressed 
similar amount of recombinant protein showing that the Cre-mediated site-specific 
integration can facilitate the construction of isogenic cell lines and thereby permit 
reproducible gene expression in stably transformed cell lines. 
Such a strategy would be advantageous if the site to which the foreign gene is to be 
targeted is favourable for high expression leading to the isolation of transfected cell 
lines expressing relatively constant, high levels of recombinant protein. This chapter 
investigates the potential of the Cre-loxP system for the construction of a cell line that 
could be used for the reproducible high level expression of recombinant proteins. 
Because this chapter investigates mammalian cells for recombinant protein expression, 
the various components involved are described in this section. 
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5.1.1 Choice of cell line 
The wide variety of transcriptional control elements and selectable markers now 
available permit the use of essentially any cell line for the purposes of hctcrologous 
gene expression. However, the consideration for the preferred cell line, depends on a 
number of factors which includes the availability of appropriate expression vectors 
(described below), growth properties such as doubling time and serum requirements, 
stability and expression levels. Furthermore, tissue-specific or temporally regulated 
gene expression may require appropriate cell lines which express tissue-specific cellular 
factors and genetic regulatory elements to produce normal patterns of expression. For 
example, immunoglobulin (Ig) genes are usually expressed in lymphoid cells were they 
are transcribed and translated into biologically active proteins (Dorai and Moore, 
1987). 
5.1.2 Methods for introducing transgenes into mammalian cells 
As previously described in chapter 1, there are two general methods of introducing 
transgenes into mammalian cells; those mediated by virus infection and those mediated 
by direct DNA transfer (reviewed in Kaufman, 1990). One advantage of the former 
relates to its efficiency; it is not unusual to achieve close to 100% DNA delivery to 
cells by exploiting the ability of the virus to efficiently infect cells. A disadvantage of 
this approach, and one that limits its utility, lies in the relative difficulty of its 
application; it requires much more effort to engineer a virus to express a foreign gene 
in a manner that does not compromise its function than it does to administer DNA 
directly. Also the use of viral vectors can raise a number of regulatory issues such as 
containment of genetically engineered viruses. As such, most attempts to express 
heterologous genes in mammalian cells rely on the construction of DNA vectors and 
their direct transfer by a number of chemical and physical methods, each with its own 
advantages and disadvantages (reviewed in Kriegler, 1990). Ray and Cage (1992) 
showed that, at least for the two cell lines and three transfection methods they studied 
(i. e. established Rat-1 cell line and rat primary skin fibroblasts; by CaPO4 co- 
precipitation, lipofection and electroporation) the transfection method does not affect 
the level of foreign gene expression achieved. 
Direct transfer methods have been used successfully in a wide variety of cell types, 
including Chinese Hamster Ovary cell line, CHO-DUKX 1311 (Page and Sydenham, 
1991) and Baby Hamster Kidney cell line, BHK-21 (Hippenmcycr and Highkin, 1993). 
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The efficiencies of these techniques, whilst not as high as with viral systems can 
approach -90% of the transfected cells, which will continue to express the protein of 
interest for a period of several days and perhaps a few weeks. The transfcctcd DNA is 
eventually lost unless a procedure is used to select for cells which have integrated the 
DNA into their genome. The limiting factor is not the uptake of the DNA into the 
cells, but rather the integration of the transfected DNA into the chromosome. 
Therefore a selection procedure is required in order to select for stably transfcctcd cell 
lines. For this reason, expression vectors (described in the next section) are often 
designed to contain the transgene and a selectable marker within the same plasmid. 
5.1.3 Design of expression vectors 
The basic elements for the control of heterologous gene expression consists of a 
promoter-enhancer element which is responsible for the transcription of the cistron, 
and a polyadenylation signal which directs the cleavage and polyadenylation of the 
transcript (Kriegler, 1990). Many vectors also contain one or more small introns, in the 
belief that intron-containing vectors are more efficient for gene expression. Following 
the promoter element is the coding sequence of the gene or cDNA to be expressed. 
Mammalian cells do not show stringent requirement for translational initiation, 
although they do exhibit a preference for the first translational initiation codon, AUG 
at the 5' end of the message and especially for initiator codons having the consensus 
sequence ..... 
CCACCAUGG.... (Kozak, 1989). Downstream AUGs can be recognised 
in mammalian cells particularly if the upstream AUG is followed by a termination 
codon or if the downstream AUG is preceded by IRES as found in 
encephalomyocarditis virus (EMCV; Kaufman, 1990). Following the gene insert is a 
sequence which allows for the cleavage and addition of the polyadenylation tail to the 
transcript. The polyadenylation signal consists of the hexanuclcotide AAUAAA 
located between 20 and 30 nucleotides upstream of the site of polyadenylation addition 
(Wickens, 1990). Lack of polyadenylation signal can severely reduce the amount of 
cytoplasmic mRNA and translated protein. Most commercial vectors are designed to 
contain multiple cloning sites, a phage origin of replication (ori) sequence and multiple 
drug-resistance markers. 
In addition to the heterologous gene, some type of selectable marker must be added on 
a second cistron to allow for the selection of stable cell lines. The selectable marker 
can be either on the expression plasmid or contained on a second plasmid. For transient 
expression systems or high-efficiency gene-transfer systems (i. e. viral vectors or 
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microinjection) a selectable marker is not needed. The first selectable markers used 
were based upon complementation systems encoding the hypoxanthinc phosphoribosyl 
transferase (hgprt) gene and the herpes thymidinc kinase (1k) gene (Wigler el al., 1977; 
Roberts et al., 1982). Somatic mutants lacking the tk or hgpri gene could be easily 
selected for by culturing the cells in the presence of nucleoside analogues such as 8- 
azaadenine or 6-thioguanine so that metabolism of the analogue results in the 
production of toxic nucleotides. The development of CHO mutants lacking 
dihydrofolate reductase (DHFR) allowed the use of SV40-DFHR chimaeric plasmids 
to select for cells able to grow in the absence of thymidine, glycine and hypoxanthine 
(Urlaub, 1980). The ease with which the expression levels of these CHO cells could be 
further increased by methotrexate selection has been the primary reason why CHO- 
DHFR system has become the most popular mammalian system used in the production 
of recombinant proteins (described in detailed below). 
The main limitation of vectors containing such selectable markers is that the host cells 
are limited to mutant cell lines. Although TK and HGPRT mutants can be easily 
selected for and against, DHFR- cell lines are very difficult to obtain. For these 
reasons, dominant selectable markers, able to be used in any cell type, have been 
derived from bacterial genes which have no equivalent sequences in mammalian cells. 
The most widely used dominant marker is derived from the transposon encoded 
aminoglycoside 3' phosphotransferase (APH), which confers neomycin (neo) resistance 
(Jimenez and Davies, 1980). The related aminoglycoside G418 (geneticin) is extremely 
toxic to mammalian cells and serves to inhibit protein synthesis. Cells expressing even 
low levels of the neomycin gene are able to survive in the presence of high levels 
(mg/ml) of G418. The selection works well on a wide variety of cell types, including 
virtually all of the cells used for recombinant DNA (rDNA) expression. Almost as 
widely used is the gene encoding hygromycin B phosphotransferase, an E. coli gene 
which acts similarly to the neomycin gene (Colbere-Gerapin et al., 1987). It confers 
resistance to hygromycin, an aminoglycoside antibiotic which affects protein synthesis 
by blocking ribosome translocation. Dominant selectable markers based on mammalian 
genes have also been developed. The three most widely used systems utilises DIiFR 
(described later), adenosine deaminase (Ycung el al., 1983) or glutaminc synthetase 
(Young and Ringold, 1983). All these components were taken into consideration in 
constructing a cell line that could be used for the reproducible high level expression of 
recombinant proteins. 
In this study, CHO cells (Levinson, 1990) were used as the host system for the 
expression work, because CHO cells are well suited for the generation of production 
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cell lines for many reasons. Chief among these is the availability of CHHO cells dcf cicnt 
in their ability to produce dihydrofolate reductase (DIIFR; Urlaub and Chasin, 1980), 
an essential enzyme which catalyses the conversion of folate to tetrahydrofolate (a 
precursor in DNA biosynthesis). CHO DIIFR- cells have been extensively 
characterised as fast growing and can be easily transfected. Also CHO DIIFR- cells 
allows the use of SV40-DHFR chimaeric plasmids (described above) to select for cells 
able to grow in the absence of thymidine, glycine and hypoxanthine. Moreover, these 
cells adapt well to growth on monolayer and in suspension and have been used 
successively in a variety of production systems such as human thyroid stimulating 
hormone (rh TSH; Lubiniecki et al., 1989) and tissue plasminogen activator (tPA; Cole 
et al., 1989). Finally, stable CHO cell lines containing a dlir expression vector can be 
amplified to achieve increased gene copy number by culturing these cells in the 
presence of methotrexate (MTX), a selective agent that is toxic to cells. Cells 
overcome the toxic effects of this selective agent by producing more DHFR as a result 
amplifying the cellular gene encoding DHFR (Bebbington and Hentschel, 1987). 
Subsequently large chromosomal regions (hundreds to thousands of kb) are amplified 
(as described in section 1.2.2.3). The strategy involved in designing a CHO cell line for 
targeted integration of transgenes is described in the next section. 
5.2 Design of Cre-loxP mediated targeted integration of transgencs in CIIO cells 
To investigate the Cre-loxP system as a tool for genomic targeting in CHO cells, a 
loxP site was initially placed into the chromosome of the CHO dl fr- cell line (CHO- 
DUKX B11) via a plasmid construct containing a reporter gene, Secreted Alkaline 
Phosphatase (SAP) and a dl fr selectable marker gene. The plasmid integrates 
randomly into CHO chromosome. The integration event can occur anywhere in the 
chromosome, either at a promoter region, an enhancer/repressor region, a non-coding 
region or a region in the chromosome under cell-cycle/tissue specific induction. 
Integration into any of these regions would have a direct effect of the level of gene 
expression, in this case the reporter gene, SAP. Thus a low SAP activity would 
indicate integration into a region in the chromosome which does not favour gene 
expression and a high SAP activity would indicate integration into a region of the 
chromosome favourable for gene expression. Because a loxP site is placed in the same 
plasmid containing the SAP gene, the level of SAP activity would be used as an 
indicator in screening a large number of cell lines each containing a single copy 
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insertion of the plasmid in order to isolate cell lines in which the loxP site has been 
placed in a region of the chromosome favourable for gene expression. 
To develop a positive selection for the site-specific integration event two approaches 
were taken: In the first approach, a promoterless lacZ/neor fusion construct containing 
a loxP site was either co-transfected with a plasmid containing the cre gene or 
recombinant Cre protein purified from the baculovirus/insect system. Cre-mediated 
site-specific recombination targets the input DNA to a chromosomal IoxP site which 
lies between the ß-actin promoter and the SAP gene. Proper targeting should activate 
the expression of the bifunctional lacZ/neor fusion gene from the chromosomally 
placed ß-actin promoter. In addition, transcription of the SAP reporter gene was under 
the control of the ß-actin promoter, thus the Cre-mediated recombination event should 
not only give rise to cells resistant to the neomycin analogue G418 and expressing f 3- 
galactosidase activity but also loss or reduction of SAP activity (Figure 5.1). 
In the second approach, a promoterless CAT gene construct containing a loxP site was 
co-transfected with a plasmid containing the cre gene. Similarly, the Cre-mediated 
integration of the promoterless CAT gene to a chromosomal ß-actin promoter-loxP 
site should activate the expression of a functional CAT gene from the chromosomally 
placed ß-actin promoter. In the case of targeting the promoterless CAT gene, the 
result of the targeting event should give rise to cells expressing CAT activity and the 
loss or reduction of SAP activity. 
5.3 Results 
The following sections describes the construction of CHO-DUKX BI1 cell line 
incorporating the Cre-loxP site-specific recombination system as a tool that would 
allow the reproducible high level expression of recombinant proteins. 
5.4 Construction of pSAP-RDN/loxP 
As described in the previous section, Cre-mediated site-specific recombination in CIHO 
cells requires a chromosomal loxP target for the integration event to occur. In order to 
develop a positive selection for the integration of loxP site(s) into CFHO 
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Figure 5.1-Schematic representation of Cre-mediated targeting of a an exogenous 
DNA to a chromosomal loxP site. Initially a IoxP site was placed in the genome of 
CHO DHFR- cells via a plasmid encoding a dihydrofolate reductase gene (Jut, ) and a 
secreted alkaline phosphatase (sap) reporter gene under the transcriptional control of 
P-actin promoter (P). Cre recombinase mediated targeting of a promoterless 
lacZ/neor fusion to the chromosomal loxP site activates the expression of the fusion 
gene from the ß-actin promoter initially driving the SAP expression. This results in 
targeted clones which resistant to the neomycin analogue G418, positive for 
galactosidase expression and give loss or reduction in SAP expression. 
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chromosomes, plasmid pSAP-RDN/loxP was constructed by cloning an 
oligonucleotide comprising the loxP sequence into pSAP-RDN. 
Plasmid pSAP-RDN (obtained from Dr. Nigel Sharp, GWR&D), encodes an 
engineered cDNA corresponding to the secreted alkaline phosphatase (SAP) gene 
under the transcriptional control of the human ß-actin promoter combined with 5' 
untranslated region (UTR), and 3' UTR plus polyadenylation site for efficient gene 
expression. The plasmid also contains a functional dihydrofolate reductase (d/Jr) gene 
under the transcriptional control of an attenuated SV40 early promoter. By 
constructing the plasmid with the dl Jr selectable marker gene under the transcriptional 
control of an attenuated promoter, expression of DHFR should be less efficient than 
the reporter SAP. This should bias for the selection of transfected cells where the 
plasmid has integrated into transcriptionally active sites. In addition, the plasmid 
contains a ß-lactamase gene to confer ampicillin resistance (Ampr), a ColEI origin of 
replication (ori) and also SV40 on. Furthermore, the plasmid contains various 
restriction endonuclease sites for cloning and restriction digestion analysis (Figure5.2). 
Plasmid pSAP-RDN/loxP was constructed by cloning a double stranded 
oligonucleotide comprising the loxP sequence into the unique Hindu site in pSAP- 
RDN. In order to bias for the ligation of the loxP sequence and the vector, pSAP-RDN 
was dephosphorylated (see section 2.2.9) after digestion with the HindIII restriction 
endonuclease. Results of the ligation event was analysed by transforming ligated DNA 
fragments into E. coli DHSa competent cells and transformed cells observed as 
ampicillin resistant colonies on L-agar plate (see section 2.2.13). The results showed 
fifteen colonies from the control plate (corresponding to self-ligated vector DNA) 
whilst forty-three colonies were observed as a result of pSAP-RDN and loxP ligation 
(test plate). This observation suggests that every 2 out of three colonies observed on 
the test plate should correspond to vector plus insert ligation. 
Out of ten colonies (corresponding to pSAP-RDN + loxP ligation) which were 
analysed by sequencing only four had the loxP sequence inserted into pSAP-RDN. The 
sequence analysis further showed that the loxP site had inserted into pSAP-RDN in 
two orientations as determined by the directionality of the spacer region. In the one 
orientation loxR (Figure 3a), the loxP sequence was observed to have two ATG 
translational initiation codons upstream of the translational initiation codon of the SAP 
gene, with the first ATG codon out of frame with the SAP gene. Furthermore, a purine 
(A) base was observed at position -3 of the first ATG codon in the loxP 
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Figure 5.2-Map of pSAP-RDN. 
Plasmid pSAP-RDN encodes a functional dihydrofolate reductase (dhfr) gene under 
the transcriptional control of attenuated SV40 early promoter. The plasmid also 
contains an engineered cDNA corresponding to the secreted alkaline phosphatase 
(SAP) gene under the transcriptional control of the human ß-actin promoter combined 
with 5' untranslated region (UTR), and 3' UTR (plus polyadenylation site). In 
addition the plasmid contains a ß-lactamase gene to confer ampicillin resistance 
(amp), a ColE! origin of replication (ori) and SV40 on. 
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Figure 5.3a- Map of plasmid loxR 
A double stranded oligonucleotide sequence corresponding to the loxP site (which 
consists of two 13 bp inverted repeats [shown in box with arrowheads] flanking an 8 
bp spacer region) with Hindill recognition ends was cloned into the unique IfindIlI 
site in pSAP-RDN (see Figure 5.2) to generate loxR. The loxP site in this orientation 
was observed by sequencing analysis to have two ATG translational initiation codons 
(shown in bold) upstream with respect to the first ATG codon of the SAP gene. 
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sequence suggesting that the ATG codon is in an appropriate context for translational 
initiation (Kozak, 1987). Translational initiation from the ATG in the loxP sequence 
instead of the authentic ATG in the SAP gene could inhibit the transcription of the 
SAP reporter gene and therefore decrease SAP expression. However no such ATG 
translational initiation codons were observed when the loxP sequence was inserted in 
the other orientation, loxL (Figure 3b). 
To construct a recombinant CHO cell line containing loxP site(s); pSAP-RDN/IoxP 
(with the loxP site in both orientations) were independently transfected into CHO- 
DUKX B 11 cell line as described in the next section. 
5.5 Construction of CHO cell lines containing a single loxP site by lipofection 
A loxP site was introduced into CHO chromosome by transfecting CHO-DUKX BI l 
cells with the plasmid pSAP-RDN/loxP (with the IoxP sites in both orientation; i. e., 
loxL and loxR). The plasmid contains a d{tfr gene to allow for the selection of 
transfected cells that have stably integrated the loxP plasmid DNA by growing 
transfected cells in medium lacking hypoxanthine and thymine. 
Circular plasmid DNA was transfected into CHO-DUKX B 11 using lipofection. In this 
method, a lipofectam reagent which contains a spermine group, with a strong affinity 
for DNA, is covalently attached to a lipid moiety. The trivalent positively charged 
spermine headgroups bind to the negatively charged DNA, and in the presence of 
excess lipopolyamine, cationic lipid-coated DNA particles are formed. The lipid allows 
association of the particles with the cell membrane and internalisation of the DNA 
probably occurs by endocytosis. 
CHO"DUKX BII (1 x 106) cells were transfected separately with 16 µg of loxL and 
16 µg of loxR mixed with 80 µg of Transfectam. Two days post transfection, cells 
were plated at six dilutions; 100,50,10,5,1,0.33 cells/well (described in 2.4.3) into 
DHFR select medium. Approximately 400 DHFR+ colonies/107 transfected cells were 
obtained twenty days post transfection. It should be noted that this transfection 
efficiency is an underestimate because wells that contained more than one colony were 
disregarded. Furthermore, the calculation is based on the assumption that no new 
colonies appeared after 20 days. Plasmids IoxL and loxR both contains the reporter 
(SAP) gene, therefore DHFR+ clones isolated after transfection can also be assayed 
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A Double stranded oligonucleotide sequence corresponding to the loxP site (which 
consists of two 13 bp inverted repeats [shown in box with arrowheads] flanking an 8 
bp spacer region) with HindIII recognition ends was cloned into the unique Hind(II 
site in pSAP-RDN (see Figure 5.2) to generate loxL. The loxP site in this orientation 
does not contain any ATG codon(s). 
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for SAP activity in order to assess the transcriptional level of SAP gene in independent 
cell lines and to select for cell lines in which the loxP site has been placed in a region of 
the chromosome favourable for gene expression. The analysis of SAP expression in 
DHFR+ clones is described in the next section. 
5.5.1 Assay for SAP activity in DIIFR+ clones 
Many genes have been used for monitoring gene expression in eukaryotic cells. This 
includes ß-galactosidase (An et al., 1982), xanthine-guanine phosphoribosyl 
transferase (Chu et al., 1985) and thymidine kinase (Searle et al., 1985). However, all 
of these genes have disadvantages, such as the presence of a similar endogenous 
enzyme activity or the requirement for a complicated assay. Another reporter gene that 
has become widely used is the E. colt enzyme chloramphenicol acetyl transferase 
(CAT; Gorman et al., 1982). The major advantages of this enzyme is the lack of any 
equivalent enzymatic activity in eukaryotic cells and the existence of highly sensitive, 
radioactivity-based assays for CAT. The assay is however expensive to do and may 
require the use of radioactivity. SAP, the secreted form of human placental alkaline 
phosphatase on the other hand avoids several of these disadvantages, for instance, it is 
far simpler and less expensive to use. 
In addition, SAP has several advantages over the membrane bound form of alkaline 
phosphatase (which is frequently assayed in diagnostic laboratories); (i) SAP is not 
significantly affected by heating at 650C for 5 minutes (Stigband, 1984; Berger et at., 
1987). The resistance of SAP to heat treatment, which effectively eliminates other AP 
activities is indicative of the high stability of SAP. (ii) Because SAP is expressed in the 
culture medium, other kinetic experiments can be done using the same culture medium, 
through sequential sampling of the medium. In addition, the lack of an extraction step 
removes the possibility of trapping AP activity in the discarded particulate material and 
also segregates the indicator SAP gene away from any endogenous cell surface AP 
activity. Consequently, the cells can be used for other purposes, such as RNA 
preparation. 
The SAP assay used (detailed in section 2.8.3) is essentially the standard colorimetric 
assay for AP (McComb and Bowers, 1972) modified by the addition of a 65°C pre- 
heating step to the reaction mixture. The increase in absorbance at 405nm, which 
results from the hydrolysis of p-nitrophenolphosphate to p-nitrophenol, is proportional 
to the AP activity (McComb and Bowers, 1972). SAP activity (N. Sharp, GWR&D, 
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pers. comm. ) can be accurately quantified in a small volume permitting the use of any 
of several available automoatic 96-well plate ELISA readers for the assay. 
Forty DHFR+ clones isolated from each transfection were assayed for SAP activity. 
The level of SAP expression from loxR transfected cells were observed to be between 
10-100 fold lower compared to the level of SAP expression from loxL transfected 
cells. Because DHFR+ clones isolated from loxR transfection contains two ATG 
codons (in the loxP sequence) upstream from the authentic ATG codon of the SAP 
gene, this result suggests that in stably transfected cells containing loxR, the ribosome 
may recognise and initiate translation from the ATG codon in the loxP sequence 
instead of the authentic ATG codon of SAP. Consequently translation of the SAP 
gene is repressed. 
Most of the DHFR+ clones isolated from loxR transfection showed similar and very 
low levels of SAP activity which, as mentioned previously, could be due to 
translational initiation from the first ATG codon in loxR which results in a decrease 
SAP expression. However, a good representation of clones expressing different levels 
of SAP were required in order to identify those clones which had integrated the loxP 
site(s) in chromosomal positions favourable for gene expression. Therefore most of the 
these clones were disregarded for further analysis. On the other hand, DIIFR+ clones 
isolated from loxL transfection showed high and relatively different levels of SAP 
expression, hence were propagated for further analysis. In addition, four of the 
DHFR+ clones isolated from loxR transfections were also propagated to investigate if 
the different SAP expression level observed from the two different plasmid 
transfections were due other factor(s) such as differing copy number of the plasmid 
integrated and/or different chromosomal position effects in the two separate 
transfection events. 
The initial SAP activity was used to identify cell lines expressing SAP. In order to 
characterise these cell lines and accurately get a representation of the level of SAP 
expressed in these cell lines, the specific production rate (S. P. R; section 2.8.4) of SAP 
was determined for each clone. Results shown in Table 5.1 confirmed the initial 
observation that the level of SAP expression from transfccted cells containing loxR 
were much lower compared to transfected cells containing loxL. It is possible that the 
different expression levels of SAP observed between the different transfected cells is 
due to differing copy numbers of the loxL and loxR plasmid integrated and also 
different positions of integration into the CHO genome. In order to investigate the 
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pSAP-RDN/loxP 
(loxL) 
SAP (arbitrary 
units/106 cells/day) 
pSAP-RDN/loxP 
(loxR) 
SAP (arbitrary 
units/10~ cells/da 
2-12 1.1 1-1 0.9 
2-20 2.3 1-3 0.05 
2-11 2.5 1-15 0.03 
2-29 4.7 1-20 0.01 
2-26 15.2 
2-9 14.8 
2-19 20.8 
2-16 22.1 
2-2 29.7 
2-21 31 
2-24 40 
2-1 81 
2-18 100 
2-6 100 
2-8 115 
Table 5.1- Comparison of standard production rate (SPR) of SAP expression from 
independent CHO-DUKX B 11 cells transfected with recombinant pSAR-RDN/loxP 
(where the loxP site is cloned in one of two orientations [L or R]). 
One million cells from transfected CHO-DUKX B 11 cells was grown in 5 ml of 
DHFR' select medium in tissue culture flask overnight. The medium was replaced 
with fresh medium. 24 hours after the addition of the fresh medium (± 30 min), 0.5 ml 
of the medium was removed to determine SAP activity (described in section 2.4.7). 
The adherent cells in the flask were detached by versene and trypsin treatment and 
viable cell density determined. Arbitrary unit is defined as the change in absorbance at 
A,,,,,,,, in 30 minutes (readings were done in duplicates). 
S. P. R. (arbitrary units/106 cells/24 hours) = Arbitrary units of SAP-activity 
cell density (107ml) 
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copy number of loxL and loxR integrated in each transfection, a Southern hybridisation 
was done, described in the next section. 
5.5.2 Analysis of loxP copy number by Southern hybridisation 
For Cre-mediated site-specific targeting of exogenous DNA into CHO-DUKX 1311 
cells, a single IoxP sequence placed in a unique site in the chromosome is required. 
This is because multiple IoxP copies in the chromosome could lead to chromosomal 
translocation and rearrangements. In order to select for CHO transfected cell lines 
containing a single copy of the loxP plasmid and to assess if the copy number of 
plasmid integrated in CHO chromosome would correlate with different expression 
level of SAP, DHFR+ clones were analysed by Southern hybridisation. 
Genomic DNA prepared from CHO transfected cell lines (10 µg) was digested with 
EcoRV and separated by electrophoresis on agarose gel. The DNA was transferred 
onto nylon membrane and hybridised with an 800 bp radioactive probe corresponding 
to SV40 polyA fragment. The SV40 polyA fragment was obtained from pSV-SB 
(obtained from Nigel Sharp, GWR&D) by digestion with Bg1II and BamHI. The CHO 
genome does not contain SV40 polyA whereas the transfected DNA (i. e. loxL and 
loxR) does. Therefore transfected cells which have integrated the plasmid should 
hybridise to this probe in Southern hybridisation. Southern hybridisation was visualised 
by autoradiography (Figure S. 4). 
The restriction enzyme EcoRV will cut the genomic DNA in many places, but the 
plasmid insert is only cut in one place. When the SV40 polyA signal is used as a probe 
in the Southern hybridisation, a genomic DNA fragment containing a single copy of 
loxP plasmid is expected to hybridise to the radioactive probe and appear on the 
autoradiograph as one signal. If however, the plasmid integrated as monomers in 
tandem repeats, then a 10.7 kb signal is expected. Multiple copy insertions into 
multiple chromosomal sites is expected to give rise to signals of variable sizes. 
Results of the Southern blot analysis showed the presence of a very intense signal of 
about 10.7 kb co-migrating with the same electrophoretic mobility in all the clones 
analysed. In addition, other signals of varying sizes were observed. The 10.7 kb signal 
probably represents the full length of the loxP plasmid, suggesting that plasmid had 
integrated into CHO chromosome in tandem repeats, whilst the other signals indicates 
multiple copy integration into different chromosomal sites. The difference in the 
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Figure 5.4- Detection of pSAP-RDN/loxP transfection into CHO-DUKX B 11 cells by 
Southern blot analysis. 
Genomic DNA (10 µg) prepared from independent CHO-DUKX B11 transformants 
was digested with HindIIl. Digested DNA was separated by electrophoresis on an 
agarose gel and DNA fragments transferred onto a nylon membrane and hybridised 
using a radioactive SV40 polyA fragment. Lanes are labelled according to clone 
number. DNA marker sizes to the right are in kilobases. 
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intensity of hybridisation between the different clones are the result of inaccuracy in the 
determination of DNA concentration which was initially observed by ethidium bromide 
staining of EcoRV digested genomic DNA in agarose gel (data not shown). No signals 
were observed in the CHO DUKX B 11 (CHO B 11) negative control lane which does 
not contain sequences homologous to the SV40 polyA fragment. Whereas the positive 
control, CHO B 11 amplified cell line (transfected with an SV40 polyA containing 
plasmid, similar to the one used in this study) showed a smeared intense signal showing 
that the observed signals in the transfected clones corresponds to the integration of 
pSAP-RDN/loxP plasmid into CHO chromosome(s). 
It is very difficult to correlate the copy number of the loxP plasmid with the level of 
SAP expression determined in each clone, because the different signals observed and 
also the varying intensities of the signals is hard to interpret. The result shows that 
lipofection method of transfection leads to multiple copy of the loxP plasmid inserted 
into multiple sites. Transfected cells containing multiple copies of the loxP sites 
inserted in multiple sites in the chromosomes cannot be used to investigate the 
subsequent site-specific integration event because this could lead to chromosomal 
translocation and rearrangements. For this reason, a different transfection method, 
electroporation (described in the next section) was used to investigate if this method 
might yield single copy transfected cell lines. 
Because the ATG codons in the loxP sequence in loxR appeared to interfere with the 
expression level of SAP in CHO-DUKX B11 cells transfected with loxR, all 
subsequent investigations were done using plasmid loxL. 
5.6 Transfection by electroporation 
Electroporation is the process whereby DNA mixed with cells in suspension is 
exposed to a high-voltage electric field. This creates pores in the plasma membranes 
(Kinosita and Tsong, 1977) of treated cells that are large enough to allow the passage 
of macromolecules such as DNA into the cells. Such DNA molecules are ultimately 
transported to the nucleus, and a subset of these molecules are stably integrated into 
the host chromosome. The reclosing of the membrane pores is both time and 
temperature-dependent and thus is delayed by incubation at 0°C, thereby increasing 
the probability that the molecule of interest will enter the cell. Linearised DNA appears 
more recombinogenic than supercoiled or nicked circular DNA (Chu et al., 1987) and 
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thus leads to a higher percentage of stably transformed cells. Supercoiled DNA serves 
as a superior transcriptional template in transient transfection experiments. 
Transfection frequency also depends on a number of other factors; the most obvious 
possibilities include DNA concentration, electric field strength and pulse length, size of 
DNA or DNA complex, cell type, and condition of the cell membrane. Voltage is a 
critical parameter for electroporation and, for a given capacitance and buffer, there is a 
sharply defined voltage for optimal transfection efficiency (Chu el al., 1987). At higher 
voltages the cells are irreversibly damaged and at lower field strengths the cells do not 
take up appreciable amounts of DNA. 
Electroporation has a number of advantages over other methods of transfection such 
as calcium phosphate co-precipitation (Graham and van der Eb, 1973) and DEAE- 
dextran (McCutchan and Pagano, 1968) mediated DNA transfection. These 
advantages include: the successful electroporation of cells which are totally resistant 
to calcium phosphate or DEAE-dextran mediated gene transfer especially those cell 
lines which grow in suspension e. g. mouse erythroleukemia cells and other cells of 
hematopoietic origin (Boggs et al., 1986); ease of operation; reproducibility of 
conditions; applicability to cells which are either adherent or those growing in 
suspension; utility for both transient and stable transfection procedures; and the 
capacity to control copy number of transfected DNA molecules. 
5.6.1 Construction of CHO cell lines containing a single IoxP plasmid by 
electroporation. 
As described in the previous section electroporation provides another method for 
transfecting DNA into mammalian cells. Electroporation though of cient for 
transfection can also kill cells. Therefore the electroporation conditions had to be 
optimised for CHO-DUKX B 11 cell line. 
Two different sets of electroporation parameters that have been used for transfection in 
CHO cell lines (Godwin et al., 1994; Fukushige and Sauer, 1992) were investigated 
for efficient transfection into CHO-DUKX 1311 cell line. CI1O-DUKX 1311 (107) cells 
were transfected with 10 µg of pSAP-RDN/loxP by electroporation at either 960 µF 
and 250V or 500 µF and 450V. Five minutes after clectroporation, cell viability was 
assessed by staining an aliquot of transfected cells with trypan blue. Cell death was not 
detected by the trypan blue staining immediately after clectroporation. Instead, the 
cells adhered to the culture dish initially, only to die and float off into the medium over 
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the next 48 hours. Cell death was estimated to be 90% when electroporation 
parameters were 500 µF and 450V, whilst cell death was estimated to be about 60% 
when electroporation parameters were 960 p. F and 250V. Cell viability of about 50% is 
required for efficient transfection, therefore all subsequent electroporations were done 
at 960 µF and 250V, with the assumption that 60% viability would be acceptable. 
In the previous transfection using lipofectam, circular plasmid DNA was used. 
However, in this transfection by electroporation, linearised plasmid DNA was used. 
This is because previous experiments comparing the transfection (electroporation) 
efficiency of linearised to supercoiled plasmid DNA have demonstrated a 2-20 fold 
greater efficiency of stable transfection with linear plasmid (Chu et at, 1987). 
CHO-DUKX B11 (107) cells were transfected with either 10 µg or 1 µg of loxL 
linearised at the EcoRV site. Electroporated cells were plated out in complete 
medium onto T-75cm2 flasks. Forty eight hours post transfection, electroporated cells 
were resuspended into select medium and dilution cloned to isolate individual clones. 
Transfected cells were plated at six dilutions; 100,50,10,5,1,0.33 cells/well (as 
described in section 2.4.3) into DHFR selection medium. 
Transfection of 10 µg of linearised pSAP-RDNIIoxP plasmid produced 158 DHFR+ 
colonies/107 transfected cells. A somewhat lower number of DHFR+ colonies, 
120/107 transfected cells were obtained by transfecting 1 µg of the linearised plasmid. 
DHFR+ clones were propagated for further analysis. 
During the propagation step to isolate stable cell lines, most of the colonies did not 
survive selection resulting in fewer colonies that are DHFR+; 40 clones survived from 
the transfection with 10 gg DNA, whilst only 13 clones survived from the transfection 
using 1 gg of DNA. The colonies that disappeared, probably survived initially by 
expression of non-integrated episomal (self ligated vector DNA) plasmid DNA and 
then died after the DNA was degraded or diluted out by cell division, because the 
plasmid does not replicate autonomously. Such "false" positive clones have been 
reported by others (Kathryn Bentley, WRL, pers. comm. ). In addition, many colonies 
picked at late times (from 20-30 days post-transfection) grew very slowly and were 
discarded. 
A quick SAP assay was done to identify those DHFR+ clones expressing SAP. Results 
showed different level of SAP expression in all of the DHFR+ clones analysed (data 
not shown). However, the difference in the level of SAP expression could be due to 
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differing copy number of the loxL plasmid integrated into CHO chromosome and also 
from chromosomal position effects. Therefore further characterisation of the DIWCIt+ 
clones was necessary to identify cell lines containing single copy insertion of the IoxL 
plasmid. 
5.6.1.1 Investigating DIIFR+ clones by polymerase chain reaction (PCR) 
A functional chromosomal loxP site is required for the site-specific integration event to 
occur. Therefore a PCR analysis was done to determine if the DHFR+ clones had 
integrated an intact loxP site. A combination of oligonucleotide primer sequences, 
designed as forward primer (CB1736- GCTATTCTCGCAGGATCAGTCGACC) to anneal 
within ß-actin 5' UTR region and the reverse primer (CB 173 8- 
CCAGTTTGTCCTTCTTCTGCCCTTT) to anneal within the SAP gene in loxL (see 
Figure 5.3), were used to amplify sequences from genomic DNA prepared from 
DHFR+ clones. If the loxP site is intact in the CHO DHFR+ clones, a PCR analysis 
using these primers is expected to yield a 380 bp product. 
Results (presented in Figure 5.5) shows a distinct band of 380 bp (indicated by an 
arrow) in all the DHFR+ clones analysed. This band comigrated with the same 
electrophoretic mobility as the amplified DNA from pSAP-RDN/loxP plasmid (positive 
control) suggesting that all the DHFR+ clones analysed contained the fragment (i. e. 0- 
actin 5' UTR-loxP-SAP) of loxL plasimd intact. In addition, a sharp band which is 
slightly smaller than the 380 bp fragment were observed in all the clones analysed. This 
band was also present in the negative controls (CHO DNA and CHO amplified DNA, 
which do not contain the loxL plasmid) but not in the positive control (pSAP- 
RDN/loxP) showing that the primer sequences also amplified other genomic 
sequences. It is difficult to explain the strong signal of this band, however the absence 
of the 380 bp band in the two negative controls clearly shows that the 380 bp band is 
the result of the loxL plasmid integrated into the CHO genome. Other non-specific 
bands were also observed again suggesting that the primer sequences are also 
amplifying other genomic DNA sequences. The result of the PCR analysis although it 
gives an indication of the structure of the loxL plasmid in CHO genome, does not 
however, give any indication of the number of loxL plasmid(s) integrated. Therefore a 
Southern hybridisation was done to investigate the copy number which is described in 
the next section. 
174 
z 1,0-1 
Ia-L 
063-5 
b9- L 
09-9 
L6v-b 
VN0 Pal; lldwe OH 0 
VNOOH 0 
dXOI/ONb-dVSd 
V 
80-t l 
9J-£ L 
oiv-Z 
ZH-1 
9H-81 
£Q-Z 
ZLJ-I 
IIH-Z 
ZA-b 
2 
dX01/Naa-dVSd 
Z. 
O 
d 
.Q 
O 
00 
oýd 
ctä 
& 13 tu 8 CA > 
y[v 
5 1Hi 
toi 
Q 10 4w 
0mV30 o 
wo .v ^' ( 
.00 ed (ý Ü 
ZZ 3 
Zo 
50V 
a 
nci ° 
-0 4) w 
Q5 
böQoü 
2N 
oV 1. 
1.2 a qa 
Qw 
J02 
(14 oo rÖ cx 
1) , ti 
Gd . mac 
y 
yo V ice, aüU 
. -. 
«r 
.S 
O 
w. 
E 
"c a 
0 
"a 
b 
m 
r 
5.6.1.2 Analysis of loxl' copy number by Southern hybridisation 
As previously mentioned, for Cre-mediated site-specific integration, it is preferable 
for the host cell line to contain a single copy of loxP site. In order to isolate DIIFR+ 
clones containing single copy insertions of the loxP site and also gain some insight 
into structural features of the integrated DNA, genomic DNA prepared from DIIFR+ 
clones was analysed by Southern hybridisation. 
Genomic DNA (10 jig) prepared from individual DHFR+ clones was digested with 
BgIH (instead of EcoRV; see section 5.4.2) and separated by electrophoresis on 
agarose gels. [Genomic DNA was digested with BgIII because the loxL plasmid was 
linearised by digesting the plasmid with EcoRV before transfection, therefore 
digesting the genomic DNA with EcoRV will probably just recover a linear loxL 
fragment which will not give much information as to whether integration occurs as 
multiple copies to multiple chromosomal regions]. The DNA was subsequently 
transferred onto nylon membranes and hybridised with a radioactive SV40 polyA 
probe (same probe used in section 5.4.2). 
The restriction enzyme Bg1II will cut the genomic DNA in many places, but the 
inserted DNA is cut only once. When the SV40 polyA signal is used as a probe with 
genomic DNA from the DHFR+ clones, the DNA fragment containing the loxP 
plasmid hybridises to the SV40 polyA probe and appears on the autoradiograph as a 
signal of 6.7 Kb plus an unpredictable amount of genomic DNA if the plasmid was 
integrated as a single copy. If two tandem copies of the plasmid are inserted at a 
single site in a head-to-tail orientation, then the restriction endonuclease site used to 
linearise the input DNA would remain intact. This event would be due to ligation of 
vector DNA via cohesive ends prior to integration. In this case restriction digestion 
with Bg1II will yield a unit length of 10.7 Kb and 4.1 Kb plus an unpredictable 
amount of genomic DNA. If two copies are integrated head-to-head or tail-to tail then 
BglII digestion would yield a 13.4 Kb fragment. However larger numbers of separate 
and or random integrations would give rise to multiple bands with varying intensities 
with or without degradation or rearrangement prior to integration. 
Results of the Southern hybridisation from 10 tg pSAP-RDN/loxP transfection 
showed multiple signals in all the clones analysed, suggesting multiple copy number 
of the plasmid integrated into different chromosomal regions (Figure 5.6). When I µg 
of lincarised pSAP-RDN/loxP was used in the Southern hybridisation analysis the 
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Figure 5.6- Detection of pSAP-RDN/loxP (10 µg) transfection into CHO B11 cells 
using electroporation. 
Genomic DNA (10 µg) prepared from CHO-DUKX B 11 cells transfected with pSAP- 
RDN/loxP was digested with BgIII. The digested DNA was separated by 
electrophoresis on an agarose gel, and DNA fragments transferred onto a nylon 
membrane and probed with a radiolabelled SV40 poly A fragment. Lanes 1 to 13 
corresponds to independent clones. DNA marker sizes to the right are in kilobases. 
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results showed that out of six clones analysed, two clones (namely 5-E10 and 1-G12) 
appeared to be single copy integrants and two other clones (namely 18-118 and 14-G8) 
appeared to have the loxP plasmid in tandem repeat (Figure 5.7a). In the negative 
control experiment where genomic DNA from CHO-DUKX B 11 cells used (which did 
not contain the SV40 polyA sequence) no signals were observed. However in the 
positive control experiment where CHO amplified DNA (which has been amplified to 
contain many copies of SV40 polyA sequence) a very strong smeared signal was 
observed. To verify further that these clones contained a single and tandemly repeated 
loxP sites respectively, genomic DNA prepared from the four clones were digested 
with XIoI and analysed alongside Eg1II digested DNA by Southern hybridisation 
(Figure 5.7b). The result provided further evidence that each of the two clones, 5-E 10 
and 1-G12 indeed contained a single copy insertion of the IoxP plasmid, whilst each of 
the other two clones, 18-1-18 and 14-G8 contained the loxP plasmid in tandem repeats. 
The results from the Southern hybridisation analysis shows that only two out of 
thirteen clones had integrated a single copy of the loxL plasmid. However, the aim of 
this work was to isolate a large number of cell lines each containing a single copy 
insertion of the loxP site in order to identify cell lines which had integrated a lox 
plasmid in a chromosomal region which will be favourable for gene expression. 
Therefore another transfection was done in the hope of isolating more cell lines 
containing a single copy insertion of the loxL plasmid. 
5.6.2 Further transfection by electroporation to isolate CHO cell lines containing 
a single loxP plasmid 
CHO-DUKX B11 (1 x 107) cells were transfected with 1 tg of EcoRV linearised IoxL 
plasmid by electroporation (as described above). Transfected cells were selected, 
propagated to establish stable cell lines and assayed for SAP expression as described 
previously. Eleven DHFR+ clones which were positive for SAP expression were 
subsequently analysed by Southern hybridisation. Southern hybridisation was done as 
described in the previous section (Figure 5.8). 
Results showed that one clone (namely 13-G6) out of the eleven clones analysed had a 
single copy of the loxP plasmid integrated into the chromosome. Whilst the other 
clones showed multiple signals to suggest multiple copy integrations into multiple 
chromosomal sites. However, clone 7-D 1 which showed one strong signal and a weak 
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Figure 5.7a- Detection of pSAP-RDN/loxP (1 lag linearised) transfection into CHO- 
DUKX B11 cells by electroporation. 
Genomic DNA (10 µg) prepared from independent CHO-DUKX BII transformants 
was digested with Bgl1I. The digested DNA was separated by electrophoresis on an 
agarose gel, and DNA fragments transferred onto a nylon membrane and probed with 
a radiolabelled SV40 polyA fragment. Lanes are labelled according to clone number. 
Clones I -G 12 and 5-E 10 each shows a single signal. Clones 14-G8 and 18-H8 each 
shows two signals. The other clones shows multiple signals. The positive control 
(CHO-DUKX B 11 + pSAP-RDNIoxP) shows a signal of -10 kh. DNA marker sizes 
to the left are in kilobares. 
179 
--------X ho 1-------- --------B gI 11 -------- 
a0 0 
= 
N 
'- 
CO co 0 N co r 
1 W 
0 
1 
_. 
1 - a 
1 W 1 o 1 I LO r r r r 
ry 
Y 2X "ýi tý1 
k{iYt, 
- ýý 
am 
0 
0 
Figure 5.7b- Detection of transformed CHO-DUKX [3I I cells containing either a 
single loxP plasmid or tandem repeats of the loxP plasmid by Southern blot analysis. 
Genomic DNA (10 µg) prepared from CHO BII transformants was digested with 
either BgIII or Xhol and analysed by Southern hybridisation as described in fig 5.7a. 
Lanes are labelled according to clone number. 1 Kb corresponds to standard molecular 
weight markers. 
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Figure 5.8- Detection of pSAP-RDN/loxP (I µg linearised) transfection into CHO- 
DUKX B 11 cells by electroporation. 
Genomic DNA (10 µg) prepared from independent CHO-DUKX BII transformants 
were digested with Bg111. The digested DNA was separated by electrophoresis on an 
agarose gel, and DNA fragments transferred onto a nylon membrane and probed with 
a radiolabelled SV40 polyA fragment. Lanes are labelled according to clone number. 
1 Kb corresponds to standard molecular weight markers. 
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signal could actually contain a single copy of the loxP insert and that the weak signal 
could be a partial digestion of genomic DNA. Unfortunately, clone 7-DI was not 
investigated further because the cells got contaminated during the propagation steps. 
Results from Southern analysis thus far shows that transfccting linearised loxL plasmid 
by electroporation leads to the isolation of stably transfected cell lines containing a 
single copy insertion of the loxL plasmid. Although, only three such cell lines were 
obtained, these cell lines can be used to investigate Crc-mediated site-specific 
integration events and to obtain information about chromosomal position effects on 
gene expression. To investigate chromosomal position effects on SAP expression, the 
specific production rate (SPR) of SAP was determined for the 3 cell lines each 
containing a single copy insertion of loxP site as described in the next section. 
5.6.2.1 Investigating SPR of SAP in DIIFR+ clones containing a single copy 
insertion of loxL plasmid 
Because each of the three cell lines contains a single copy of the loxL plasmid 
randomly integrated into the CHO chromosome, any variation in SAP expression 
should be due to different chromosomal position effect on gene expression. The 
specific production rate (SPR) of SAP was determined as described in section 2.8.4. 
Results presented in Figure 5.9 shows that the three cell lines 13-G6,1-G12 and 5-E10 
showed a high, medium and a low level of SAP expression respectively. The high SAP 
expressing clone, 13-G6 showed a five fold higher expression compared to the medium 
SAP expressing clone, 1-G12 and a hundred fold higher expression compared to the 
low SAP expressing clone, 5-E10. This result suggests that compared to cell lines 5- 
E10 and 1-G12, cell line 13-G6 contains a loxL plasmid integrated into a chromosomal 
region more favourable for gene expression. 
5.6.3 Summary of CHO transfected cells containing a single copy of loxP site 
Three CHO transfected cell lines has been constructed each containing a single copy of 
loxP insert by transfecting 1 µg of linearised pSAP-RDN/loxP (loxL) into CHO 
DUKX B 11 cells by electroporation. The three cell lines showed different levels of 
SAP expression. Because each cell line contains a single copy of the SAP gene (under 
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the transcriptional control of a O-actin promoter) randomly integrated into the CI-1O 
chromosome, the different levels of SAP expression is a direct indication of different 
chromosomal position effect on SAP expression. Thus, cell line expressing a high SAP 
activity suggests that the SAP gene has integrated into a chromosomal region 
favourable for gene expression, whilst the cell line expressing low SAP activity 
suggests that the SAP gene has integrated into a chromosomal region less favourable 
for gene expression. 
The identification of CHO transfected cell lines each containing a single copy of the 
loxL plasmid insert, means that the second part of the site-specific recombination (i. e. 
Cre-mediated targeting integration of transgenes to the chromosomal loxP site) can be 
investigated. As previously mentioned a source of Cre recombinase was to be provided 
by co-transfecting the targeting vector with a cre expression plasmid or recombinant 
Cre protein purified from the - baculovirus/insect expression system (described in 
chapter 3) to compare which source of Cre recombinase would be more efficient at 
mediating site-specific recombination. The recombinant Cre protein has been shown to 
be biologically active at least in vitro (described in chapter 4), however it is not known 
if the cre expression plasmid expresses active Cre recombinase. Therefore, a transient 
transfection analysis was done to investigate if the cre expression plasmid expresses 
biologically active recombinase before using the plasmid in stable transfections. 
5.7 Transient transfection assays 
Following DNA transfection into a mammalian host cell, the DNA is translocated to 
the nucleus where it is transiently expressed from 12 hours up to 72 hours post- 
transfection (Wynshaw-Boris et a!., 1986). After this time plasmid copies are gradually 
lost from the dividing cells and foreign gene expression stops unless stable 
transfections, that contain a copy of the plasmid capable of replication either by the 
presence of a viral replicon in the vector or by integration into the host genome, are 
selected. 
Transient transfections have a number of advantages over stable transfections: (i) levels 
of throughput especially in the study of large numbers of small-scale transfections e. g. 
comparison of different ratios of substrate plasmid to protein plasmid, (ii) they are 
rapid to analyse, with expression of foreign gene being assayed from 1-3 days post- 
infection. In contrast, stable transfections require approximately two to four weeks 
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selection in order to isolate stable transformants. (iii) the expression level of the foreign 
gene in the transfected vector is not influenced by the number of vector copies that 
integrate (except in COS cells were vectors containing the SV40 replicon and can 
replicate to very high copy number; >104 copies/cell), or by the position of integration 
into the host genome, as in the case of stable transfection (Kaufman et al., 1985). (iv) 
potential DNA rearrangements that may occur during integration into the genome arc 
avoided. 
A limitation to transient transfection studies is the potential variation in transfection 
efficiency. Various strategies have been used to solve this problem including; the use of 
"internal control" plasmids (encoding reporter proteins), whose activity may be 
measured in each transfection. Comparison of the levels of the reporter protein activity 
in each transfection may indicate any variation in the transfection efficiency, which can 
be taken into account when analysing results by normalising the expression levels of 
the test construct to the reporter protein to be a reliable measure of transfection 
efficiency (Lake and Owen, 1991). A second method to control for variation in 
transient transfection efficiency, described by Abken and Reifenrath (1992), involves 
determining the amount of plasmid DNA transfected into the cells in each transfection, 
by "dot-blot" procedure. Despite these limitations transient transfection assays 
continues to be used for investigating various kinetic parameters of protein reactions 
in vivo. In this study, transient transfection assay was used to establish if cre 
expression plasmid encodes active Cre recombinase and also to gain an idea of the 
amount of substrate DNA and Cre plasmid DNA required for site-specific 
recombination to take place in vivo. 
5.7.1 Investigating the activity of Cre expression plasmid in transient 
transfection assays 
A simple way to assess if the Cre plasmid encodes active recombinase was to transfect 
the plasmid into cells to mediate intramolecular (excision) recombination event because 
a quantifiable assay system for the intramolecular recombination event has previously 
been described (section 3.7). Transfection was done using Transfectam (a synthetic 
cationic lipopolyamine molecule whose mode of action is described in section 5.4), 
instead of electroporation because the number of plasmid DNA copies transfected into 
cells was not essential whilst at the same time an efficient way of introducing DNA into 
cells was needed. 
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Initially CHO-DUKX B 11 (2.5 x 105) cells were transfected with 20 tg of the crc 
plasmid, pMC1-Cre (using 60 tg of transfectam reagent) to determine if the cre 
plasmid expressed functional Cre recombinase in CHO cells. Crude extracts prepared 
from CHO transfected cells 24 hours post infection were used in an in vitro assay to 
investigate Cre-mediated recombination using plasmid pAT-lacZloxP2 as substrate. 
Results shown in Table 5.2 indicated that the crude extract prepared from CHO- 
DUKX 1311 cells transfected with pMCI-Cre expressed a low level of active 
recombinase which can mediate site-specific recombination in vitro. 
This initial observation suggested that the Crc plasmid could mediate intramolecular 
recombination in vivo. To investigate this, CHO-DUKX Bil (2.5 x 105) cells were 
transfected with 10 µg of pAT-lacZloxP2 and different amounts of the Crc expressing 
plasmid, pMCI-Cre using 60 . tg of Transfectam for each transfection. In addition 
CHO-DUKX B 11 (2 x 105) cells were co-transfected with 10 µg pAT-lacZ (negative 
control) and 20 µg pMCI-Cre, to investigate if Cre recombination is specific at loxP 
sites. In another experiment CHO-DUKX B 11 (2 x 105) cells were co-transfected with 
10 µg of pAT-lacZloxP2 and 20 µg of plasmid pSAP-RDN (which does not contain 
the cre gene) to investigate if the host recombinases could catalyse site-specific 
recombination at the loxP sites in pAT-lacZloxP2. 
Plasmid DNA was prepared from transfected cells, by harvesting the cells either 24 or 
48 hours post infection and Cre-mediated recombination analysed as described in 
section 3.7.2. Basically, aliquots of plasmid DNA (- 50 ng) were transfected into E. 
coil DH5a competent cells and plated onto L-agar (supplemented with amp, X-gal and 
IPTG). The ratio of white to blue colonies observed on L-agar plate was taken to be 
the % recombination efficiency. 
Results presented in Table 5.3 showed that Cre-mediated recombination occurred 
when 10 tg of the substrate plasmid (pAT-lacZloxP2) and 20 pg of Crc plasmid were 
used in the transfection. It is possible that increasing the amount of the Cre plasmid 
would increase the efficiency of the recombination. However, it is also possible that the 
presence of more Crc protein could catalyse the integration of the excised molecules 
reducing the efficiency of the excision event. The recombination efficiency was 
observed to be 18% 24 hour post-transfection and 6% 48 hours post-transfection. The 
difference in the recombination efficiency (measured as % excision) suggests that Cre 
recombinase activity was maximal before 48 hours post infection. Alternatively the 
substrate plasmid must have been degraded after 24 hour post infection, therefore 
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Source of recombinase % Recombination 
Crude cell extract (141) 0 
Crude cell extract (2 µl) 0 
Crude cell extract (5 µl) 1.5 
Crude cell extract (10 µl) 2 
Untransfected crude cell extract (5 µl) 0 
Table 5.2- Investigating Cre recombinase activity in crude cell extract. 
CHO-DUKX B 11 (2 x 105 cells) was transfected with 20 µg of pMC 1-Cre. 
Different volumes of crude cell extract prepared from transfected cells (24 hours post 
transfection) were incubated with 2 pg of pAT-lacZloxP2 in an iii vitro recombination 
assay. After termination of each reaction, aliquots (containing -50 ng of DNA) were 
transfected into E. coli DH5a competent cells and dilutions analysed on L-agar plates 
(containing ampicillin, X-gal and IPTG). The ratio of white and blue colonies 
corresponding to recombinants and substrates respectively (see section 3.7.11) is a 
measure of the percentage (%) recombination. 
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Amount of Cre plasmid, 
pMC (pg) 
% Recombination (24 
hours post transfection) 
% Recombination (48 
hours post transfcction) 
5 0 0 
10 0 0 
15 9 2 
20 18 6 
Table 5.3- Investigating the minimum ratio of substrate to Cre protein required for the 
in vivo site-specific recombination. 
Plasmid pAT-lacZloxP2 (10 µg) was co-transfected with different amounts of the cre 
expression plasmid, pMCI-Cre in transient transfections assay using CHO-DUKX 
B II cells as host. Plasmid DNA was prepared from transfected CHO-DUKX B 11 
cells either 24 or 48 hours after transfection. Aliquots (- 100 ng) of the plasmid DNA 
were transfected into E. coli DH5a competent cells and plated onto L-agar 
(supplemented with ampicillin, X-gal and IPTG). The ratio of white to blue colonies 
observed on the L-agar plate was taken to be the % recombination efficiency. 
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reducing the amount of substrate DNA for Cre. However, the amount of substrate 
DNA at various times after the transfection was not determined using techniques such 
as "dot-blot". When recombination resulting from co-transfecting pAT-lacZ and cre 
plasmid into CHO cells were analysed on L-agar plate, only blue (17) colonies were 
observed. No white (recombinant products) colonies were observed indicating that the 
Crc protein is specific for the loxP site (data not shown). Furthermore, in the 
experiment, where pAT-lacZloxP2 was co-transfected with pSAP-RDN into CHO 
cells, recombination events analysed on L-agar plate produced only blue (9) colonies, 
no white colonies were observed suggesting that recombination at loxP sites is 
mediated by Cre protein and not host recombination protein(s) (data not shown). 
These results demonstrates that site-specific recombination in vivo is dependent on the 
presence of Cre recombinase and occurs specifically at loxP sites. 
The observation that the cre plasmid expressed maximal Cre recombinase under 48 
hours post transfection is in agreement with previous report by Sauer and Henderson 
(1988). These authors showed in the swine kidney cell line, PK15 that Cre mediated 
recombination activity accumulated to near its maximal level 15 hours post-infection 
by monitoring the generation of Cre-mediated excision reaction at various time points 
in an in vivo assay reaction. They also showed that there was a lag of about 5 hours in 
the Cre-mediated recombination compared to the accumulation of Cre protein. This 
contrasts the rapid Cre-mediated recombination in vitro which takes place within a few 
minutes (reported in chapter 4). The difference in the kinetics of Cre recombination in 
vitro and in vivo is due to a different cellular environment. For instance, during 
transfection the cre plasmid must be transported to the nucleus where the cre gene is 
transcribed and subsequently transported back into the cytoplasm where it is assembled 
into active Cre protein before recombination can take place. Furthermore, mammalian 
cells contain many DNA binding proteins which might be expected to compete with 
Cre protein for its loxP sites so perhaps preventing productive encounters between the 
Cre protein and the substrate DNA. This may explain the lag in Cre-mediated 
recombination compared to the accumulation of Cre protein. 
The observations made from the transient transfections shows that the cre plasmid can 
produce active Cre protein to mediate site-specific targeting of transgenes to a 
chromosomal loxP site, however it should be borne in mind that the kinetics of the in 
vitro integration analysis observed in chapter 4, may be different from the integration 
event in CHO cells. 
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5.8 Site-specific targeting of transgenes to a chromosomal loxP site 
As previously mentioned, CHO cell lines containing a single copy of loxP insertions 
were to be used as host expression systems to investigate Cre-mediated precise 
targeting of any exogenous DNA to the chromosomal loxP sites. For the integration to 
occur, the incoming DNA must also contain a loxP site. Therefore two different 
targeting vectors each containing a single loxP site were constructed to investigate the 
integration event. 
5.8.1 Construction of loxP targeting plasmids 
The two targeting vectors are pMAMneoCAT-loxP and plM3-loxP. These vectors 
were designed to contain different reporter genes as indicators for the site-specific 
recombination event (described in detail in sections 5.7.2 and 5.7.3). 
Plasmid pMAMneoCAT-loxP was constructed by cloning a loxP site in a promoterless 
pMAMneoCAT vector. Plasmid pMAMneoCAT (Clontech) contains the 
chloramphenicol acetyltransferase (CAT) locus as a reporter gene to provide a positive 
control for expression from an inducible MMTV-LTR promoter. The plasmid also 
contains the neomycin resistance gene, under the transcriptional control of the SV40 
early promoter to permit positive selection of transformed cells, the ß-lactamase gene 
conferring ampicillin resistance (Ampr) and pBR322 on for propagation of the plasmid 
in bacteria. To construct pMAMneoCAT-loxP (Figure 5.10), pMAMneoCAT was 
digested with NdeI and NheI to remove the entire MMTV-LTR promoter. The 
digestion gave rise to two fragments, a large fragment of about 7 kb comprising a 
promoterless CAT vector and a small fragment of about 2 kb comprising the MMTV- 
LTR promoter. The two fragments were separated on an agarose gel and the large 
fragment purified from the gel. This vector was dephosphorylated (to prevent self- 
ligation in a ligation reaction) and used in a ligation reaction with a double stranded 
oligonucleotide sequence comprising loxP site and the necessary protruding ends for 
ligation. The ligation products were analysed by transfecting an aliquot of the ligation 
reaction into E. coli DH5a competent cells and transformed cells plated onto L-agar 
supplement with ampicillin. Results showed that in the control ligation reaction 
(containing only the vector DNA) only one colony was observed on L-agar plates 
whereas in the ligation between the loxP sequence and the vector DNA thirteen 
colonies were observed suggesting that about 90% ligation between loxP and 
pMAMneoCAT. Sequence analysis was done to check that the recombinant DNA 
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NdeI 
5'TATGAGTCT ATAACTTCGTATA 
ACTCAGA TATTGAAGCATAT 
7160, Nhe 
7108, NdeI 
loxP 
AmpR 
4000 3000 
20C V40 prom 
Neomycin R 
SV40 poly A 
NruI, 3289 
indIII, 1952 
Figure 5.10- Map of pMAMneoCAT-loxP 
A double stranded oligonucleotide sequence corresponding to the loxP site (which 
consists of two 13 bp inverted repeats [shown in box with arrowheads] flanking an 8 
bp spacer region [shown in bold]) with NdeI and NheI recognition ends was cloned 
into pMAMneoCAT digested with NdeI and NheI restriction endonucleases. 
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contained the loxP insert, and in the right orientation and that the sequence 
corresponds to the loxP site (data not shown). 
Plasmid pHM3-loxP (Figure 5.11) was constructed by cloning a loxP site into pIIM3. 
Plasmid pHM3 (Kaestner et al., 1994) contains a promoterless tacZ coding region of 
E. coli (reviewed in Alan and Cook, 1990) and neomycin resistance (neor) marker 
(Southern and Berg, 1982) fused to generate a single open reading frame (ORF) 
followed by the poly(A) of mouse phosphoglycerate kinase (pgk) gene. A multiple 
cloning site and the polyadenylation signal of the human growth hormone (Gi)- 
encoding gene (to terminate any spurious transcripts that might arise from cryptic 
promoters within the vector) is present upstream of the lacZ/neor fusion gene. The 
plasmid also contains the ß-lactamase gene (bla) and on from plasmid pUC 19. The 
fusion gene has been shown to be bi-functional in embryonic stem (ES) cell chimaeras 
(Zachgo and Gossler, 1993) and is especially useful when a promoterless gene 
targeting construct is to be used in homologous recombination experiments to decrease 
the frequency of illegitimate recombination and to increase the chance of obtaining a 
homologous recombinant clone (reviewed in Porter, 1989). 
To construct pHM3-loxP, a double stranded oligonucleotide comprising the loxP 
sequence with the neccessary protruding ends for ligation was cloned into the unique 
HindlII site in pHM3. In order to bias for the ligation of the loxP sequence and the 
vector, the vector was dephosphorylated (see section 2.2.9) after digestion with the 
HindIII restriction endonuclease. Results of the ligation event was analysed by 
transfecting ligated DNA fragments into E. coli DH5a competent cells and 
transformed cells observed as ampicillin resistant colonies on L-agar plate containing 
ampicillin (see section 2.2.13). The results showed forty-four colonies from the control 
plate (corresponding to self-ligated vector DNA) whilst only fifteen colonies were 
observed on the test plate (i. e. ligation between p1IM3 and the loxP sequence). 
Because of the high proportion of self-ligated vector DNA, DNA was prepared from 
cultured samples of all the colonies observed on the test plate and digested with PtiiiII. 
Digestion of pHM3 DNA with PvuII gives rise to five fragments of approximately 2.9, 
2.8,0.5,0.3, and 0.22 kb sizes. If however, loxP sequence in inserted into Ifm dlII site 
in pHM3, then PvuII digestion is expected to increase the 0.5 kb fragment by the 50 bp 
loxP fragment which can be observed on an agarose gel. Results of PvuII digestions 
showed that three out of the fifteen colonies analysed had the loxP sequence insert 
(data not shown). DNA from these three colonies were sequenced to further confirm 
that they contain the loxP sequence and also to check that the sequence corresponded 
to loxP (data not shown). 
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Figure 5.11- Map of pHM3-loxP. 
A double stranded oligonucleotide sequence corresponding to the loxP site (which 
consists of two 13 bp inverted repeats [shown in box with arrowheads] flanking an 8 
bp spacer region [shown in bold]) with the HindIIl recognition ends was cloned into 
the unique HindIII site in pHM3. 
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The two plasmids, i. e. pMAMneoCAT-loxP and p11M3-loxP were independently used 
as targeting vectors to investigate Cre-mediated site-specific integration into 
chromosomal loxP site in cell line 1-G12 (which showed the medium SAP expression 
level out of the three cell lines identified to contain a single copy of the loxP insert; see 
section 5.5.2.1). 
5.8.2 Cre expression plasmid mediated site-specific targeting of pMAMneoCAT- 
loxP into cell line 1-G12. 
To investigate if Cre recombinase can direct the precise integration of an exogenous 
DNA (containing a loxP site) to a chromosomal loxP site, pMAMncoCAT-loxP was 
co-transfected with the cre expression plasmid, pMCI-Cre into cell line 1-G12. 
The targeting vector was designed such that Cre-mediated integration of the 
promoterless CAT gene to the chromosomal loxP site would integrate the CAT gene 
at the loxP site which is downstream from the ß-actin promoter (Figure 5.12). The 
result of site-specific recombination should therefore activate the expression of CAT 
gene from the ß-actin promoter. In addition, because transcription of the SAP reporter 
gene was under the control of the ß-actin promoter, site-specific recombination should 
therefore separate the SAP gene from the ß-actin promoter. Thus the recombination 
event should not only give rise to the expression of CAT activity (which can be 
quantitatively assayed by an in vitro ELISA [section 2.8.2]) but also the loss or 
reduction of SAP activity. 
Cell line 1-G12 (1 x 107 cells) was transfected with 10 pg of pMAMneoCAT-loxP 
and 20 µg of either pMCI-Cre or pBS (Bluescript plasmid; as a negative control for 
the targeting event) by electroporation at 960µF and 250V. This ratio of the amount of 
substrate to cre plasmid was used because this same ratio was used in transient 
transfections to show site-specific recombination. Two days after transfection, 
transfected cells were split three fold and grown in DHFR+ select medium 
supplemented with G418 to 400 µg/ml final concentration. Adherent transfected cells 
were re-fed after 6 days to remove non-transfected cells and cell debris. 
The transfection efficiency was approximately found to be 1.5 times higher when 
pMAMneoCAT-loxP was co-transfected with pBS than when co-transfected with 
pMCI-Cre; approximately 1100 colonies/107 transfected cells compared to 740 
colonies/107 cells (calculated from crystal violet staining of individual resistant 
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colonies arising from transfected cells grown in G418 by 20 days post infection), It 
should be pointed out that this transfection efficiency is a rough estimate, since a few 
colonies which appeared to be of a smaller diameter than the average were disregarded 
as true colonies and it is also possible that some daughter colonies which originate 
from the same parental clone after cell division may have been counted twice. 
When a pool of colonies from the test and control plates were used in a quick CAT 
ELISA assay (to investigate if the promoterless CAT gene was being transcribed under 
the transcriptional control of the ß-actin promoter), only background CAT activity was 
observed in the test and the control plate (data not shown), suggesting that the 
targeting experiment had not been successful. It is however, possible that the targeting 
event occurred at a very low frequency compared to a high frequency of random 
integration. Therefore a pooled clone comprising a large number of "non-expressing" 
CAT clones will mask the detection of clones which are expressing CAT. Furthermore, 
the high frequency of G418 resistant colonies observed on the control and test plates 
indicates that a large numbers of individual colonies would need to be propagated for 
further analysis in order to identify colonies which are the result of targeting event. 
However if the Cre-loxP system is to be useful for the large scale expression of 
recombinant proteins then screening of hundreds of colonies to identify targeted 
events would not be beneficial. To overcome the problem of having to screen a large 
number of colonies in order to identify targeted events, plasmid pHM3-loxP was used 
as the targeting vector for the Cre-mediated recombination event. 
5.8.3 Cre expression plasmid mediated site-specific targeting of pIIM3-loxP into 
Cell line 1-G12 
Following the failure to isolate the site-specific targeted event using pMAMneoCAT- 
loxP, the Cre mediated site-specific recombination was repeated. This time, pHM3- 
loxP was used as the targeting vector to enrich for targeting over illegitimate events by 
selecting for the activation of lacZ and neomycin resistance as a result of Crc-mediated 
fusion of the promoterless lacZ/neor gene to the ß"actin promoter. 
Cell line 1-G12 (1 x 107 cells) was transfected with 10 tg of pIIM3-loxP and 20 ýtg of 
either pMCI-Cre or pBS by electroporation at 960 tF and 250V. Two days after 
transfection, transfected cells were split three fold and grown in D1IFR+ select medium 
supplemented with G418 to 400 tg/ml final concentration. Transfected cells were re- 
fed 6 days after transfection to remove non-transfected cells and cell debris. 
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The transfection efficiency was approximately 1.6 fold higher when pIlM3-loxP was 
co-transfected with pBS than when co-transfected with pMCI-Crc; -240 colonies/107 
transfected cells compared to -150 colonies/107 transfccted cells (calculated from 
crystal violet staining of individual resistant colonies arising from transfected cells 
resistant to G418 by 20 days post infection). The observation of a high number of 
G418 resistant colonies on the control plate suggested that random integration also 
leads to the activation of the neor gene. Because the »eor gene is fused to the IacZ 
gene (encoding ß-galactosidase), it is possible that the lacZ gene is also activated. An 
advantage for using plasmid pHM3-loxP to monitor Cre-mediated recombination event 
is that a large number of colonies can be rapidly screened in situ for ß-gal expression. 
Therefore, ß-gal staining was used to investigate the frequency of IacZ activation as a 
result of illegitimate recombination and compared to that as a result of Cre-mediated 
targeted integration. 
5.8.3.1 3-gal staining of G418 resistant clones 
To analyse G418 resistant colonies for ß-galactosidase expression, a third of the 
colonies isolated from the control transfection (- 80 colonies on a large petri dish) and 
a third of the colonies from the test plate (the Cre-mediated reaction; - 50 colonies) 
were stained for ß-gal activity (Lim and Chae, 1989; see section 2.8.5 for the staining 
reaction). G418 resistant colonies which expressed ß-galactosidase were observed 
under a light microscope as blue colonies (data not shown). Of the 50 colonies 
resulting from Cre-mediated reaction, 13 were positive for ß-gal staining. Whilst only 
3 out of 80 colonies from the control transfection were positive for ß-gal staining. This 
result correlates to approximately 26% of the colonies from the Cre-mediated reaction 
expressing ß-galactosidase whilst only about 4% of the colonies resulting from random 
integration activated ß-galactosidase expression. Because the targeting vector contains 
a promoterless lacZ and 'reor coding sequences fused to generate a single open reading 
frame, the high frequency of G418 resistant colonies expressing ß-galactosidase from 
the Cre-mediated reaction suggests that the activation of both the lacZ and neor is the 
result of Cre-mediated targeted integration to the ß-actin promoter. In contrast, the 
low frequency of G418 resistant colonies which expressed ß-galactosidase 
demonstrates that spontaneous activation of both lacZ and neor as a result of 
illegitimate recombination occurs at low frequency. 
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As a result of this initial observation that the Cre plasmid can mediate site-specific 
integration of pHM3-loxP vector to a chromosomal lox? site, G418 resistant colonies 
resulting from the targeted and non-targeted events were propagated for further 
analysis. 
5.8.3.2 ß-gal and SAP assays of targeted clones 
As previously mentioned, the result of the targeting event should not only activate the 
expression of lacZ/neor fusion gene but also give loss or reduction of SAP activity. In 
order to investigate this, 15 G418 resistant clones from Cre-mediated event and 6 
clones from the control reaction were assayed for ß-gal activity (sec section 2.8.6 for 
method) and SAP activity and compared to the parental cell line (Table 5.4). Results of 
ß-gal assay showed that the average clone isolated from the Crc-mediated reaction 
expressed about 3.5 fold higher ß-galactosidase than the control clones. Although the 
level of lacZ expression from a ß-promoter was not investigated (because the only way 
of determining the expression level of a single copy insertion of the lacZ reporter gene 
to a specific chromosomal position would require Cre-mediated site-specific 
recombination), the observation of higher ß-galactosidase expression from the Cre- 
mediated reaction compared to random integration suggests that spontaneous 
activation of lacZ/neor gene occurs at chromosomal regions other than the ß-actin 
promoter locus. 
The average level of SAP activity from the targeted clones was less than half compared 
to the parental, indicating that the SAP phenotype is not completely abolished by the 
targeting event. This result suggests a residual SAP expression in the targeted clones 
which could be the result of transcriptional read-through from the ß-actin promoter. In 
contrast, the average SAP expression level from the control clones with the exception 
of one clone was about the same as the parental cell line. The low expression level of 
SAP observed in this clone was due to the poor growth rate of cells in this clone. 
The results from ß-galactosidase and SAP assays suggests that both the Cre-mediated 
targeting and random integration events leads to the activation of ß-galactosidase 
expression and a reduction in SAP activity. Although there arc differences in the 
expression levels of ß-galactosidase and SAP from the targeted and the non-targeted 
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Transformant 0-galactosidase (mU) SAP (arbitrary unit/10" 
cells/day) 
1-G12 (parental) - 0.37 
Targeted 1 1.2 0.1 
2 3.3 0 
3 2.5 0.17 
4 1.8 0.08 
5 2.9 0.3 
6 2.3 0.24 
7 1.9 0.4 
8 2.5 0.12 
9 1.7 0.08 
10 3.4 0.1 
11 1.9 0 
12 3.1 0.09 
Mean 2.37 0.15 
Random 13 0.2 0.26 
14 0.8 0.3 
15 1.9 0.25 
16 0.7 0.39 
17 0.4 0.16 
18 - 0.34 
Mean 0.66 0.28 
Table 5.4- Estimation of ß-galactosidase and SAP (SPR) activity from independent 
pHM3-loxP transfected 1-G12 cells. 
One million cells from (cell line 1-G12) transformants were assayed for ß- 
galactosidase activity (described in section 2.4.10) and SAP activity (described in 
section 2.4.8). Results of ß-galactosidase and SAP activity are the average of assays 
from duplicate extracts from each transformant. Background ß"galactosidasc activity 
in 1-G12 parent cell line was subtracted from activities of the transformants. One unit 
of ß-galactosidase hydrolyses 1 micromole of o-nitrophenyl-ß-D-galactopyranoside 
(ONPG) to o-nitrophenol and galactose per minute at p117.5 at 37"C. Arbitrary unit of 
SAP is defined as the change in absorbance at AWn,, in 30 minutes ( readings were 
done in duplicates). 
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events, these differences do not prove site-specific recombination. Therefore, further 
investigations of the targeting event was necessary. 
5.8.3.3 PCR analysis of targeted clones 
A PCR was used to investigate if Cre-mediated recombination juxtaposed the pHM3- 
loxP to the chromosomal loxP site. A combination of oligonuclcotidc primer sequences 
designed as forward primer to anneal within ß-actin promoter (CB1736- 
GCTATTCTCGCAGGATCAGTCGACC) and a reverse primer (CB 1739- 
ATAATTCGCGTCTGGCCTTCCTGTA) to anneal within and the lacZ gene were used 
to amplify sequences from genomic DNA prepared from clones isolated from the Cre- 
mediated reaction (Figure 5.13). If pHM3-loxP is targeted to the chromosomal loxP 
site, PCR analysis using these primers is expected to produce a 590 bp fragment . 
Results of the PCR reaction showed a lot of bands in all of the targeted clones 
analysed including a 590 bp fragment band (indicated by arrow; lanes 4-12) which 
probably corresponds to the targeted event. Unfortunately, a very faint band migrating 
at about the same distance as the 590 bp was also observed in the control reaction 
using genomic DNA from the parental cell line 1-G12 (lane 2). In addition to this faint 
band, other bands were observed in the control reaction which migrated to the same 
distance as those seen in the clones isolated from the Cre-mediated reaction. This 
suggests that the 590 bp fragment like the other bands are the result of the primer 
sequences amplifying genomic DNA sequences non-specifically. Various PCR 
parameters such as Mg2+ salt concentration and the annealing temperature were varied 
in the hope of improving the specificity of the primer sequences. Furthermore, different 
primers were designed and used to investigate the targeting event. Unfortunately, none 
of the PCR reactions done unambiguously showed the expected DNA fragment to 
suggest targeted event. Consequently, a Southern hybridisation was done to investigate 
the targeting event. 
5.8.3.4 Southern blot analysis of targeted clones 
Genomic DNA (10 µg) prepared from the clones isolated from the Cre-mediated 
reaction and control clones was digested with BgIII and the digested DNA separated 
by gel electrophoresis on an agarose gel. The DNA fragments were transferred onto a 
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Figure 5.13- Agarose gel separation of' PCR reaction of indIcpendent clones resuiltinr 
from pHM3-loxP tranfection into cell line 1-G 12. 
PCR reactions were done using genomic DNA prepared from independent cell line 1- 
G12 transformants. A pair of oligonucleotide primers designed to prime within the (3- 
actin UTR region and the lacZ gene was used to amplify sequence from the genomic 
DNA. M indicates the 1 Kb molecular weight DNA marker; lane 1; negative control 
reaction (primer sequence only), lane 2; genomic DNA from 1-G12 (negative control), 
lane 3; genomic DNA from CHO-DUKX BII (negative control), lanes 4-12; genomic 
DNA from independent clones representing Cre-mediated transfection of pHM3-loxP 
into cell line 1-G 12. A 590 bp fragment band is indicated to the right of the gel 
picture. 
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nylon membrane and hybridised with a radiolabelled lacZ gene (980 bp fragment 
obtained by digesting pHM3 with C1aI and MOM). 
The restriction enzyme Bg1II will cut the genomic DNA in many places, however, if 
Cre-mediated recombination had occurred efficiently and integrated the targeting 
vector, pHM3-loxP to the chromosomal loxP site, then genomic digestion with 13g1II is 
expected to produce a 7.7 kb fragment. When the lacZ fragment is used as a probe in 
the Southern blot, the DNA fragment containing the targeted fragment is expected to 
hybridise and appear on the autoradiograph as a signal of a 7.7 kb fragment (Figure 
5.14a). 
Results of Southern hybridisation (Figure 5.14b) showed that eight out of twelve G418 
resistant and ß-gal+ clones (from the Cre-mediated reaction) analysed showed one 
signal (lanes 1,2,4,8-12) which suggests single-copy integrants. However the signals 
were approximately 6.5 kb in size (1.2 kb less than would be anticipated for the 
targeted event). Three other targeted clones (lanes 5,6 and 7) showed this 6.5 kb 
signal and other signals to suggest multiple insertions. The other targeted clones (lanes 
3 and 14) gave different size signals characteristic of random integration or multiple 
insertions. The clones isolated from the control reaction (lanes 15-20) gave different 
signals to suggest random integration. However, the 6.5 kb signal was observed in lane 
19 and appeared very faint in in the other control clones investigated. Because this 6.5 
kb signal appears to be present in the control clones as well, this would suggests that 
the targeted event had not occurred. However, this signal is smaller than anticipated 
for the targeted event which could suggest a partial deletion of the targeting vector. If 
this 6.5 kb signal is indeed due to a partial deletion in the vector, then it is possible to 
observe this signal in both the Cre-mediated and the control events especially if it 
corresponds to a fragment of vector DNA. Furthermore, eight out of twelve clones 
from the Cre reaction only showed this 6.5 kb signal whereas the control clones 
showed multiple signals suggesting that this single copy integration is probably the 
result of Cre-mediated site-specific recombination. However, because of the size 
discrepancy between the observed and expected signals it was necessary to investigate 
the targeting event further. 
To investigate the structural features of the single-copy integrants in more detail, other 
restriction digestion analyses were done. Genomic DNA from three targeted clones 
(single copy integrants) were digested with either Hindu !, Pvul or Asp718 + NruI. 
Digested DNAs were separated on an agarose gel and DNA fragments transferred to a 
nylon membrane and hybridised with a radiolabelled IacZ probe as described above. 
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Figure 5.14a- Linearised map of the chromosomal target before Cre-mediated 
integration (parental)and after targeting with pHM31oxP. 
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Figure 5.14b- Southern blot analysis of Cre-mediated transfection of pHM3-loxP into 
cell line 1-G12. 
Genomic DNA (10 µg) from independent cell line 1-G12 transformants was digested 
with BgllI. Digested DNA was separated by electrophoresis on an agarose gel, and 
DNA fragments transferred onto a nylon membrane and probed with a radioactive 
lacZ fragment. Lanes 1-14 corresponds to clones from the Cre-mediated integration 
events; lanes 15-20 corresponds to random integrants. 1 kb corresponds to standard 
molecular weight DNA marker. 
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The Cre-mediated proper targeting event is expected to produce 6.7 kb; 17 kb plus 
unpredictable amount of genomic DNA; and 14 kb signals corresponding respectively 
to HindII!, PvruI or Asp718 + NMI restriction digestions in the Southern hybridisation 
(fig 5.15). The result showed an approximately 6 kb signal from the HindIIl restriction 
digestion, a signal of more than 12 kb from the PvuI restriction digestion and a signal 
of about 10 kb from Asp718 + Nrul restriction digestions. This signal pattern of the 
Southern hybridisation correlates with the expected sizes from the individual 
digestions, however the signals again migrated at smaller sizes than expected. This is a 
further indication that perhaps the targeting event had occurred but there is a deletion 
of a segment of the targeting vector probably by host cell endonucleases. Partial 
deletion of a targeting vector in a Cre-mediated recombination event has also been 
observed by Fukushige and Sauer, (1990). However, they reported a much lower 
frequency of vector deletion than observed here. To investigate if the anomaly of the 
predicted to the observed DNA fragment sizes is due to deletion would require 
restriction endonuclease digestion, and/or PCR, and sequence analysis of subcloned 
genomic DNA fragments prepared from targeted clones. 
Although the clones isolated from the Cre-mediated reaction were not analysed 
further, the isolation of clones which were: G418 resistant, positive for ß-galactosidase 
expression and showed a reduction in SAP activity (compared to parental) and also the 
observation of single copy integrants in the Cre-mediated reaction (all gave the same 
size signal) suggests that the targeted event had occurred.. 
The Cre-mediated targeting experiment was repeated using recombinant Cre protein 
which was purified from the baculovirus-insect expression system (see chapter 3) 
instead of a cre expression plasmid to investigate if the direct introduction of Cre 
protein into cells would be more efficient at mediating targeted integration. 
Unfortunately, cell line 1-G12, when revived from frozen (see section 2.3.5), grew 
very poorly therefore another cell line, 13-G6 which also contains a single loxP 
insertion was used as the host to repeat the targeted event. Cell line 13-G6 showed a 
higher expression level of SAP compared to 1-G12 suggesting that the chromosomal 
loxP site is in a region more favourable for gene expression. Therefore proper 
targeting of exogenous DNA to the loxP site in this cell line should give a 
characteristic higher level of ß-galactosidase expression (compared to ß-galactosidase 
expression from 1-G12) if the expression level of the targeted transgenes correlate 
with the SAP activity in the different cell lines. Thus proper targeting would also give 
information about the effect of different chromosomal regions on gene expression. 
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Figure 5.15- Detection by Southern blot analysis of single-copy integration of pl IM3- 
loxP into 1-G 12. 
Genomic DNA (10 µg) from three independent Cre-mediated targeted transformants 
was each digested with either Hind! I!, PvuI or Asp718 + N"d. Digested DNA was 
analysed by Southern hybridisation using IacZ probe (essentially as described in Figure 
5.14b). 
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5.9 Use of recombinant Cre protein in site-specific recombination 
As previously mentioned in the introduction chapter, a drawback of the Crc-loxP 
system for targeted integration of transgenes into mammalian cells is that the 
recombination event is freely reversible, and excision is kinetically favoured over bi- 
molecular integration thus integrated products are inherently unstable in the presence 
of the recombinase. Therefore if the cre gene was stably integrated into the CHO cells, 
constitutive expression of the Crc recombinase will catalyse the excision of the 
integrated DNA. Southern analysis using radiolabelled cre gene as a probe did not 
show any signal (data not shown) to indicate the co-integration of the crc plasmid in 
the targeted event. However, any residual Cre activity in the cell (as evidenced by Cre 
activity in cells 48 hours post infection in transient transfection assay) would be 
expected to catalyse the re-excision of the integrated plasmid reducing targeting 
efficiency. A strategy that has been shown to obviate the possibility of cre gene 
integrating into cells was to directly introduce purified Crc protein into cells to mediate 
the targeting event (Baubonis and Sauer, 1993). Using this approach, Baubonis and 
Sauer showed that Cre protein purified from an E. coli source was able to mediate the 
integration of neomycin-phosphotransferase and thymidine kinase marker genes to a 
previously integrated loxP site in human osteosarcoma cell line, 143B. 
The direct introduction of Cre protein into cells has a number of distinct advantages 
compared to using cre expression plasmids. First, use of purified protein, rather than 
DNA, eliminates the possibility of stable integration of the cre gene. For example, in 
the construction of targeted knockout mutations in embryonic stem cells it is often 
necessary to remove the selectable marker gene used to generate the knockout. This 
can be done by flanking the marker gene by directly repeated loxP sites in the targeting 
construct and later excising the marker gene in the resulting knockout cell line by 
transient expression of the cre gene (Sauer, 1993). Use of purified Cre protein 
eliminates the need to check marker gene "popout" colonies for the presence of the cre 
gene. Second because direct protein transfer should be possible with many different 
transfer cell types, there is no need for customised cre vectors having particular cell 
and tissue specific transcription and translation signals. Third, recombinase activity is 
temporally prescribed by the actual presence of functional Cre protein in the cell, thus 
averting problems for efficient integration of loxP targeting vectors arising from long 
term persistence (and expression) of DNA, as occurs in certain cells, such as striatal 
muscle (Wolfe et al., 1992). 
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The recombinant Cre protein purified from baculovirus/insect expression system has 
been well characterised in two in vitro assay systems (chapter 4): First, gel retardation 
assays showed that the Cre protein was very specific for its recognition lox? site. 
Second, the Cre protein was shown to mediate intramolecular (excision) and 
intramolecular recombination in DNA substrates containing loxP sites. The in vitro 
characteristics of the Cre protein is identical to native Cre suggesting that it can be 
used to mediate site-specific recombination in vivo. 
5.9.1 Cre protein mediated targeted integration into cell line 13-G6 using 
electroporation 
The direct introduction of proteins into cells by electroporation (which occurs by the 
passive transport through temporary created pores in plasma membrane) has been 
shown for various proteins including viral transactivator (Kashanchi e! al., 1992) and 
antibodies (Berglund and Sarkey, 1991) and therefore should be possible for the 
recombinant Cre protein. Furthermore, the recombinant Cre protein contains an 
engineered nuclear localisation signal which should increase the rate of transport into 
the nucleus of the cell to mediate site-specific recombination. 
Cell line 13-G6 (1 x 107 cells) was transfected with 10µg of pHM3-loxP and different 
amounts of recombinant Cre protein (i. e., 1,5 and 10 µg; 27000 U/mg [section 3.8]) 
by electroporation at 960 µF and 250V. In a control experiment cell line 13-G6 (1 x 
107 cells) was transfected with 10 µg of pHM3-loxP and 10 µg of pBS by 
electroporation at 960 µF and 250V. Two days after transfection, transfected cells 
were split three fold and grown in DHFR+ select medium supplemented with G418 to 
400 µg/ml final concentration. Transfected cells were refed 6 days after transfection to 
remove non-transfected cells and cell debris. 
The transfection efficiency (calculated from crystal violet staining of individual colonies 
resistant to G418 by 20 days post infection) was similar between the control and the 
targeted events; -175 colonies/107 transfected cells were obtained using 1 tg of Cre 
protein in the transfection; -206 colonies/107 transfected cells were obtained using 5µ 
g of Cre protein in the transfection; -193 colonies/107 transfected cells were obtained 
using 10 µg of Cre protein in the transfection whilst -219 colonies/107 transfected 
cells were obtained using 10 jig of pBS in the transfection. 
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The observation of similar transfection efficiency between the control and the targeted 
events suggests that the recombinant Crc protein had not mediated very efficient 
targeting of pHM3-loxP to the chromosomal loxP sites. Because the recombinant Crc 
protein is clearly active, as shown by in vitro studies, the result suggests that perhaps 
the amounts of Cre protein investigated were not sufficient to observe site-specific 
recombination or that perhaps the electroporation conditions used (basically mixing the 
targeting vector and Cre protein on ice prior to transfection) were not optimum. 
Further investigations would require titrating different amounts of the Crc protein and 
the targeting vector and varying electroporation conditions. An alternative method that 
has successfully been used to investigate Cre-protein mediated recombination was 
lipofection (Baubonis and Sauer, 1993) therefore the targeting experiment was 
repeated this time transfecting the targeting vector and the recombinant Crc protein 
into cell line 13-G6 by lipofection. 
5.9.2 Cre protein mediated targeted integration into cell line 13-G6 using 
lipofectACE 
The mode of action of lipofectACE reagent is the same as transfectam reagent. 
Basically lipofectACE reagent interacts with DNA to form lipid-DNA complex which 
then associates with the cell plasma membrane. Internalisation of the DNA then occurs 
by endocytosis whilst internalisation of Cre protein should occur by passive transport 
into the cell because of its small size. The lipofectACE procedure requires 
transfections to be done in a six-well plate using about 105 cells. Because a small 
number of cells was to be used and also lipofection is a very efficient way of 
transfecting DNA into cells (as shown previously in section 5.4) 1 µg of the targeting 
vector was used in this transfection instead of the 10 µg used in transfection by 
electroporation. 
Cell line 13-G6 (1 x 105 cells) was transfected with a constant amount of pHM3-loxP 
(1 µg) and either 1,5 or 10 µg of recombinant Cre protein using lipofectACE 
(GIBCO BRL; see section 2.4.4 for procedure) to investigate optimal targeting 
(highest frequency of G418 resistance). In the control reaction, cell line 13-G6 (1 x 
105 cells) was transfected with 1 pg of pHM3-loxP and 10 µg of pBS (Stratagene) 
using lipofectACE. Transfected cells were incubated in complete medium overnight. 
Twenty four hours post transfection, cells were fed with DHFR+ select medium 
supplemented with G418 to 400 pg/ml final concentration. Cells were re-fed every six 
days to remove dead cells and cell debris. 
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Results showed 7 colonies/105 transfected cells using 1 µg of Crc protein; 27 
colonies/105 transfected cells using 5 µg of Crc protein; 57 colonies/105 transfccted 
cells using 10 µg of Crc protein and 22 colonies/105 cells using 10 µg of pBS 
(calculated from crystal violet staining of individual resistant colonies arising from 
transfected cells resistant to G418 by 20 days post infection). This is however an 
estimate on the assumption that there are no more colonies appearing 20 days. Results 
showed the highest targeting when 10 pg of Cre protein was used, this may not be the 
optimum amount of Crc required for targeting because higher amounts of Crc protein 
were not investigated. 
Forty DHFR+ and G418 resistant colonies were isolated from the targeted transfection 
using 10 µg of recombinant Cre protein and propagated for further analysis. Initially a 
Southern hybridisation analysis was used to investigate if Cre protein had directed the 
targeting of pHM3-loxP to the chromosomal loxP site (instead of by PCR because 
previous PCR analysis of the Cre-mediated event [see section 5.8.3.3] showed a lot of 
non-specific bands). 
5.9.2.1 Southern hybridisation of the targeting event 
Genomic DNA (10 µg) prepared from clones isolated from the Cre-mediated reaction 
and control clones was digested with BgIII and the digested DNA separated by gel 
electrophoresis on an agarose gel. The DNA fragments were transferred to a nylon 
membrane and hybridised with a radiolabelled lacZ gene (980 bp fragment obtained 
by digesting pHM3 with Cal and HindIIl). 
The restriction enzyme BglII will cut the genomic DNA in many places, however, if 
Cre-mediated recombination had occurred efficiently and integrated the targeting 
vector, pHM3-loxP to the chromosomal loxP site, then genomic digestion with BglII 
is expected to produce a 7.7 kb fragment. When the IacZ fragment is used as a probe 
in the Southern blot, the DNA fragment containing the targeted fragment is expected 
to hybridise and appear on the autoradiograph as a signal of 7.7 kb fragment (Figure 
5.16). 
Results of Southern hybridisation showed that out of 36 clones analysed 11 clones 
showed a single corresponding to a 7.7 kb fragment (lanes 3,5,10,16 and 17 in 
Figure A; lanes 21,22,28,29,31 and 34 in Figure B) suggesting that about 30% of 
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Figure 5.16- Detection of recombinant Cre protein mediated integration of pHM3- 
loxP into cell line 13-G6. 
Genomic DNA (10 µg) prepared from independent transformants was digested with 
BglII. Digested DNA was separated by electrophoresis on an agarose gel, and DNA 
fragments transferred onto a nylon membrane and probed with a radioactive lacZ 
fragment. A- shows targeted clone numbers 1 to 19; B- shows targeted clone numbers 
20 to 36. The 7.7 Kb indicated on the right corresponds to the expected size from a 
Cre-mediated integration event. 
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the clones analysed are single copy targeted integrants. However, some clones showed 
the 7.7 kb signal and other signals (lanes 2,6,11,12,13,15 in Figure 5.16a; lanes 24; 
25; 32 and 34 in Figure 5.16b) indicating targeted integrations as well as random. 
Other clones showed different signals indicating random integration or re- 
arrangements. To verify that the 7.7 kb signal observed as single copy integrant in 
some clones corresponds to targeted integration products, another Southern 
hybridisation was done. 
5.9.2.2 Further Southern hybridisation to analyse the targeting event 
Genomic DNA (10 µg) prepared from 10 clones which appeared to be single copy 
targeted integrants (observed as 7.7 kb signals, section 5.8.1) was digested with Nrul 
and Cal. Digested DNA was separated on an agarose gel and DNA fragments 
transferred to a nylon membrane and probed with a radiolabelled 824 bp DNA 
fragment from pSAP-RDN (Figure 5.3) comprising a region of ß-actin promoter 
(obtained by digesting pSAP-RDN with XhoI and BstEII). Restriction digestion of the 
parental cell line 13-G6 with Nrul and Gal is expected to produce a 6.8 kb fragment, 
however, if the Cre protein mediated proper targeting of pHM3-loxP to the 
chromosomal loxP site, then restriction digestion of genomic DNA from targeted 
clones with Nrul and Gal is expected to yield a 5.9 kb fragment (Figure 5.17a). When 
the radiolabelled ß-actin fragment is used as a probe in the Southern analysis, the DNA 
fragment containing the targeted fragment is expected to hybridise and appear on an 
autoradiograph as a signal of 5.9 kb whilst DNA from parental cell line would appear 
as a signal of 6.8 kb (Figure 5.17b). 
Results showed the expected signal of 6.8 kb fragment in the parental clone. Seven out 
of the 10 clones investigated showed the expected 5.9 kb signal confirming that they 
are single integrants. Interestingly, these clones also showed the 6.8 kb parental signal. 
The 3 other clones (i. e transformants 5,10, and 29) investigated showed signals which 
were smaller than the expected 5.9 kb fragment suggesting that they are not true single 
copy targeted integrants. However, the smaller signals could be due to a deletion in the 
targeting vector sequence which was not observed in the initial Southern analysis 
(using genomic DNA digested with Bg1II) because it occurred in sequences outside the 
Bg1II recognition sites. The observation of the signal corresponding to the parental 
fragment in the targeted clones shows that the targeted clones comprise a mixture of 
unrecombined parental cells and cells which have undergone the site-specific 
recombination event. Mixed colonies would be expected if 
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Figure 5.17a- Linearised map of the chromosomal target before Crc-mediated 
integration (parental)and after targeting with pHM3IoxP. P corresponds to ß-actin 
promoter. 
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I4igure 5.17b- Detection of single-copy integrants corresponding to recombinant Crc 
protein mediated targeted integration of pHM3-loxP into the parental cell line, 13-G6. 
Genomic DNA (10 pg) from 10 independent transformants (observed as single copy 
integrants; see Figure 5.16) was each digested with Nrul and C1aI. Digested DNA was 
separated by electrophoresis on an agarose gel, and DNA fragments transferred onto a 
nylon membrane and probed with a radioactive human ß-actin promoter fragment. The 
6.8 Kb size indicated to the right corresponds to the parental fragment, whilst the 5.9 
Kb fragment corresponds to the Cre-mediated targeted event (see Figure 5.17a). 
Lanes arc labelled according to the number of the targeted clone. 1 Kb corresponds to 
molecular weight DNA marker. 
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recombination occurred after mitosis in only one descendant of a transfected cell, or if 
recombined and unrecombined cells mixed at replating or during subsequent growth. 
These unrecombined cells could have survived the G418 selection as a result of their 
close proximity to the targeted clones. 
The results from the Southern hybridisation shows that the recombinant Cre protein 
can mediate the site-specific integration of pHM3-loxP to the chromosomal loxP site in 
cell line 13-G6. To characterise this targeted event further and also to show that the 
Cre protein mediated recombination event leads to the activation of the IacZ gene from 
the ß-actin promoter and the subsequent loss or reduction of SAP expression, ß-gal 
and SAP assays were determined. 
5.9.2.3 Assay for ß-gal and SAP expression from targeted clones 
Single copy transgenes targeted to the same chromosomal loxP sites should express 
the same amount of recombinant proteins. Therefore, targeted clones were assayed for 
ß-gal and SAP expression to see if they were reproducible and compared to the 
parental cell line (Result is shown in Table 5.5). 
Results showed that the targeted event led to activation of IacZ (ß-galactosidase 
activity) in all the clones analysed. With the exception of one transformant (clone 28 
which showed a high level of ß-galactosidase) all the clones analysed showed similar ß 
-galactosidase activity. The high expression level of ß-galactosidase in clone 28 was 
surprising however, because the integrated plasmid and the chromosomal content are 
identical in all cell lines. Although this clone was not examined in more detail (for 
instance to check if it showed the normal diploid karyotype) chromosomal duplication 
and/or tetraploidisation may account for this exceptional expression level. Only 
background ß-galactosidase expression was observed in the parental cell line which did 
not contain the lacZ gene. The average level of SAP expression observed in the 
targeted clones was lower (although not significantly) than the level of SAP from the 
parental cell line. This high background of SAP expression in the targeted clones 
could be due to the mixture of unrecombined SAP expressing cells in the targeted 
clones as shown by Southern hybridisation (see section 5.8.2). 
The result shows that the direct introduction of Cre protein into cells can mediate site- 
specific integration of an exogenous DNA to a chromosomal loxP site. In addition, the 
observation that lipofected recombinant Cre protein can catalyse site-specific 
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Transformant O-galactosidase (mU) SAP (arbitrary unit/10" 
cells/day) 
13-G6 (parental) - 2.45 
3 6.2 1.9 
5 4.9 1.45 
10 1.7 2.51 
17 8.2 1.21 
21 7.9 1.38 
22 4.7 2.75 
28 16.1 1.58 
29 5.8 3.85 
31 9.6 2.1 
34 7.4 1.78 
Mean 7.25 2.05 
Table 5.5- Estimation of 0-galactosidase and SAP (SPR) activity from independent 
Cre-mediated targeted clones. 
Transformants (1 x 106) cells were assayed for (3-galactosidase activity (described in 
section 2.4.10) and SAP activity (described in section 2.4.8). Results of 0- 
galactosidase and SAP activity are the average of assays from duplicate extracts from 
each transformant. Background ß-galactosidase activity in 13-G6 parent cell line was 
subtracted from activities of the transformants. One unit of (3-galactosidase hydrolyses 
1 micromole of o-nitrophenyl-ß-D-galactopyranoside (ONPG) to o-nitrophenol and 
galactose per minute at pH 7.5 at 37°C. Arbitrary unit of SAP is defined as the change 
in absorbance at A,,, 5nm in 30 minutes (readings were done in duplicates). 
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recombination in cultured cells has important practical implications. Because of the 
ease of the procedure, it can be used for transformation of a target cell line with a 
battery of targeting plasmids to allow rapid generation of a series of isogonic cell lines. 
Moreover, removal of a marker gene flanked by loxP sites is simply accomplished by 
direct introduction of Cre protein, obviating the possibility of unwanted adventitious 
integration of a cre expression plasmid. 
5.10 Summary 
In this chapter, the Cre-loxP site-specific recombination system has been used to 
investigate the targeting of a promoterless lacZ/neor fusion gene to a chromosomal 
loxP site. A source of Cre recombinase to mediate the recombination event was 
provided by co-transfecting the targeting vector with either a cre expression plasmid or 
recombinant Cre protein purified from a baculovirus/insect system. 
In order to use the Cre-loxP system for gene targeting in mammalian cell lines, it was 
necessary to establish an initial cell line which contains a single loxP site as a 
chromosomal target. Clearly, if multiple copies of the loxP sites are present in the 
chromosome, the Cre mediated recombination could lead to chromosomal 
translocation and re-arrangements which would be difficult to interpret. Southern blot 
analysis of transformants obtained using the Transfectam reagent, showed that this 
method of transfection favoured introduction of multiple copies of the loxP plasmid 
into the CHO chromosome. In contrast electroporation favoured the uptake of fewer 
copies of the foreign DNA. Furthermore, using I µg of linearised DNA was found to 
favour the integration of one copy of the loxP plasmid into the CHO chromosome as 
shown by Southern blot analysis. Three cell lines containing a single copy of the loxP 
inserts were isolated by electroporating 1 pg of linearised DNA into CHO cells. 
The three cell lines (each containing a single loxP copy insert) showed different 
reporter SAP activity. Because the expression of the SAP gene in the plasmid pSAP- 
RDN/loxP is under the transcriptional control of 0-actin promoter and integration of 
the SAP plasmid a random process, differences in SAP expression were a direct result 
of the effect of position of integration in the chromosome. Thus if integration disrupts 
the ß-actin promoter, no detectable SAP expression would be observed, whilst a high 
level of SAP expression would indicate that integration had occurred in a favourable 
region in the chromosome for gene expression without disrupting the SAP gene. 
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Therefore, the difference in SAP activity between the 3 cell lines 13-G6 (highest), I- 
G12 (medium) and 5-E10 (lowest) suggests that the loxP site had integrated in a 
favourable region for expression in 13-G6. 
If the difference in SAP activity is the result of the chromosomal position effects, then 
the expression level of subsequent targeted genes to the same chromosomal position 
should correlate with SAP. To investigate this, the targeted vector, pllM3-loxP was 
co-transfected with a source of Cre recombinase into cell line 1-G12 and 13-G6. An 
estimate of the level of ß-galactosidase activity from single copy integrants from the 
two different cell lines showed on average, approximately three fold higher 13- 
galactosidase expression as a result of Cre mediated targeting of pHM3-loxP vector to 
13-G6 than 1-G12. Because the targeting vector was directed to the same ß-actin 
promoter which was initially driving the transcription of the SAP gene in both cell lines 
this result suggests that the environment of the chromosomal loxP site may have a 
direct effect on subsequent expression of the targeted gene. Thus in cell line 13-G6 
where the loxP site integrated in a relatively favourable region in the CH-HO 
chromosome for expression as evidenced by the higher SAP activity, the same 
chromosomal position effect was observed on the targeted vector. This observation 
shows that Cre mediated targeted integration ensures that the same position effect 
(depending on the genomic location of the loxP target) is imposed on the incoming 
targeted gene. This is an important advantage in the use of the Cre-loxP site-specific 
recombination system as a tool for recombinant protein expression in mammalian cells. 
Thus if a loxP site is placed in a transcriptionally active region in the chromosome such 
as a region juxtaposed to a strong promoter or an enhancer region, Cre-mediated site- 
specific integration should favour the reproducible high level expression of the targeted 
gene. The SAP gene therefore provides a potential tool as an indicator for monitoring 
large numbers of transfected cells each containing a single loxP site in order to isolate 
cell line(s) which had integrated the loxP site in chromosomal regions favourable for 
the reproducible high level expression of subsequent targeted transgenes. 
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CHAPTER 6 
Discussion 
As described previously, large scale production of recombinant proteins such as 
recombinant antibodies have many applications in research and in the diagnosis and 
treatment of human diseases, and their efficient production will be of immense 
commercial importance. However, it is generally found that expression levels of 
recombinant proteins from stable clones isolated from a single transfection in 
mammalian cells show extreme variability, from a few nanograms of proteins to several 
micrograms per 106 cells/mIday (Kaufman el al., 1985). This is due to a highly 
variable number of copies integrated into the genome and from position effects on gene 
expression due to random integration hence extensive number of isolated clones must 
be screened in order to isolate a suitable donor for the high level expression of the 
recombinant protein. Thus, a system of introducing foreign DNA into mammalian cells 
that would eliminate variability in expression and which will allow high level expression 
of recombinant proteins would be beneficial for the industrial, large scale production 
of recombinant proteins. 
The Cre-loxP site-specific recombination system (and other conservative site-specific 
recombination systems which have been shown to be active in heterologous eukaryotic 
cells; Golic and Linquist, 1989; O'Gorman et al., 1991; Onouchi el al., 1992) provides 
a strategy for the site-specific targeting of DNA into a single pre-selected region in the 
genome which should facilitate the construction of isogenic cell lines for the 
reproducible expression levels of recombinant proteins (Fukushige and Sauer, 1992). 
Such a strategy would be advantageous if the site to which the foreign gene is to be 
targeted is favourable for gene expression. 
The objective of this work was to construct a mammalian cell line incorporating the 
Cre-loxP site-specific recombination system as a tool that would allow the site-specific 
targeting of exogenous DNA to pre-selected regions in the chromosomes which have 
been identified as favourable for gene expression. To achieve this, a chromosomal loxP 
target was constructed by linking a loxP site to a reporter gene encoding secreted 
alkaline phosphatase (SAP) to monitor gene expression in transfected cells. 
Transfected cells which contained a single copy of the loxP inserts were screened 
(using SAP expression) in order to isolate cell lines which had integrated the loxP site 
in regions of the chromosomes favourable for expression. Thus, subsequent targeting 
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of exogenous DNA to these sites, should allow the reproducible expression of high 
levels of recombinant proteins. 
In this work, the Cre-loxP site-specific recombination reaction was initially studied in 
vitro using recombinant Cre protein which was purified from baculovirus-insect 
expression system with the aim of gaining a greater understanding into the mechanism 
of the reaction and also to identify irreversible substrates that would improve the 
efficiency of targeted integration in mammalian cells. 
The Cre recombinase protein has been previously purified from E. coli (Abremski and 
Hoess, 1984). However, high level production of recombinant proteins have been 
reported in baculovirus-insect system by utilising the strong polyhedrin promoter to 
drive gene expression. For instance when placed under the transcriptional control of 
the polyhedrin promoter, human fibroblast interferon (Smith el al., 1983), E. coli ß- 
galactosidase (Pennock et al., 1984) and human C-myc protein (Miyamoto el al., 
1985) were all expressed to very high levels, processed, modified and secreted 
appropriately in insect cells compared to the products synthesised in E. coli and 
Saccharomyces cerevisiae cells. For these reasons the Cre protein was expressed in the 
baculovirus/insect expression system. 
Although the baculovirusrnsect system allows the high level expression of recombinant 
proteins, purification from host endogenous proteins can be a time consuming task and 
a rate-limiting step in obtaining large quantities of material. To overcome this problem 
the Cre protein was expressed as a fusion with a hexa-histidine tag. Because histidine 
residues interact with a strong binding affinity for metal chelate adsorbents, a rapid 
single-step purification of the Cre protein from immobilised Ni+'-NTA affinity 
chromatography column was possible. Insect cells infected with a recombinant 
baculovirus. (containing the hexa-histidine-cre fusion) expressed Cre protein, which 
was purified in a single-step from immobilised Ni+'-NTA affinity chromatography 
column. The purified protein migrated as a single polypeptide band on an SDS- 
polyacrylamide gel, with a molecular weight of approximately 38 kDa. Approximately 
0.9 mg of Cre protein was produced from 1x 109 insect infected cells compared to the 
levels of purified Cre protein from E. coli, reported to be 0.4 mg/g (wet weight) of cell 
culture (equivalent to approximately 2x 1011 cells; Abremski and Hoess, 1985). It is 
possible that the high levels of Cre protein achieved with the baculovirus/insect system 
is due to the single purification step introduced, whereas a substantial amount of Cre 
protein was lost during the various purification steps with the E. coli system. The 
amount obtained from the baculovirus-insect system compares favourably with that of 
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c-myc protein produced from the same system (i. e. I tg of c-myc protein produced 
from 106 infected insect cells; Miyamoto el al., 1985). 
The Cre-lox? site-specific recombination reaction in vitro was verified by (i) Band shift 
assays and (ii) Cre-mediated intermolecular and intramolecular site-specific 
recombination at loxP sites: 
(i) In Band shift (Revzins) assays, the Cre protein formed specific complexes with 
oligonucleotide sequences corresponding to loxP sites. The stoichiometry of the Cre- 
loxP interaction was consistent with two molecules of Cre bound to a full loxP site or 
one molecule bound to a half loxP site as reported by Mack el al., (1992). The Crc- 
loxP interaction appeared to be temperature independent. However, it seems unlikely 
that an enzymatically catalysed reaction of this complexity would be entirely 
temperature independent. Furthermore, Drew el al., (1985) proposed that the TpA 
sequence in the spacer region of the loxP site maybe predisposed to melting. Thus, it 
seems that the temperature effect maybe essential for other steps in the recombination 
process such as unwinding of the loxP site either during the pairing or strand exchange. 
The initial binding of the recombinant Cre protein to its target loxP sites occurred very 
fast (under 30 seconds) making it difficult to determine the association/dissociation 
kinetics of the interaction. An "on-rate/off-rate" competition assay showed that a loxP 
site filled with two molecules of Cre was more stable than a half-filled loxP site, 
implying a possible protein-protein interaction between the Cre molecules that 
stabilises the complex formed at the loxP site probably through co-operative binding. 
The stability of the Cre-loxP binding interaction has important implications for the in 
vivo site-specific recombination in eukaryotic cells. This is because eukaryotic cells 
contain many DNA binding proteins which might be expected to compete with Cre for 
loxP sites so perhaps preventing productive encounters between Cre and its loxP sites. 
Thus the observation that the Cre-loxP complex is highly stable suggests that, not only 
can the complex be stable from non-specific interactions in the cell, but it can also be 
stable until it encounters another such complex for site-specific recombination. 
Although the rate of dissociation of the Cre molecules from the loxP site was not 
determined, the in vitro site-specific recombination can occur in less than a minute 
suggesting that the "ofd rate" can be as rapid as the "on-rate". 
One approach to investigate the dissociation/association constants of the Cre-loxP 
interaction would be the use of an automated analytical system; Biospecific Interaction 
Analysis (BIA) using BIAcoreTM (Pharmacia Biosensor). This technique uses 
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biosensors to detect and measure the kinetic interaction of any analyte-ligand reaction 
in real time (milliseconds). The principle depends on immobilising one component of 
the reaction, preferably the ligand on a sensor chip surface. As the analyte is passed 
over the chip and binds to the immobilised ligand, there is a change in mass on the 
sensor chip surface which correlates to a change in refractive index. The change in 
refractive index is measured as surface plasmon resonance (S. P. R. ). The S. P. R. is 
monitored continuously so that chemical interactions between biochemicals can be 
studied in real time. For example, the BlAcore has provided useful information on the 
kinetics of the interaction of the Campath-Il series of antibodies with the CDW52 
antigen; CHO-derived Campath-1H had an affinity constant (Kaff) 1.33-2.26 x 108 M_ 
for CDW52, whereas Campath-1H aggregate material has a significantly different 
kinetic profile (slower on-rate and slower ofd rate) from Campath-1H (Jon Ellis; pers. 
comm., GWR&D). 
(ii) The recombinant Cre protein catalysed site-specific recombination in vitro without 
requiring any high energy cofactor(s) e. g., ATP or host protein(s) typically required for 
general recombination: recombination between two loxP sites in direct repeats relative 
to each other on a circular molecule gave rise to products each containing a single 
loxP site. These fragments then became substrates themselves because each of them 
contains an active loxP site (however the integration process is less favourable than the 
intramolecular excision event [Abremski et al., 1983]). Recombination between two 
loxP sites which were inverted relative to each other resulted in the inversion of the 
intervening sequence flanked by the loxP sites. In the context of the substrates 
described, recombination was absolutely dependent on the presence of the recombinant 
Cre protein and functional loxP sites. The efficiency of recombination was dependent 
upon the concentration of the enzyme and its substrates and the duration of the 
reaction. Varying salt concentration did not significantly affect the efficiency of the 
reaction, however the effect of omitting Mg2+ was more significant than other salts on 
the efficiency of the reaction. Furthermore, cofactors such as BSA or spermidine were 
found to be essential for efficient recombination. The role of Mg2+ maybe to improve 
the stability of the Cre-loxP binding interaction because Cre protein has been observed 
to dimerise in the presence of Mg2+ (Abremski and Hoess, 1984), BSA may act to 
prevent denaturing of the protein as a result of non-specific interactions whilst 
spermidine may act to condense the DNA substrate bringing the loxP sites into close 
proximity for recombination to take place. These observations suggest that although 
the complexity and the large size of the chromatin compared to the loxP site may 
reduce the number of productive encounters between the loxP sites in the cell, the high 
concentrations of salts (especially polyamines) may act to condense the chromatin 
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structure and thereby bring the loxP sites into closer proximity for site-specific 
recombination to take place. 
The Cre-loxP reaction is reversible, and excision is kinetically favoured over bi- 
molecular integration. Therefore, integrated products arc inherently unstable in the 
presence of the recombinase and this can be a major drawback for the efficient use of 
the Cre-loxP site-specific recombination as a tool for targeted integration of transgenes 
in mammalian cells. The loxP site was manipulated in vitro in an attempt to identify 
substrates that could be used to improve the stability of the targeted integrations in 
mammalian cells. Substrate plasmids containing a wild-type loxP and a hybrid loxP 
(comprising half sites of loxP and frt) were used to investigate whether Cre would 
mediate intramolecular excision between the two sites. Although band shift assays 
showed that the Cre protein did not bind frt site, it is possible that Cre might have a 
weak interaction with the frt site which was not detected by the band shift conditions 
used. A hybrid loxP site would have reduced binding affinity for the recombinase, 
hence recombination event between a wild-type and a hybrid loxP site would be less 
probable; in effect excision would be less favourable because of weak association. 
Unfortunately, no recombination event was observed in vitro using the wild-type and 
the hybrid loxP site indicating that such hybrid loxP site could not be used as substrates 
for targeted integration. Rather than changing whole half sites, Alberts et al., 1995; 
reported the introduction of selective base changes into the left (LE) and right (RE) 13 
bp inverted repeats flanking the 8 bp spacer of the loxP site, such that recombination 
between a loxP site with a mutation in the LE and a site with a mutation in RE would 
produce two recombination product sites: one with mutation in neither the LE or RE 
(wild-type) site and the other with mutations in both LE and RE. If the LE and RE 
mutant sites has reduced binding affinity for the recombinase, subsequent 
recombination between the wild-type and mutant sites would be less probable hence 
reducing the frequency at which successfully integrated plasmids are subsequently 
excised. Recently, Araki el al., (1997) reported site-directed DNA integration in ES 
cells using a pair of mutant loxP sites described by Alberts el al., (1995) described 
above. Araki el al., reported a 32-fold increase in site-specific integration using the 
mutant loxP sites compared to wild-type loxP sites. Such mutant loxP sites might be 
useful for the efficient Cre-mediated site-specific integration of transgenes in 
mammalian cells. 
In conclusion, the results presented here shows that the recombinant Cre protein can 
mediate site-specific recombination in vitro with efficiency comparable to that of native 
Cre protein (Abremski et al., 1983). Thus, although the recombinant Cre protein 
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contains a nuclear localisation signal and a hexa-histidine tag, they do not interfere with 
the recombinant Cre protein's activity. The histidine tag therefore acts as an 
independent domain which can be used for the detection of histidine-tagged Cre 
protein in Western blot assays or for the in vivo localisation of the Crc protein without 
the need to raise specific sera against the Cre protein. The nuclear localisation signal 
should increase the rate of nuclear import of the Cre protein. This is important for site- 
specific recombination events in mammalian cells where high concentration of the 
recombinase in the nucleus may be required for efficient recombination. The case with 
which the protein was expressed and purified suggests that this system can be used for 
the large scale production of Cre recombinase for site-specific recombination in vitro 
and in vivo and for further elucidation of the mechanism of site-specific recombination. 
In the second part of this work, the Cre-loxP site-specfic recombination system was 
used as a tool that would allow the rapid targeting of any exogenous DNA to pre- 
selected regions in Chinese Hamster Ovary (CHO) genome for the reproducible 
expression of recombinant proteins. The Cre-mediated site-specific recombination in 
CHO cells requires a chromosomal loxP target for the integration event. Therefore, 
plasmid pSAP-RDN/loxP (which contains a loxP site between a ß-actin promoter and 
SAP reporter gene) was used as the chromosomal loxP target such that stably 
transfected cells could be assayed for SAP expression in order to select cell lines which 
had integrated a single copy of the loxP plasmid in regions of the chromosomes 
favourable for gene expression. The loxP site was cloned in two orientations as 
determined by the directionality of the spacer region. In the one orientation (loxR), the 
loxP sequence was observed to have two ATG translational initiation codons upstream 
of the translational initiation codon of the SAP gene. The first upstream ATG codon 
was out of frame with the authentic translational initiation codon of the SAP gene and 
there is a purine (A) base at position -3, suggesting that this ATG codon was in a good 
context for translational initiation (Kozak, 1987). However no such ATG translational 
initiation codons were observed when the loxP site was cloned in the opposite 
orientation (loxL). 
Plasmid pSAP-RDN/loxP (with the IoxP site in both orientations) were independently 
transfected into CHO cells to determine whether a loxP site cloned in either orientation 
could have an effect on the expression of the SAP reporter gene. Results from the 
transfections showed that transfected cells containing loxR showed lower SAP 
expression compared to the transfected cells containing loxL. This observation showed 
that loxR. cannot be used as the chromosomal loxP indicator because the upstream 
ATG codons in the loxP sequence interfered with SAP expression. For this reason, all 
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investigations were done using loxL which did not contain any other ATG codons 
apart from the authentic ATG codon of the SAP reporter gene. 
For the Cre-mediated site-specific integration event, it was necessary to construct a 
cell line containing a single loxP site. This is because if multiple copies of the loxP sites 
are present in the chromosome, the Cre-mediated recombination event could lead to 
complex chromosomal translocations and re-arrangements. When the loxP plasmid 
(loxL), was transfected into CHO cells by the transfectam reagent, Southern blot 
analysis showed that transfected cells had incorporated multiple copies of the loxP 
plasmid into the genome showing that the transfectam reagent favoured the integration 
of many copies of the plasmid DNA into the genome. In contrast, electropration 
favoured the integration of fewer copies of the plasmid DNA into the CHO genome. 
Linearisation and low concentration of DNA favoured single copy integration. This 
observation is consistent with previous reports which showed that electroporation 
favours integration of one or few copies of exogenous DNA (Fromm et al., 1986; 
Reiss et al., 1986). 
The decision to choose SAP expressing cell lines which have a single copy of the loxP 
insert resulted in only three cell lines out of forty which had a single loxP site. The low 
frequency of SAP expressing cell lines containing a single loxP site could be due to 
screening for cell lines which express medium to high levels of SAP activity. In 
addition, transfected cells contains a dhfr selectable marker under the transcriptional 
control of an attenuated SV40 early promoter, such that expression of DHFR should 
be less efficient than the reporter SAP. This bias for selection of transfected cells where 
the plasmid had integrated into transcriptionally active site and/or in multiple copies. 
Taken together, transfected cells containing single copy insertions may be under 
represented. 
The difference in the reporter SAP expression levels observed in the three cell lines 
suggests that the loxP site had integrated into a different chromosomal region in each 
cell line. Thus the cell line expressing the highest SAP activity suggests that the loxP 
plasmid had integrated into a region in the chromosome favourable for gene expression 
whereas the cell line expressing the lowest SAP expression suggests that the loxP 
plasmid had integrated into a less favourable region. The SAP reporter gene could 
therefore be used to monitor the chromosomal environment of cell lines containing a 
single loxP site to establish cell lines where the loxP site is integrated in regions 
favourable for heterologous gene expression. 
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To investigate site-specific targeting of an exogenous DNA to the chromosomal loxP 
site, a promoterless lacZ/neon fusion plasmid containing a loxP site was co-transfcctcd 
independently with both a cre expression plasmid and recombinant Crc protein 
(purified from baculovirus-insect system) to provide a source of the Cre recombinase. 
The targeting event was designed such that proper targeting of the promoterless 
lacZ/neor gene to the chromosomal loxP site (located between a ß-actin promoter and 
the SAP gene) would displace the SAP gene from its' upstream ß-actin promoter. Thus 
proper targeting is expected to give rise to individual G418 resistant transformants 
expressing similar levels of ß-galactosidase and give loss or reduction of SAP activity. 
Random integration events on the other hand should give rise G418 resistant clones 
expressing different levels of ß-galactosidase and the same level of SAP activity as the 
parental cell line. 
The cre expression plasmid (which has been shown to encode active Crc rccombinase 
in transient transfection assays) was used to mediate site-specific integration of the 
targeting vector (promoterless lacZ/neor fusion gene) to a chromosomal loxP site in 
cell line 1-G12. The advantage of using the promoterless lacZ/neor fusion gene to 
monitor Cre-mediated recombination event is that a large number of colonies can be 
rapidly screened in situ for ß-gal expression. Results of ß-gal staining of G418 
resistant colonies isolated from this transfection showed that 26% of colonies resulting 
from Cre-mediated targeting event were positive for ß-gal staining whilst only 4% of 
the colonies resulting from random integration activated ß-galactosidase expression. 
The high frequency of ß-galactosidase expression from the Cre-mediated 
recombination event indicates that the Cre-mediated reaction can direct the targeting of 
the promoterless lacZ/neon fusion gene to the chromosomal ß-actin promoter site. 
Spontaneous activation of the lacZ gene as a result of illegitimate recombination to 
active region(s) in the chromosome such as near a promoter site occurred at low 
frequency. 
A PCR analysis to investigate if the Cre-mediated event juxtaposed the targeting 
vector to a chromosomal loxP gave a lot of non-specific PCR products therefore a 
Southern hybridisation was used to investigate the recombination event. Results 
showed that eight out of twelve clones analysed from the Cre-mediated reaction 
showed one signal to suggest single-copy integrations. However, this signal was 1.2 kb 
smaller than would be expected for the targeted event suggesting a partial deletion of 
the targeting vector. Another Southern hybridisation using various restriction 
endonuclease digestions of genomic DNA from clones (isolated from the Cre-mediated 
reaction) to investigate the structural features all gave signals which migrated at 
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smaller sizes than expected. This result was a further indication that perhaps the 
targeting event had occurred but there was a deletion of a segment of the targeting 
vector probably by host cells' endo- and exo-nucleases activity prior to site-specific 
integration. Partial deletion of a targeting vector sequence as a result of Cre-mediated 
site-specific integration event has also been reported by Fukushige and Sauer, (1990); 
and Sauer and Henderson, (1989) although at much lower frequency in targeted clones 
than observed here. Although clones isolated from the Cre-mediated reaction were not 
analysed further, the isolation of clones which were: G418 resistant, positive for 13- 
galactosidase expression (discuss later) and showed a reduction in SAP activity 
(discuss later) and also the result from Southern hybridisation analysis all suggests that 
the targeted event had occurred. 
Because the Cre mediated reaction is freely reversible, and excision is kinetically 
favoured over bi-molecular integration, thus integrated products are inherently unstable 
in the presence of the recombinase. To avoid the possibility of the cre gene integrating 
into the CHO genome and being constitutively expressed, the targeted integration 
experiment was repeated using recombinant Cre protein which had been purified from 
baculovirus/insect expression system (described in chapter 3). The recombinant Crc 
protein mediated targeting event was investigated using cell line 13-G6. Results of the 
recombination event analysed by Southern hybridisation showed that ten out thirty-six 
clones isolated from the Cre-mediated recombination event showed one signal of the 
expected size suggesting that the recombinant Cre protein can mediate single-copy 
integration of the targeting vector in CHO cells. Other clones showed additional 
signals to suggest additional copies of the targeting vector randomly integrated 
elsewhere in the genome, presumably by illegitimate recombination. 
Because site-specific integration using the cre expression plasmid and Crc protein were 
investigated in two different cell lines using two different methods of transfection in 
each case, the efficiency of the recombination cannot be compared. However, the 
direct introduction of Cre protein into cells shows a number of distinct advantages 
compared to using cre expression plasmids. First, use of purified protein rather than 
DNA eliminates the possibility of stable integration of the crc gene. For example, in 
the construction of targeted knockout mutations in embryonic stem cells it is often 
required to remove the selectable marker gene used to generate the knockout. This can 
be done by flanking the marker gene by directly repeated loxP sites in the targeting 
construct and later excising the marker gene in the resulting knockout cell line by 
transient expression of the cre gene (Sauer, 1993). Use of purified Cre protein 
eliminates the need to check marker gene "pop-out" colonies for the presence of the 
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cre gene. Second because direct protein transfer should be possible with many different 
transfer cell types, there is no need for individualised cre vectors having particular cell 
and tissue specific transcription and translation signals. Third, recombinase activity is 
temporally prescribed by the actual presence of functional Cre protein in the cell, thus 
averting problems for efficient integration of loxP targeting vectors arising from long 
term persistence (and expression) of DNA, as occurs in certain cells, such as striated 
muscle (Wolfe el al., 1992). The baculovirus-insect expression system can therefore be 
used for the large scale production of recombinant Crc protein which can be delivered 
to many different cell types to investigate site-specific recombination. 
As previously mentioned, the targeting event was designed such that proper targeting 
would give rise to G418 resistant transformants expressing ß-galactosidase and give 
loss or reduction of SAP activity. None of the clones isolated from the Cre-mediated 
reaction in the two different cell lines showed a complete loss of SAP expression 
suggesting a residual SAP expression which could be due to transcriptional read- 
through from the ß-actin promoter. With few exceptions, most of the clones showed a 
small but a reproducible level of ß-galactosidase expression as a result of Cre-mediated 
targeted integration of the promoterless lacZ/neor fusion gene into the two 
independent single loxP cell lines. The level of ß-galactosidase correlated with 
expression levels of the initial SAP reporter. Thus the cell line which showed the 
highest SAP expression also showed the highest ß-galactosidase expression. This result 
indicates that the Cre-mediated targeting event ensures that the same position effect 
(depending on the genomic location of the loxP target) is imposed on the incoming 
targeting vector. This observation is consistent with previous report by Fukushige and 
Sauer, (1992). Fukushige and Sauer showed that Cre-mediated integration of 
exogenous DNA to different chromosomal positions resulted in expression levels of 
recombinant proteins characteristic of the particular chromosomal position. Thus the 
Cre-loxP system can be used for the controlled expression of recombinant protein by 
targeting the heterologous gene to a region in the chromosome which should favour 
gene expression. 
Differences in gene expression observed in single copy integrants from one particular 
integration site must have come from influences other than copy number and position 
effect. One source of such variation is fluctuation in chromosome number from 
aneuploidy or tetrapoidy in cultured cells. Differences in methylation patterns which 
has been show to regulate gene expression (where methylated genes are inactive and 
the absence of methyl groups is associated with gene expression) may also affect gene 
expression (Doerfler, 1983). 
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In conclusion, the results presented here show that the Crc-loxP site-specific 
recombination system can be used as a tool for the targeting of any exogenous gene to 
a pre-selected region in the chromosome of CHO cells. Cre-mediated site-specific 
integration of a targeting vector to the chromosomal loxP site was investigated by co- 
transfecting a promoterless lacZ/neor fusion gene with a source of Cre recombinase 
into CHO cell lines containing loxP sites. The targeting event led to the activation of 
the promoterless IacZ/neor fusion gene from a ß-actin promoter (upstream from the 
chromosomal loxP site). Both cre plasmid and recombinant Cre protein purified from 
baculovirus expression system successfully mediated the targeting event. The 
expression level of the targeted gene (ß-galactosidase) correlated with the expression 
of SAP from the two independent loxP cell lines investigated, indicating that Cre- 
mediated targeting would ensure the same position effect (depending on the genomic 
location of the loxP target) on the incoming reporter gene. The ease and predictability 
of Cre-mediated single-copy transgene targeting suggests that this system would be 
beneficial for the large scale production of recombinant proteins because the Cre-loxP 
site-specific recombination system will provide a useful tool for the rapid generation of 
isogenic cell lines that should express reproducible levels of recombinant proteins. This 
is made possible because Cre can mediate the targeting of a single copy of transgenes 
to a pre-selected region in the chromosome which should eliminate extreme variability 
in expression levels (due to differing number of copies integrated into the genome and 
also from chromosomal "position effects") between individual clones isolated from a 
single transfection and therefore removing the need to screen large numbers of 
transformed cell lines for a suitable donor for recombinant protein expression. 
Future Work 
The work presented here shows that Cre-loxP site-specific recombination system can 
be used for both the in vitro and in vivo manipulation of transgenes. However, for the 
Cre-loxP system to be a useful tool for the reproducible high level expression of 
recombinant proteins in mammalian cells, the chromosomal region (containing a loxP 
site) to which the foreign gene is to be targeted must be favourable for gene 
expression. Thus a large number of cell lines each containing a single loxP site (linked 
to a reporter gene to monitor gene expression) must be screened in order to select cell 
lines where the loxP site had integrated into a favourable region for gene expression. 
Whilst the construction of CHO cell line containing a single loxP site for the targeting 
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event was successful, only three such cell lines were isolated when the loxP plasmid 
was transfected into CHO cells by electroporation. Although transfection by 
electroporation has been reported by Boggs et al., (1986) to produce high frequency 
(79%) of single copy integrants, the low frequency of single loxP transformants (7.5%) 
obtained could be due to the different cell line used here than that reported by Boggs el 
al.,. It would be informative to investigate the electroporation conditions used further; 
such as comparing voltage versus transformation frequency and exposing high number 
of CHO cells (109/ml) to relatively low concentrations of linearised DNA to improve 
the frequency of single copy integration. Other electroporation parameters such as 
pulse length, size of DNA and conditions of the cell membrane could also be 
investigated for efficient transfection. Alternatively, large numbers of independent 
transfections could be done to obtain more transfected cell lines with the likelihood of 
obtaining more cell lines containing single loxP sites. However this would be a 
laborious way to achieve large numbers of loxP cell lines. 
A more efficient way of constructing transformed cell lines containing single loxP sites 
could be the use a retrovirus vector mediated transfection. Retrovirus vectors (Palmer 
et al., 1987; Miller and Rosman, 1989) can be genetically manipulated by replacing 
their genes with a cDNA containing the loxP sequence. Retrovirus vectors have the 
advantage of high infectivity (- 100%) into a variety of cell types with the number of 
provirus being as low as one per cell. This may give rise to a high number of CIHO 
transformants with a corresponding high numbers of CHO cell lines containing a single 
loxP site integrated randomly throughout the chromosome. 
In order to improve the level of expression of a chromosomally integrated loxP 
plasmid, the loxP plasmid could be designed such that it is flanked by DNA elements 
known as MARs (Matrix attachment regions) or SARs (Scaffold attachment regions). 
These DNA elements act as matrices where chromatin loops of both interphase nuclei 
and metaphase chromosomes attach (Berenzney el al., 1974; Mirkovitch el al., 1984). 
However, these DNA elements are not only important for structural reasons as they 
have been shown to improve the expression levels of genes; Poljak et al., (1994) and 
Phi-Van cl al., (1990). For instance, in the SARs/CAT expression system described by 
Poljak et al., (1994), a SAR stimulatory effect of between 10-40 fold on CAT 
expression was observed when two minimal copies of Drosophila hsp70 or histone 
gene repeat SAR elements were used to flank an SV40 promoter-CAT reporter gene in 
a stable transfection. The SAR stimulatory effects however do not buffer the reporter 
gene from position effects, rather they consistently stimulate the average level of 
expression by over an order of magnitude and the effect appears not be tissue or gene- 
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specific. (There is contradicting evidence between the Poljak el at., report and others 
[Stief et al., 1989; Klehr et al., 1991] that the minimal Drosophila SARs confer 
position-independent expression). A drawback to the stimulatory effect of SARs is that 
they appear to be blocked by GC-rich sequences when placed between SARs and the 
reporter gene. 
Rather than random targeting of the loxP plasmid into mammalian cells to select for 
cell lines which have integrated the IoxP plasmid in a favourable region for gene 
expression, a loxP plasmid could be targeted to a transcriptionally active regions such 
as an immunoglobulin enhancer region (by homologous recombination) so that 
subsequent targeted event would favour the high level expression of transgcncs. 
However, this could only be applicable if the site-specific integration event is to be 
used for tissue-specific gene (e. g. Immunoglobulins) expression in the appropriate cell 
lines such as NSO. 
An alternative approach to enhance gene expression would be to construct a loxP 
vector flanked by sequences comprising locus control region (LCR). This vector can 
then be targeted to the chromosomal LCR by homologous recombination to alleviate 
variation in gene expression due to random integration. LCR is a genetic element that 
contains dominant regulatory sequences that specify position-independent expression. 
In the LCR/MEL expression system described by Needham et a!., (1995), the human 
globin LCR was used to drive high-level, integration and position-independent 
expression of heterologous cDNAs in murine erythroleukaemia (MEL) cells. A vector 
was constructed to contain the human LCR upstream of the foreign cDNA expression 
cassette, which utilises the human ß-globin promoter. This group expressed the human 
calcitonin receptor, a seven-transmembrane helix receptor, in this system achieving 
expression levels higher than previously achieved using an amplified CHO line and the 
baculovirus/insect cell system. Individual clones isolated following the use of LCR 
showed reproducible levels of gene expression. However, some studies have reported 
that the levels of expression obtained with the use of such LCR sequences arc not 
higher than obtained following random integration and extensive screening (Grosveld 
et al., 1987; Phi-Van et al., 1990). 
The Cre mediated site-specific recombination at loxP sites is reversible, and excision is 
kinetically favoured over bi-molecular integration, therefore Cre-mediated integration 
event is less efficient that the excision event. Furthermore, integrated products arc 
inherently unstable in the presence of the recombinase. For these reasons, it is 
important to deliver the Cre recombinase efficiently and transiently for intermolecular 
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(integration) event to occur. Various approaches have been applied to improve the 
efficiency of gene targeting that abolishes post-integration events: The use of transient 
cre expression plasmid or Crc protein has been described in this work and previously 
by Sauer and Henderson, (1990), Gu eta!., (1993), Baubonis and Sauer (1993). 
Another approach that could be used to abolish post-integration recombination would 
be insertional inactivation of cre. For instances, a promoterless loxP-neor (linked to the 
transgene) construct could be targeted to a transformed parental cell line containing a 
promoter-loxP-cre construct. The parental cell line would synthesis Crc, which would 
mediate the insertion of the targeting vector into the genomic loxP site to produce 
promoter-loxP-neo-loxP-cre linkage. Integration of loxP-neon would displace the 
promoter from the cre to terminate cre transcription and fuses the promoter to the 
neor gene to confer a neomycin resistance phenotype. This strategy has been tested in 
plants (Alberts et al., 1995). However constitutive expression of Cre could accumulate 
a large amount of the recombinase which could be slow to deplete. Alternatively or in 
addition, promoter displacement may fail to abolish Crc production completely, but 
may leave a residual level of de novo synthesis. Residual Cre activity could delete 
inserts flanked by wild-type loxP sites. However, this would not be a problem if mutant 
loxP sites (discussed above) are used. 
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Appendices 
Appendix 1: Nucleotide sequence coding for cre which is modified to include 
nuclear localisation sequence (NLS). The transcriptional initiation (ATG) and 
termination (TAG) codons are shown in bold and the NLS sequence is 
underlined. 
TCGACCATGa 
CCAAAATTTG 
AGAACCTGAT 
TGGAAAATGC 
GAATAACCGG 
TTCTATATCT 
TTGGGCCAGC 
TGACAGCAAT 
TTGATGCCGG 
TTCGACCAGG 
ACGTAATCTG 
CCGAAATTGC 
AGAATGTTAA 
TGTAGAGAAG 
TTTCCGTCTC 
GTCAGAAAAA 
TCGCGCCCTG 
CTAAGGATGA 
CGTGTCGGAG 
GATCATGCAA 
TCCGTAACCT 
GGCGATTAGC 
CCAAGAAGAA 
CCTGCATTAC 
GGACATGTTC 
TTCTGTCCGT 
AAATGGTTTC 
TCAGGCGCGC 
TAAACATGCT 
GCTGTTTCAC 
TGAACGTGCA 
TTCGTTCACT 
GCATTTCTGG 
CAGGATCAGG 
TCCATATTGG 
GCACTTAGCC 
TGGTGTAGCT 
ATGGTGTTGC 
GAAGGGATTT 
CTCTGGTCAG 
CCGCGCGAGA 
GCTGGTGGCT 
GGATAGTGAA 
CATTAACGCG 
GAGGAAGGTG 
CGGTCGATGC 
AGGGATCGCC 
TTGCCGGTCG 
CCGCAGAACC 
GGTCTGGCAG 
TCATCGTCGG 
TGGTTATGCG 
AAACAGGCTC 
CATGGAAAAT 
GGATTGCTTA 
GTTAAAGATA 
CAGAACGAAA 
TGGGGGTAAC 
GATGATCCGA 
CGCGCCATCT 
TTGAAGCAAC 
AGATACCTGG 
TATGGCCCGC 
GGACCAATGT 
ACAGGGGCAA 
TAAATGATTG 
TCCAATTTAC 
AACGAGTGAT 
AGGCGTTTTC 
TGGGCGGCAT 
TGAAGATGTT 
TAAAAACTAT 
TCCGGGCTGC 
GCGGATCCGA 
TAGCGTTCGA 
AGCGATCGCT 
TAACACCCTG 
TCTCACGTAC 
ACGCTGGTTA 
TAAACTGGTC 
ATAACTACCT 
GCCACCAGCC 
TCATCGATTG 
CCTGGTCTGG 
GCTGGAGTTT 
AAATATTGTC 
TGGTGCGCCT 
CTATAATTAG 
TGACCGTACA 
GAGGTTCGCA 
TGAGCATACC 
GGTGCAAGTT 
CGCGATTATC 
CCAGCAACAT 
CACGACCAAG 
AAAGAAAACG 
ACGCACTGAT 
GCCAGGATAT 
TTACGTATAG 
TGACGGTGGG 
GCACCGCAGG 
GAGCGATGGA 
GTTTTGCCGG 
AGCTATCAAC 
ATTTACGGCG 
ACACAGTGCC 
CAATACCGGA 
ATGAACTATA 
GCTGGAAGAT 
TTGATA 
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Appendix 2: Sequence of oligonucleotide primers (synthesised by II. Spence, 
WRL [now GWR&D]) used in either PCR or Sequencing reactions. 
CB1741: GACAAGAGATCTATGCCCAAGAAGAAGAGGAAGG 
CB1742: GACAAGAGATCTCTAATCGCCATCTTCCAGC 
CB 1741 anneals at the 5' end at position 7bp-28bp and CB 1742 anneals at the 3' end 
at position 1059bp-1041bp of the cre coding sequence (appendix 1). CB1741 and 
CB1742 were used in a PCR reaction to amplify cre gene from pMC1-Cre. The ATG 
initiation and the CTA (anti-sense) termination codons in CB 1741 and CB 1742 
respectively are in bold. The introduced 13g11I sites are underlined. 
BK59: CGTGTTTTAATACGCCGGACC 
BK59 anneals upstream of KpnI site at position 4967bp-4946bp in pAc116N1 (Figure 
3.3). BK59 and CB 1741 (above) were used in a PCR reaction to screen recombinant 
baculovirus. 
BK62: CATACCGTCCCACCATCGGG 
BK62 anneals upstream of BamHI site at position 5062bp-5082bp in pAcH6N 1 
(Figure 3.3). BK62 and CB 1742 (above) were used in a PCR reaction to screen 
recombinant baculovirus. 
B142: GACGTCGAATTCTTTCCATTCGCCATTCAGGCT 
B143: GACGTCAAGCTTGCGCAACGCAATTAATGTGA 
B 142 anneals at the 5' end at position 460bp-480bp, whilst B 143 anneals at the 3' end 
at position 940bp-920bp in pBluescript II KS (-) (Stratagene). B142 and B143 were 
used in a PCR reaction to amplify lacZ gene from ipBS KS II (section 3.6). The 
introduced EcoRI site in B 142 and HindIIl site in B 143 are underlined. 
CB2076: CATTATTATCATGACATTAACCT 
CB2076 anneals upstream of EcoRI site at position 4300bp-4323bp in pAT-lacZloxP2 
(fig 3.7). CB2076 was used in a sequencing reaction with template DNA from product 
A (Figure 3.8). 
234 
CB1736: GCTATTCTCGCAGGATCAGTCGACC 
CB1738: CCAGTTTGTCCTTCTTCTGCCCTTT 
CB1736 anneals upstream of the HindIII site at position 10663bp-10688bp whilst 
CB 1738 anneals downstream of the HindIIl site at position 263bp-288bp in pSAP- 
RDN (Figure 5.3a). CB 1736 and CB 1738 were used in a PCR reaction to confirm the 
presence of intact loxP site in transfected cells. 
CB1739: ATAATTCGCGTCTGGCCTTCCTGTA 
CB 1739 anneals upstream of the Cal site at position 3169bp-3194bp in pHM3 
(Figure 5.12). CB 1739 and CB 1736 (above) were used in a PCR reaction to confirm 
targeting event. 
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Appendix 3: Composition of Boehringer Mannheim restriction enzyme buffers 
A, B, L, M and II. 
Buffer 
Composition 
A B L M 11 
Tris acetate 33 - - - - 
Tris-HCI - 10 10 10 50 
Mg-acetate 10 - - - - 
MgC12 - 5 10 10 10 
K-acetate 66 - - - - 
NaCl - 100 - 50 100 
Dithioerythritol - - 1 1 1 
Dithiothreitol 0.5 - - - - 
2-Mercaptoethanol - I - - - 
pH at 370C 7.9 8.0 7.5 7.5 7.5 
Final concentration in nM (following 1: 10 dilution of lOx buffer). 
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Appendix 4: Oligonucleotide sequences synthesised (by It. Spence; WRL [now 
GWR&D]) as sense and antisense strands to correspond to loxt'; Frt; 1ox1'/IF rt 
hybrids. 
LoxP TAATATAACTTCGTATA ATGTATGC TATACGAAGTTATTAGG 
ATTATATTGAAGCATAT TACATACG ATATGCTTCAATAATCC 
Frt taatgaagttcctatac tttctaga gaataggaacttctagg 
attacttcaaggatatg aaagatct cttatccttgaagatcc 
LoxP/Frt hybrid 
(loxP spacer) TAATATAACTTCGTATA ATGTATGC gaataggaacttctagg 
ATTATATTGAAGCATAT TACATACG cttatccttgaagatcc 
LoxP/Frt hybrid 
(frt spacer) TAATATAACTTCGTATA 
ATTATATTGAAGCATAT 
tttctaga gaataggaacttctagg 
aaagatct cttatccttgaagatcc 
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Appendix 5: Lambda (? ) DNA Hind III digest ((: 11; CO 881. ) molecular weight 
size markers for agarose gel electrophoresis. The sizes of fragments (in base 
pairs) and their expected pattern following agarose gel separation are indicated 
below. 
/ 
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Appendix 6: 100 hp ladder ((: 1I ('O BRI. ) molecular weight size markers for 
agarose gel electrophoresis. The sizes of fragments (in base pairs) and their 
expected pattern following agarose gel separation are indicated below. 
ICJ) 
1500 
-600 
23 () 
Appendix 7: 1 kb ladder DNA (GIBCO BRI, ) molecular weight size markers 
for agarose gel electrophoresis. The sizes of fragments (in base pairs) and their 
expected pattern following agarose gel separation are indicated below. 
12 216 
11 198 
10 180 
9 162 
8 144 
7 126 
6 108 
5 090 ----__ 
4 072 ---ý 
3052 
2 U3(ß 
1 010 
1 018 
5(X/517 
344 
29 8 ----'- 
220 
201 
154 
134 
75 
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Appendix 8: Sea Blue (Noºvcx) molecular weight size markers for PAGE. 
The sizes of' proteins On Id)a) and Ilreir expected pattern following separation on 
a 10-20%, acry'lamiclt' gel are Indicated below. 
Protein Approx. mol. 
weight (kIa) 
myosin 250 
BSA 
- 
98 
glutamic dehydrogenase 64 
alcohol dehydrogenase 50 ,..... 
carbonic anhydrase 36 
myoglobin 30 m 
lysozyme 16 
aprotinin 6 
insulin, B chain 4 
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Appendix 9: The degenerate codes for DNA nucleotide sequences 
R=AorG 
Y=CorT 
M=AorC 
K=GorT 
S=GorC 
W=AorT 
H=AorTorC 
B=GorTorC 
G=GorAorT 
N=AorGorCorT 
V=GorAorC 
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